query_id stringlengths 24 420 | query_text stringlengths 46 525k | neighbor_rank int64 0 2 | neighbor_index int64 0 169k | distance float64 0 1.13 | url stringlengths 24 587 | crawl_date stringdate 2022-04-01 13:20:24 2022-09-19 05:17:15 | text stringlengths 45 362k |
|---|---|---|---|---|---|---|---|
https://www.daytondailynews.com/nation-world/live-updates-eu-chief-backs-asylum-for-russian-deserters/L5IWPJUUEBAKTHGFVA2N7DB4TA/ | LONDON — Ukrainian President Volodymyr Zelenskyy has accused Russia of using hunger as a weapon of war by deliberately targeting Ukraine’s essential food supplies.
In an address to Irish lawmakers Wednesday, Zelenskyy said Russian forces “are destroying things that are sustaining livelihoods” including food storage depots, blocking ports so Ukraine could not export food and “putting mines into the fields.”
“For them hunger is also a weapon, a weapon against us ordinary people,” he said, accusing Russia of “deliberately provoking a food crisis” in Ukraine, a major global producer of staples including wheat and sunflower oil.
He said it would have international ramifications, because “there will be a shortage of food and the prices will go up, and this is reality for the millions of people who are hungry, and it will be more difficult for them to feed their families.”
Zelenskyy spoke by video to a joint session of Ireland’s two houses of parliament, the latest in a string of international addresses he has used to rally support for Ukraine.
___
KEY DEVELOPMENTS IN THE RUSSIA-UKRAINE WAR:
— In Bucha, Ukraine, burned, piled bodies among latest horrors
— Russian setback in Kiev was memorable military failure
— Ukraine president Zelenskyy at UN accuses Russian military of war crimes
— EU proposes Russian coal ban in new sanctions
— US official: US, allies, to ban new investments in Russia
— Harvard students' site helping Ukraine refugees find housing
— Japan's top envoy brings back 20 Ukrainians from Poland
— Go to https://apnews.com/hub/russia-ukraine for more coverage
___
OTHER DEVELOPMENTS:
BRUSSELS — A senior European Union official says the bloc’s member countries should think about ways of offering asylum to Russian soldiers willing to desert Ukraine battlefields.
European Council president Charles Michel on Wednesday expressed his “outrage at crimes against humanity, against innocent civilians in Bucha and in many other cities.”
He called on Russian soldiers to disobey orders.
“If you want no part in killing your Ukrainian brothers and sisters, if you don’t want to be a criminal, drop your weapons, stop fighting, leave the battlefield,” Michel, who represents the bloc’s governments, said in a speech to the European Parliament
Endorsing an idea previously circulated by some EU lawmakers, Michel added that granting asylum to Russian deserters is “a valuable idea that should be pursued.”
___
ATHENS, Greece — Greece has joined a list of European countries expelling Russian diplomats, with the foreign ministry announcing on Wednesday it had declared 12 diplomats unwelcome.
The ministry said it had declared 12 members of Russian diplomatic and consular missions accredited to Greece as “personae non gratae,” and that the Russian ambassador had been informed.
It did not specify which diplomats were being expelled or state a reason, beyond citing that the move was carried out in accordance with international treaties.
___
NICOSIA, Cyprus — Cyprus’ foreign minister says a second batch of food, medicine and other articles dispatched to Ukraine is the most humanitarian aid the east Mediterranean island nation has ever sent abroad.
Foreign Minister Ioannis Kasoulides said Wednesday the batch weighing 215 metric tons (237 tons) was on its way to the war-torn country through the European Union’s civil protection mechanism. He valued it at more than 2 million euros ($2.2 million). It includes items such as tents and sleeping bags.
According to, Citizens’ Commissioner Panayiotis Sentonas told state broadcaster CyBC that contributions came from ordinary citizens, private businesses, the Cyprus Red Cross and the government.
___
BERLIN — Germany’s foreign minister has accused Russia of spreading disinformation to justify its war in Ukraine.
Foreign Minister Annalena Baerbock said Wednesday that “as Russian tanks destroy Ukrainian cities, the Kremlin’s propaganda machine is censoring news, restricting social media, spreading disinformation and punishing those who dare to speak the truth.”
She said the aim was “both clear and cynical: to demoralize the courageous people of Ukraine while keeping Russians in the dark.”
Baerbock spoke in a video message to a conference on disinformation organized by her ministry at which participants also cited examples of Russian efforts to stoke resentment in Europe against refugees from Ukraine.
___
LONDON — Intel says it is suspending all its business operations in Russia, becoming the latest foreign company to leave because of Moscow’s war in Ukraine.
“Effective immediately, we have suspended all business operations in Russia,” the U.S. chipmaker said late Wednesday.
The company had already suspended shipments to customers in Russia and neighboring ally Belarus after the war broke out.
Intel said it’s working to support its 1,200 employees in Russia and has put in place “business continuity measures” to reduce disruption to its global operations, though it didn’t provide details.
“Intel continues to join the global community in condemning Russia’s war against Ukraine and calling for a swift return to peace,” it said in a statement.
___
BEIJING — China says the reports and images of civilian deaths in the Ukrainian town of Bucha are “deeply disturbing” and is calling for an investigation.
Foreign Ministry spokesperson Zhao Lijian said Wednesday that China supports all initiatives and measures “conducive to alleviating the humanitarian crisis” in the country and is “ready to continue to work together with the international community to prevent any harm to civilians.”
The killings in Bucha may serve to put further pressure on Beijing over its largely pro-Russian stance and attempts to guide public opinion over the war.
China has called for talks while refusing to criticize Russia over its invasion. It opposes economic sanctions on Moscow and blames Washington and NATO for provoking the war and fueling the conflict by sending arms to Ukraine.
Zhao’s remarks echo those the previous day of China’s ambassador to the United Nations, Zhang Jun, who called for an investigation, describing the reports and images of civilian deaths in Bucha as “deeply disturbing.”
___
VATICAN CITY — Pope Francis has kissed a battered Ukrainian flag that was brought to him from the Ukrainian city of Bucha and called again for an end to the war.
Francis welcomed a half-dozen Ukrainian children up to the stage of the Vatican audience hall at the end of his Wednesday general audience and gave them each a giant chocolate Easter egg. He urged prayers for them and for all Ukrainians.
“The recent news from the war in Ukraine, instead of bringing relief and hope, brought testimony of new atrocities, like the massacre in Bucha, even more horrendous cruelty carried out against civilians, defenseless women and children," the pope said. "They are victims whose innocent blood cries up to the sky and implores that this war be stopped, and that the weapons be silenced. Stop disseminating war and destruction.”
He told the crowd: “These children had to flee to arrive in a safe place. This is the fruit of war.”
The pontiff held up a grimy Ukrainian flag that he said had arrived the previous day at the Vatican from Bucha, where evidence has emerged of what appears to be intentional killings of civilians during the city’s occupation by Russian troops.
Kissing it, he said: “This flag comes from the war, from that martyred city Bucha ... Let us not forget them. Let us not forget the people of Ukraine.”
___
BUDAPEST, Hungary — Hungary’s Foreign Ministry summoned the Ukrainian ambassador on Wednesday after days of the two countries’ officials trading barbs over Hungary’s position on the war.
Hungarian Foreign Minister Peter Szijjarto wrote in a social media post on Wednesday that “we condemn military aggression, we stand by Ukraine’s sovereignty,” but that “this is not our war, so we want to and will stay out of it.”
Hungary’s government has refused to supply weapons to Ukraine or allow their transfer across the Hungarian-Ukrainian border, and has fought against applying sanctions on Russian energy imports.
That position has prompted criticisms of Hungary’s government by Ukrainian President Volodymyr Zelenksyy, who on Monday said in an address on Ukrainian television that Hungarian Prime Minister Viktor Orban would need to choose between Moscow and “the other world” of the West.
Orban, who won a landslide victory in Hungarian elections on Sunday, in a victory speech depicted Zelenskyy as one of the opponents he and his right-wing party had defeated.
On Tuesday, Szijjarto called on Ukrainian leaders to “stop insulting Hungary and to take note of the will of the Hungarian people.”
___
COPENHAGEN, Denmark — Norway is beefing up its police and intelligence work, chiefly in the northern part of the country, which has a nearly 200-kilometer (124-mile) land border with Russia, and wants to spend 100 million kroner ($11.5 million) on it.
Norway’s domestic intelligence service considers the intelligence threat from Russia in the Scandinavian country to have increased, Justice Minister Emilie Enger Mehl said Wednesday.
The money would be spent on staff and equipment. The government also wants to exert more control over Svalbard, a Norwegian archipelago in the Arctic with a Russian settlement. Under a 1920 treaty, Norway has sovereignty over Svalbard, but other signatory countries have rights to exploit its natural resources — coal.
___
The governor of Russia’s Kursk region on the border with Ukraine said Wednesday that Russian border guards were fired at with mortars on Tuesday.
Governor Roman Starovoit said on the messaging app Telegram that the border guards returned fire and that there were “no casualties or destruction” on the Russian side as a result of the incident.
The Ukrainian military has not yet commented on the allegation, and it could not be independently verified.
___
LONDON — British defense officials say 160,000 people remain trapped in the besieged city of Mariupol, where Russian airstrikes and heavy fighting are continuing.
The Ministry of Defense said in an intelligence update Wednesday that those in the city have “no light, communication, medicine, heat or water.” It accused Russian forces of deliberately preventing humanitarian access, “likely to pressure defenders to surrender.”
Repeated attempts by the International Committee of the Red Cross to get a humanitarian convoy into the southern port city have failed. Ukraine’s Deputy Prime Minister Iryna Vereshchuk said Russian forces stopped buses accompanied by Red Cross workers from traveling to Mariupol, which had a pre-war population of about 400,000. She said Russian troops allowed 1,496 civilians to leave the Sea of Azov port on Tuesday.
___
ANKARA, Turkey — Turkey says it shares the pain of the Ukrainian people over the “horrifying” images that emerged from towns near Kyiv and is calling for an independent investigation.
A statement from Turkey’s Foreign Ministry on Wednesday stopped short, however, of blaming Russia or describing the atrocities as a war crime.
Turkey has been measured in its criticism of Russia as it tries to balance its close relations with both Moscow and Kyiv. The country has hosted officials from the two countries for talks in a bid to end the war.
“The images of the massacre ... are horrifying and sad for humanity. We share the pain of the Ukrainian people,” the statement read.
“The targeting of innocent civilians is unacceptable. It is our basic expectation that the issue is subjected to an independent investigation, that those responsible are identified and are held accountable,” it said.
Scenes that have emerged from Bucha, Irpin and other Ukrainian towns liberated by Ukrainian forces have led to accusations of war crimes and demands for tougher sanctions against Russia.
The ministry statement said Turkey would continue its efforts to end such “shameful scenes for humanity and to ensure peace as soon as possible.”
___
LVIV, Ukraine - Russian forces overnight struck a fuel depot and a factory in Ukraine’s Dnipropetrovsk region, and the number of casualties remains unclear, the region’s Governor Valentyn Reznichenko said Wednesday on the Telegram messaging app.
“The night was alarming and difficult. The enemy attacked our area from the air and hit the oil depot and one of the plants. The oil depot with fuel was destroyed. Rescuers are still putting out the flames at the plant. There is a strong fire,” Reznichenko wrote.
In the eastern Luhansk region, Tuesday’s shelling of Rubizhne city killed one and injured five more, Governor Serhiy Haidai said Wednesday on Telegram.
The Russian military continues to focus its efforts on preparing for an offensive in Ukraine’s east, according to a Wednesday morning update by Ukraine’s General Staff, with the aim “to establish complete control over the territory of Donetsk and Luhansk regions.”
Parts of the two regions have been under control of Russia-backed rebels since 2014 and are recognized by Moscow as independent states.
___
BUCHAREST, Romania — Police in the Romanian capital say a car has crashed into the gate of the Russian Embassy, bursting into flames and killing the driver.
Police in Bucharest say the sedan rammed into the gate at about 6 a.m. Wednesday but did not enter the embassy compound.
Video of the aftermath showed the car engulfed in flames as security personnel ran through the area.
According to police, firefighters who arrived at the scene were able to put the fire out but the driver died at the scene.
There was no immediate information on a possible motive or other details.
___
WASHINGTON — President Joe Biden approved a $100 million transfer of Javelin anti-armor missiles to Ukraine on Tuesday, according to an administration official.
The transfer brings the total of U.S. military assistance for Ukraine to $2.4 billion since Biden took office last January.
The White House announced late Tuesday that Biden approved the assistance, which is funded as part of a broader $13.6 billion in aid for Ukraine approved by Congress last month after Russia’s invasion.
The administration official confirmed that it was for a transfer of the Javelin missiles, which have been requested by the Ukrainian military to combat Russian armor.
The official spoke to The Associated Press on the condition of anonymity to discuss the matter.
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy said French President Emmanuel Macron has agreed to provide technical and expert support for an investigation into crimes committed by Russian troops in Bucha and elsewhere.
Zelenskyy said Tuesday that he also asked Macron to help the people trapped in the besieged southern city of Mariupol.
In an interview with Turkey’s Haberturk television in Kyiv, Zelenskyy accused Russia of trying to hide its actions in Mariupol and didn’t want humanitarian aid to enter the city “until they clean it all up.”
Zelenskyy said he also expects European Commission President Ursula von der Leyen and EU foreign policy chief Josep Borrell to visit Kyiv soon.
__
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy says Russian forces still are trying to push deep into Ukraine in the east, but the Ukrainian army is holding them back.
In his daily night-time video address to the nation late Tuesday, Zelenskyy said Ukraine was aware that Russia was gathering up reinforcements for another offensive.
Zelenskyy also said Ukraine is outnumbered both in troops and equipment.
“We don’t have a choice – the fate of our land and of our people is being decided,” he said. “We know what we are fighting for. And we will do everything to win.”
__
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy said late Tuesday that he and Western leaders have discussed a new round of sanctions against Russia.
“After what the world saw in Bucha, the sanctions against Russia must be commensurate with the gravity of the war crimes committed by the occupiers,” Zelenskyy said in his daily night-time video address to the nation.
In coordination with the European Union and Group of Seven nations, the U.S. will roll out more sanctions against Russia on Wednesday. That reportedly will include a ban on all new investment in the country.
Also, the EU’s executive branch has proposed a ban on coal imports from Russia in what would be the first time the 27-nation bloc has sanctioned the country’s lucrative energy industry over the war.
The coal imports amount to an estimated 4 billion euros ($4.4 billion) per year.
__
KYIV, Ukraine — A Ukrainian official says Russian troops have allowed 1,496 civilians to evacuate the besieged city of Mariupol by private vehicle but blocked a convoy of evacuation buses from entering.
Deputy Prime Minister Iryna Vereshchuk said the Russian forces stopped the buses accompanied by workers of the International Committee of the Red Cross from traveling to the Sea of Azov port on Tuesday. The civilians who were able to leave in their personal vehicles traveled to Zaporizhzhia.
Mariupol has been besieged by Russian forces for a month, cut off from food, water and energy supplies and has faced relentless artillery barrage and air raids that killed thousands.
__
LVIV, Ukraine — A regional official in western Ukraine says a Russian missile hit fertilizer tanks, polluting ground water.
Ternopil region Gov. Volodymyr Trush said Tuesday that the Russian missile strike destroyed six reservoirs filled with fertilizers, resulting in an ammonia leak into ground water and the Ikva River.
Authorities are advising residents not to use water wells and stop fishing and officials have organized drinking water deliveries. Trush say the environmental situation is expected to stabilize in a few days.
___
MOSCOW — The Russian foreign minister is accusing Ukraine's government of sabotaging talks on ending the fighting in Ukraine, warning that Moscow will not “play cat and mouse.”
Sergey Lavrov specifically warns that Moscow will not accept the Ukrainian demand that a prospective peace agreement include an immediate pullout of Russian troops to be followed by a referendum in Ukraine on accepting the deal.
In televised remarks Tuesday, he says that if the peace deal fails to win approval in a referendum, a new deal will have to be negotiated. He says that “we don’t want to play such cat and mouse.”
Lavrov pointed at a 2015 peace deal for eastern Ukraine signed in Minsk, Belarus, that was brokered by France and Germany but never implemented. He says that “we don’t want a repeat of the Minsk agreements.”
He also says Ukraine is “sabotaging” the talks by stonewalling Russian demands for “demilitarization” and “denazification” of the country.
The tough statements from Lavrov contrasted with optimistic signals made by both Ukrainian and Russian representatives after the latest round of talks in Istanbul, Turkey, on March 29.
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: John Minchillo
Credit: John Minchillo
Credit: Nariman El-Mofty
Credit: Nariman El-Mofty
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: Nariman El-Mofty
Credit: Nariman El-Mofty
Credit: Sergei Grits
Credit: Sergei Grits
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: Andriy Andriyenko
Credit: Andriy Andriyenko
Credit: Rodrigo Abd
Credit: Rodrigo Abd
Credit: Alessandra Tarantino
Credit: Alessandra Tarantino | 2 | 6,243 | 0 | https://www.springfieldnewssun.com/nation-world/live-updates-eu-chief-backs-asylum-for-russian-deserters/L5IWPJUUEBAKTHGFVA2N7DB4TA/ | 2022-04-06 11:07:14+00:00 | LONDON — Ukrainian President Volodymyr Zelenskyy has accused Russia of using hunger as a weapon of war by deliberately targeting Ukraine’s essential food supplies.
In an address to Irish lawmakers Wednesday, Zelenskyy said Russian forces “are destroying things that are sustaining livelihoods” including food storage depots, blocking ports so Ukraine could not export food and “putting mines into the fields.”
“For them hunger is also a weapon, a weapon against us ordinary people,” he said, accusing Russia of “deliberately provoking a food crisis” in Ukraine, a major global producer of staples including wheat and sunflower oil.
He said it would have international ramifications, because “there will be a shortage of food and the prices will go up, and this is reality for the millions of people who are hungry, and it will be more difficult for them to feed their families.”
Zelenskyy spoke by video to a joint session of Ireland’s two houses of parliament, the latest in a string of international addresses he has used to rally support for Ukraine.
___
KEY DEVELOPMENTS IN THE RUSSIA-UKRAINE WAR:
— In Bucha, Ukraine, burned, piled bodies among latest horrors
— Russian setback in Kiev was memorable military failure
— Ukraine president Zelenskyy at UN accuses Russian military of war crimes
— EU proposes Russian coal ban in new sanctions
— US official: US, allies, to ban new investments in Russia
— Harvard students' site helping Ukraine refugees find housing
— Japan's top envoy brings back 20 Ukrainians from Poland
— Go to https://apnews.com/hub/russia-ukraine for more coverage
___
OTHER DEVELOPMENTS:
BRUSSELS — A senior European Union official says the bloc’s member countries should think about ways of offering asylum to Russian soldiers willing to desert Ukraine battlefields.
European Council president Charles Michel on Wednesday expressed his “outrage at crimes against humanity, against innocent civilians in Bucha and in many other cities.”
He called on Russian soldiers to disobey orders.
“If you want no part in killing your Ukrainian brothers and sisters, if you don’t want to be a criminal, drop your weapons, stop fighting, leave the battlefield,” Michel, who represents the bloc’s governments, said in a speech to the European Parliament
Endorsing an idea previously circulated by some EU lawmakers, Michel added that granting asylum to Russian deserters is “a valuable idea that should be pursued.”
___
ATHENS, Greece — Greece has joined a list of European countries expelling Russian diplomats, with the foreign ministry announcing on Wednesday it had declared 12 diplomats unwelcome.
The ministry said it had declared 12 members of Russian diplomatic and consular missions accredited to Greece as “personae non gratae,” and that the Russian ambassador had been informed.
It did not specify which diplomats were being expelled or state a reason, beyond citing that the move was carried out in accordance with international treaties.
___
NICOSIA, Cyprus — Cyprus’ foreign minister says a second batch of food, medicine and other articles dispatched to Ukraine is the most humanitarian aid the east Mediterranean island nation has ever sent abroad.
Foreign Minister Ioannis Kasoulides said Wednesday the batch weighing 215 metric tons (237 tons) was on its way to the war-torn country through the European Union’s civil protection mechanism. He valued it at more than 2 million euros ($2.2 million). It includes items such as tents and sleeping bags.
According to, Citizens’ Commissioner Panayiotis Sentonas told state broadcaster CyBC that contributions came from ordinary citizens, private businesses, the Cyprus Red Cross and the government.
___
BERLIN — Germany’s foreign minister has accused Russia of spreading disinformation to justify its war in Ukraine.
Foreign Minister Annalena Baerbock said Wednesday that “as Russian tanks destroy Ukrainian cities, the Kremlin’s propaganda machine is censoring news, restricting social media, spreading disinformation and punishing those who dare to speak the truth.”
She said the aim was “both clear and cynical: to demoralize the courageous people of Ukraine while keeping Russians in the dark.”
Baerbock spoke in a video message to a conference on disinformation organized by her ministry at which participants also cited examples of Russian efforts to stoke resentment in Europe against refugees from Ukraine.
___
LONDON — Intel says it is suspending all its business operations in Russia, becoming the latest foreign company to leave because of Moscow’s war in Ukraine.
“Effective immediately, we have suspended all business operations in Russia,” the U.S. chipmaker said late Wednesday.
The company had already suspended shipments to customers in Russia and neighboring ally Belarus after the war broke out.
Intel said it’s working to support its 1,200 employees in Russia and has put in place “business continuity measures” to reduce disruption to its global operations, though it didn’t provide details.
“Intel continues to join the global community in condemning Russia’s war against Ukraine and calling for a swift return to peace,” it said in a statement.
___
BEIJING — China says the reports and images of civilian deaths in the Ukrainian town of Bucha are “deeply disturbing” and is calling for an investigation.
Foreign Ministry spokesperson Zhao Lijian said Wednesday that China supports all initiatives and measures “conducive to alleviating the humanitarian crisis” in the country and is “ready to continue to work together with the international community to prevent any harm to civilians.”
The killings in Bucha may serve to put further pressure on Beijing over its largely pro-Russian stance and attempts to guide public opinion over the war.
China has called for talks while refusing to criticize Russia over its invasion. It opposes economic sanctions on Moscow and blames Washington and NATO for provoking the war and fueling the conflict by sending arms to Ukraine.
Zhao’s remarks echo those the previous day of China’s ambassador to the United Nations, Zhang Jun, who called for an investigation, describing the reports and images of civilian deaths in Bucha as “deeply disturbing.”
___
VATICAN CITY — Pope Francis has kissed a battered Ukrainian flag that was brought to him from the Ukrainian city of Bucha and called again for an end to the war.
Francis welcomed a half-dozen Ukrainian children up to the stage of the Vatican audience hall at the end of his Wednesday general audience and gave them each a giant chocolate Easter egg. He urged prayers for them and for all Ukrainians.
“The recent news from the war in Ukraine, instead of bringing relief and hope, brought testimony of new atrocities, like the massacre in Bucha, even more horrendous cruelty carried out against civilians, defenseless women and children," the pope said. "They are victims whose innocent blood cries up to the sky and implores that this war be stopped, and that the weapons be silenced. Stop disseminating war and destruction.”
He told the crowd: “These children had to flee to arrive in a safe place. This is the fruit of war.”
The pontiff held up a grimy Ukrainian flag that he said had arrived the previous day at the Vatican from Bucha, where evidence has emerged of what appears to be intentional killings of civilians during the city’s occupation by Russian troops.
Kissing it, he said: “This flag comes from the war, from that martyred city Bucha ... Let us not forget them. Let us not forget the people of Ukraine.”
___
BUDAPEST, Hungary — Hungary’s Foreign Ministry summoned the Ukrainian ambassador on Wednesday after days of the two countries’ officials trading barbs over Hungary’s position on the war.
Hungarian Foreign Minister Peter Szijjarto wrote in a social media post on Wednesday that “we condemn military aggression, we stand by Ukraine’s sovereignty,” but that “this is not our war, so we want to and will stay out of it.”
Hungary’s government has refused to supply weapons to Ukraine or allow their transfer across the Hungarian-Ukrainian border, and has fought against applying sanctions on Russian energy imports.
That position has prompted criticisms of Hungary’s government by Ukrainian President Volodymyr Zelenksyy, who on Monday said in an address on Ukrainian television that Hungarian Prime Minister Viktor Orban would need to choose between Moscow and “the other world” of the West.
Orban, who won a landslide victory in Hungarian elections on Sunday, in a victory speech depicted Zelenskyy as one of the opponents he and his right-wing party had defeated.
On Tuesday, Szijjarto called on Ukrainian leaders to “stop insulting Hungary and to take note of the will of the Hungarian people.”
___
COPENHAGEN, Denmark — Norway is beefing up its police and intelligence work, chiefly in the northern part of the country, which has a nearly 200-kilometer (124-mile) land border with Russia, and wants to spend 100 million kroner ($11.5 million) on it.
Norway’s domestic intelligence service considers the intelligence threat from Russia in the Scandinavian country to have increased, Justice Minister Emilie Enger Mehl said Wednesday.
The money would be spent on staff and equipment. The government also wants to exert more control over Svalbard, a Norwegian archipelago in the Arctic with a Russian settlement. Under a 1920 treaty, Norway has sovereignty over Svalbard, but other signatory countries have rights to exploit its natural resources — coal.
___
The governor of Russia’s Kursk region on the border with Ukraine said Wednesday that Russian border guards were fired at with mortars on Tuesday.
Governor Roman Starovoit said on the messaging app Telegram that the border guards returned fire and that there were “no casualties or destruction” on the Russian side as a result of the incident.
The Ukrainian military has not yet commented on the allegation, and it could not be independently verified.
___
LONDON — British defense officials say 160,000 people remain trapped in the besieged city of Mariupol, where Russian airstrikes and heavy fighting are continuing.
The Ministry of Defense said in an intelligence update Wednesday that those in the city have “no light, communication, medicine, heat or water.” It accused Russian forces of deliberately preventing humanitarian access, “likely to pressure defenders to surrender.”
Repeated attempts by the International Committee of the Red Cross to get a humanitarian convoy into the southern port city have failed. Ukraine’s Deputy Prime Minister Iryna Vereshchuk said Russian forces stopped buses accompanied by Red Cross workers from traveling to Mariupol, which had a pre-war population of about 400,000. She said Russian troops allowed 1,496 civilians to leave the Sea of Azov port on Tuesday.
___
ANKARA, Turkey — Turkey says it shares the pain of the Ukrainian people over the “horrifying” images that emerged from towns near Kyiv and is calling for an independent investigation.
A statement from Turkey’s Foreign Ministry on Wednesday stopped short, however, of blaming Russia or describing the atrocities as a war crime.
Turkey has been measured in its criticism of Russia as it tries to balance its close relations with both Moscow and Kyiv. The country has hosted officials from the two countries for talks in a bid to end the war.
“The images of the massacre ... are horrifying and sad for humanity. We share the pain of the Ukrainian people,” the statement read.
“The targeting of innocent civilians is unacceptable. It is our basic expectation that the issue is subjected to an independent investigation, that those responsible are identified and are held accountable,” it said.
Scenes that have emerged from Bucha, Irpin and other Ukrainian towns liberated by Ukrainian forces have led to accusations of war crimes and demands for tougher sanctions against Russia.
The ministry statement said Turkey would continue its efforts to end such “shameful scenes for humanity and to ensure peace as soon as possible.”
___
LVIV, Ukraine - Russian forces overnight struck a fuel depot and a factory in Ukraine’s Dnipropetrovsk region, and the number of casualties remains unclear, the region’s Governor Valentyn Reznichenko said Wednesday on the Telegram messaging app.
“The night was alarming and difficult. The enemy attacked our area from the air and hit the oil depot and one of the plants. The oil depot with fuel was destroyed. Rescuers are still putting out the flames at the plant. There is a strong fire,” Reznichenko wrote.
In the eastern Luhansk region, Tuesday’s shelling of Rubizhne city killed one and injured five more, Governor Serhiy Haidai said Wednesday on Telegram.
The Russian military continues to focus its efforts on preparing for an offensive in Ukraine’s east, according to a Wednesday morning update by Ukraine’s General Staff, with the aim “to establish complete control over the territory of Donetsk and Luhansk regions.”
Parts of the two regions have been under control of Russia-backed rebels since 2014 and are recognized by Moscow as independent states.
___
BUCHAREST, Romania — Police in the Romanian capital say a car has crashed into the gate of the Russian Embassy, bursting into flames and killing the driver.
Police in Bucharest say the sedan rammed into the gate at about 6 a.m. Wednesday but did not enter the embassy compound.
Video of the aftermath showed the car engulfed in flames as security personnel ran through the area.
According to police, firefighters who arrived at the scene were able to put the fire out but the driver died at the scene.
There was no immediate information on a possible motive or other details.
___
WASHINGTON — President Joe Biden approved a $100 million transfer of Javelin anti-armor missiles to Ukraine on Tuesday, according to an administration official.
The transfer brings the total of U.S. military assistance for Ukraine to $2.4 billion since Biden took office last January.
The White House announced late Tuesday that Biden approved the assistance, which is funded as part of a broader $13.6 billion in aid for Ukraine approved by Congress last month after Russia’s invasion.
The administration official confirmed that it was for a transfer of the Javelin missiles, which have been requested by the Ukrainian military to combat Russian armor.
The official spoke to The Associated Press on the condition of anonymity to discuss the matter.
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy said French President Emmanuel Macron has agreed to provide technical and expert support for an investigation into crimes committed by Russian troops in Bucha and elsewhere.
Zelenskyy said Tuesday that he also asked Macron to help the people trapped in the besieged southern city of Mariupol.
In an interview with Turkey’s Haberturk television in Kyiv, Zelenskyy accused Russia of trying to hide its actions in Mariupol and didn’t want humanitarian aid to enter the city “until they clean it all up.”
Zelenskyy said he also expects European Commission President Ursula von der Leyen and EU foreign policy chief Josep Borrell to visit Kyiv soon.
__
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy says Russian forces still are trying to push deep into Ukraine in the east, but the Ukrainian army is holding them back.
In his daily night-time video address to the nation late Tuesday, Zelenskyy said Ukraine was aware that Russia was gathering up reinforcements for another offensive.
Zelenskyy also said Ukraine is outnumbered both in troops and equipment.
“We don’t have a choice – the fate of our land and of our people is being decided,” he said. “We know what we are fighting for. And we will do everything to win.”
__
LVIV, Ukraine — Ukrainian President Volodymyr Zelenskyy said late Tuesday that he and Western leaders have discussed a new round of sanctions against Russia.
“After what the world saw in Bucha, the sanctions against Russia must be commensurate with the gravity of the war crimes committed by the occupiers,” Zelenskyy said in his daily night-time video address to the nation.
In coordination with the European Union and Group of Seven nations, the U.S. will roll out more sanctions against Russia on Wednesday. That reportedly will include a ban on all new investment in the country.
Also, the EU’s executive branch has proposed a ban on coal imports from Russia in what would be the first time the 27-nation bloc has sanctioned the country’s lucrative energy industry over the war.
The coal imports amount to an estimated 4 billion euros ($4.4 billion) per year.
__
KYIV, Ukraine — A Ukrainian official says Russian troops have allowed 1,496 civilians to evacuate the besieged city of Mariupol by private vehicle but blocked a convoy of evacuation buses from entering.
Deputy Prime Minister Iryna Vereshchuk said the Russian forces stopped the buses accompanied by workers of the International Committee of the Red Cross from traveling to the Sea of Azov port on Tuesday. The civilians who were able to leave in their personal vehicles traveled to Zaporizhzhia.
Mariupol has been besieged by Russian forces for a month, cut off from food, water and energy supplies and has faced relentless artillery barrage and air raids that killed thousands.
__
LVIV, Ukraine — A regional official in western Ukraine says a Russian missile hit fertilizer tanks, polluting ground water.
Ternopil region Gov. Volodymyr Trush said Tuesday that the Russian missile strike destroyed six reservoirs filled with fertilizers, resulting in an ammonia leak into ground water and the Ikva River.
Authorities are advising residents not to use water wells and stop fishing and officials have organized drinking water deliveries. Trush say the environmental situation is expected to stabilize in a few days.
___
MOSCOW — The Russian foreign minister is accusing Ukraine's government of sabotaging talks on ending the fighting in Ukraine, warning that Moscow will not “play cat and mouse.”
Sergey Lavrov specifically warns that Moscow will not accept the Ukrainian demand that a prospective peace agreement include an immediate pullout of Russian troops to be followed by a referendum in Ukraine on accepting the deal.
In televised remarks Tuesday, he says that if the peace deal fails to win approval in a referendum, a new deal will have to be negotiated. He says that “we don’t want to play such cat and mouse.”
Lavrov pointed at a 2015 peace deal for eastern Ukraine signed in Minsk, Belarus, that was brokered by France and Germany but never implemented. He says that “we don’t want a repeat of the Minsk agreements.”
He also says Ukraine is “sabotaging” the talks by stonewalling Russian demands for “demilitarization” and “denazification” of the country.
The tough statements from Lavrov contrasted with optimistic signals made by both Ukrainian and Russian representatives after the latest round of talks in Istanbul, Turkey, on March 29.
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: John Minchillo
Credit: John Minchillo
Credit: Nariman El-Mofty
Credit: Nariman El-Mofty
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: Nariman El-Mofty
Credit: Nariman El-Mofty
Credit: Sergei Grits
Credit: Sergei Grits
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Felipe Dana
Credit: Vadim Ghirda
Credit: Vadim Ghirda
Credit: Andriy Andriyenko
Credit: Andriy Andriyenko
Credit: Rodrigo Abd
Credit: Rodrigo Abd
Credit: Alessandra Tarantino
Credit: Alessandra Tarantino |
https://www.devonlive.com/news/devon-news/gallery/music-entertainment-mark-special-night-6906090 | Music and entertainment mark special night for boy in the tent Max Woosey
The Pride of Britain winner has so far raised more than £700,000
Pride of Britain winners have joined Max Woosey for a special celebration to mark his two years sleeping in a tent. Max Woosey’s Big Camp Out took to Lobb Field in Braunton on Saturday, March 26 to celebrate his achievement in raising £700,000 for the North Devon Hospice.
More than 100 people came together to enjoy food and drink, as well as music provided on stage by local talent. Max was joined by Harmonie-Rose Allen, the brave seven-year-old who won a Child of Courage Award after losing her limbs to meningitis and best pals Hughie Higginson, 10, and Freddie Xavi, 11 – who won a Young Fundraiser accolade after raising more than £200,000 for Royal Manchester Children’s Hospital Charity.
Tilly Lockey, who is known for her bionic arms and was the champion of the CBBC series Got What it Takes? entertained, and was joined by other singers include Chloe Marie Aston and solo artist Yazzy. After the entertainment had finished, Pride of Britain host Carol Vorderman also visited.
Max, 12, was initially inspired by a family friend who had been helped by the hospice. He has been through 15 tents so far and has no intention on stopping. He said: “Tonight, is Max’s Big Camp Out and it’s absolutely amazing. We’re all having a good time, and it’s lovely to see the stage full of music, see people enjoying themselves, and socialising, and everyone together.
“I never thought anything like this would happen. It’s been a great experience and great fun. Thanks to everyone who has supported me over the years including North Devon Hospice who have been amazing in their support of me throughout the two years. I can’t thank them enough for the work they do. It’s fantastic to see them here tonight.
“I have no plans to stop sleeping in my tent. Hopefully I’ll be able to go on forever.”
He apologised to those who joined him for the Big Camp Out adding: “I hope nobody will be woken up because my parents snore a lot.”
Stephen Roberts, chief executive of North Devon Hospice added: “I think Max deserves a celebration like this; two years in a tent is phenomenal. I don’t think he’ll ever realise what a difference that money will make. We were all at the start wondering how far this would go, but I don’t think anyone thought it would be two years and £700,000 later. He’s a legend and he deserves every accolade he’s got. We are all so proud of him.
“Like every organisation and particularly for charities, our income turned off overnight. Our shops were closed, fundraising events were shut down, so the fact that timing is everything, Max stepped up and the money he has raised has directly paid for all our community nursing team. You can tangibly see the difference he’s making to local families here in North Devon.” | 0 | 68,103 | 0.766356 | https://www.devonlive.com/news/local-news/devons-tent-boy-max-woosey-7061209 | 2022-05-11 04:23:03+00:00 | A Devon boy has received the British Empire Medal after spending more than two years sleeping in a tent for charity. Twelve-year-old Max Woosey is among 11 Devon residents in the Queen’s New Year’s Honours who received MBEs and BEMs from Her Majesty’s representative in Devon, Lord Lieutenant David Fursdon, in a ceremony at the Royal Marines Commando Training Centre in Lympstone last week.
“It feels absolutely incredible to be awarded this,” said Max, from Braunton, who has raised over £640,000 for the North Devon Hospice since his marathon camp started. The idea came about when a tent was gifted to him by his elderly neighbour and family friend Rick Abbott, just before he died in 2020.
Max promised him he would have his own adventures with it and has stayed true to his word, spending every night in the tent since March that year, including stays at London Zoo and the garden of 10 Downing Street. Speaking at the award ceremony, Max added: “I never thought [sleeping in the tent] would last this long. It’s been an incredible experience though, and I’ve not regretted any of it. I’m so grateful to everyone who has donated.”
Read more:Man detained after armed police called to Torquay town centre
His fundraising efforts have so far raised enough money to fund 16 community nurses for North Devon Hospice. When asked what’s kept him going, especially during bad weather, Max said: “Knowing that the money was going to such a good cause.” Also attending the ceremony and receiving awards were:
Andrew Willard, Plymouth, who received a Member of the British Empire, MBE, for services to HM Prison and Probation Service.
Verna Pollard, Plymouth, a foster carer who received an MBE for services to children.
Dr Miles Joyner, Exeter, Founder of the Exeter Leukaemia Fund, who received an MBE for services to people suffering from blood cancer in Devon.
Anne Muriel Stapleton, Plymouth, who received a British Empire Medal, BEM, for voluntary service to Young People.
Janet Webber, Sidmouth, Director of Development for The Mission to Seafarers, who received a BEM for services to women in the international maritime sector.
Emma Jones, Plymouth, who received a BEM for services to the community in Plymouth during covid.
Gerald Millington, Otterton, who received a BEM for services to local history in Devon and Hertfordshire.
Jill Diprose, Dawlish, who received a BEM as Founder of ‘Activities Interests Music Support’, for services to families of children with special needs in Dawlish.
Brian Stanley Smith, Newton Abbot, who received a BEM for services to the community in Newton Abbot, particularly during covid.
Lt Cdr Louise Moxworthy, from Exeter, who received the Royal Red Cross (Second Class) ARRC – a military decoration – for excelling in two senior nursing roles.
The Lord Lieutenant said handing out such awards to people is one of the best things he does.
Mr Fursdon added: “Being able to thank these individuals for what they have done, show recognition for them … what can be better than that? What this does is highlight the quieter, steadier people who just, in their communities, deliver year-on-year services to their fellows and peers.
“These are modest people. They don’t seek the lime light, and some may even be embarrassed to be here today. I love that understated nature, and yet there they are, delivering day after day after day.
“People have stepped up during Covid in a way that you would not have imagined, and the number of people who have learned to volunteer and are now appreciated by their community has increased. In a world full of bad news, this is just unalloyed good news, isn’t it!” |
https://www.devonlive.com/news/devon-news/gallery/music-entertainment-mark-special-night-6906090 | Music and entertainment mark special night for boy in the tent Max Woosey
The Pride of Britain winner has so far raised more than £700,000
Pride of Britain winners have joined Max Woosey for a special celebration to mark his two years sleeping in a tent. Max Woosey’s Big Camp Out took to Lobb Field in Braunton on Saturday, March 26 to celebrate his achievement in raising £700,000 for the North Devon Hospice.
More than 100 people came together to enjoy food and drink, as well as music provided on stage by local talent. Max was joined by Harmonie-Rose Allen, the brave seven-year-old who won a Child of Courage Award after losing her limbs to meningitis and best pals Hughie Higginson, 10, and Freddie Xavi, 11 – who won a Young Fundraiser accolade after raising more than £200,000 for Royal Manchester Children’s Hospital Charity.
Tilly Lockey, who is known for her bionic arms and was the champion of the CBBC series Got What it Takes? entertained, and was joined by other singers include Chloe Marie Aston and solo artist Yazzy. After the entertainment had finished, Pride of Britain host Carol Vorderman also visited.
Max, 12, was initially inspired by a family friend who had been helped by the hospice. He has been through 15 tents so far and has no intention on stopping. He said: “Tonight, is Max’s Big Camp Out and it’s absolutely amazing. We’re all having a good time, and it’s lovely to see the stage full of music, see people enjoying themselves, and socialising, and everyone together.
“I never thought anything like this would happen. It’s been a great experience and great fun. Thanks to everyone who has supported me over the years including North Devon Hospice who have been amazing in their support of me throughout the two years. I can’t thank them enough for the work they do. It’s fantastic to see them here tonight.
“I have no plans to stop sleeping in my tent. Hopefully I’ll be able to go on forever.”
He apologised to those who joined him for the Big Camp Out adding: “I hope nobody will be woken up because my parents snore a lot.”
Stephen Roberts, chief executive of North Devon Hospice added: “I think Max deserves a celebration like this; two years in a tent is phenomenal. I don’t think he’ll ever realise what a difference that money will make. We were all at the start wondering how far this would go, but I don’t think anyone thought it would be two years and £700,000 later. He’s a legend and he deserves every accolade he’s got. We are all so proud of him.
“Like every organisation and particularly for charities, our income turned off overnight. Our shops were closed, fundraising events were shut down, so the fact that timing is everything, Max stepped up and the money he has raised has directly paid for all our community nursing team. You can tangibly see the difference he’s making to local families here in North Devon.” | 1 | 132,146 | 0.771875 | https://www.newsbreak.com/news/2593321483172/max-woosey-charity-camping-boy-receives-british-empire-medal | 2022-05-09 12:42:51+00:00 | Max Woosey: Charity camping boy receives British Empire Medal
Charity camper 12-year-old Max Woosey has collected his British Empire Medal (BEM) for raising hundreds of thousands of pounds for charity. Max, from Braunton, Devon, has spent two years camping and has raised nearly £800,000 for the North Devon Hospice. He was awarded a BEM in the New...
www.bbc.com |
https://www.devonlive.com/news/devon-news/gallery/music-entertainment-mark-special-night-6906090 | Music and entertainment mark special night for boy in the tent Max Woosey
The Pride of Britain winner has so far raised more than £700,000
Pride of Britain winners have joined Max Woosey for a special celebration to mark his two years sleeping in a tent. Max Woosey’s Big Camp Out took to Lobb Field in Braunton on Saturday, March 26 to celebrate his achievement in raising £700,000 for the North Devon Hospice.
More than 100 people came together to enjoy food and drink, as well as music provided on stage by local talent. Max was joined by Harmonie-Rose Allen, the brave seven-year-old who won a Child of Courage Award after losing her limbs to meningitis and best pals Hughie Higginson, 10, and Freddie Xavi, 11 – who won a Young Fundraiser accolade after raising more than £200,000 for Royal Manchester Children’s Hospital Charity.
Tilly Lockey, who is known for her bionic arms and was the champion of the CBBC series Got What it Takes? entertained, and was joined by other singers include Chloe Marie Aston and solo artist Yazzy. After the entertainment had finished, Pride of Britain host Carol Vorderman also visited.
Max, 12, was initially inspired by a family friend who had been helped by the hospice. He has been through 15 tents so far and has no intention on stopping. He said: “Tonight, is Max’s Big Camp Out and it’s absolutely amazing. We’re all having a good time, and it’s lovely to see the stage full of music, see people enjoying themselves, and socialising, and everyone together.
“I never thought anything like this would happen. It’s been a great experience and great fun. Thanks to everyone who has supported me over the years including North Devon Hospice who have been amazing in their support of me throughout the two years. I can’t thank them enough for the work they do. It’s fantastic to see them here tonight.
“I have no plans to stop sleeping in my tent. Hopefully I’ll be able to go on forever.”
He apologised to those who joined him for the Big Camp Out adding: “I hope nobody will be woken up because my parents snore a lot.”
Stephen Roberts, chief executive of North Devon Hospice added: “I think Max deserves a celebration like this; two years in a tent is phenomenal. I don’t think he’ll ever realise what a difference that money will make. We were all at the start wondering how far this would go, but I don’t think anyone thought it would be two years and £700,000 later. He’s a legend and he deserves every accolade he’s got. We are all so proud of him.
“Like every organisation and particularly for charities, our income turned off overnight. Our shops were closed, fundraising events were shut down, so the fact that timing is everything, Max stepped up and the money he has raised has directly paid for all our community nursing team. You can tangibly see the difference he’s making to local families here in North Devon.” | 2 | 134,900 | 0.945312 | https://www.campaignlive.co.uk/article/british-media-awards-winners-2022-event-year-consumer-media/1755764 | 2022-05-18 01:13:31+00:00 | Pride of Britain Awards shines a light on normal people who do great things, with celebrities as the supporting cast. Winners range from courageous children and members of the emergency services and armed forces to extraordinary teachers, nurses, charity fundraisers and local champions.
The 2021 event was held against a backdrop of challenges: as well as the pandemic and remote working, organisers Reach were grieving the sudden loss of Pride of Britain founder and driving force, Peter Willis.
Following a massive advertising campaign, there were 100,000 nominations from which to decide a shortlist. Reach also put together a distinguished panel of judges.
The event was held in-person in October 2021, and with restrictions removed, more than 800 guests were in attendance, complete with a military brass brand and giant screen, with the event also broadcast on Facebook Live.
Host Carol Vorderman was joined by new co-host Ashley Banjo on a revamped stage and the event featured performances from rapper KSI and Westlife. Pride of Britain Awards 2021 was Reach’s best PR and media turnout in recent years, with coverage across regional and national ITV news; Global Radio stations Capital, Heart, LBC, Smooth and Radio X; BBC coverage across the regions, BBC Breakfast and The One Show.
More people watched it on television than in the previous year, there were 11 million views of TikTok-related content and sponsor TSB renewed its initial five-year deal 12 months early. Judges said the event had fantastic reach and a brilliant message - to celebrate ordinary heroes. |
https://www.hucknalldispatch.co.uk/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. | 0 | 107,934 | 0 | https://www.chad.co.uk/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | 2022-04-06 07:54:04+00:00 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. |
https://www.hucknalldispatch.co.uk/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. | 1 | 110,841 | 0 | https://www.burnleyexpress.net/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | 2022-04-06 08:10:34+00:00 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. |
https://www.hucknalldispatch.co.uk/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. | 2 | 112,575 | 0 | https://www.derryjournal.com/read-this/rare-collection-launch-toast-of-whisky-industry-3642520 | 2022-04-06 08:19:47+00:00 | Rare collection launch toast of whisky industry
Distillery Reserve Collection
The Glenlivet has announced the release of three fine and iconic whiskies in the new Distillery Reserve Collection.
The 10, 14 and 22 Year Old single cask editions showcase the finest Scotch craftsmanship mastered over decades. The Glenlivet has made each of the 50cl bottles of the Distillery Reserve Collection available for pre-order.
Each bottle of cask strength captures The Glenlivet's pioneering style. Every bottle is drawn from a single cask by the makers themselves before being numbered to identify the age, cask type and bottling date.
The Glenlivet Distillery Reserve Collection 10 Year Old
This is the first in the collection. With flavours of juicy poached pears, raisin fudge and cinnamon, the whisky gives way to warming ginger and freshly baked glazed cinnamon buns. Only 849 bottles of this expression will be available.
The Glenlivet Distillery Reserve Collection 14 Year Old follows with a limited run of 700 bottles. The rich finish from the first fill sherry cask is rooted in the heritage of The Glenlivet distillery. Every precious drop from this limited release delivers, with flavours of plum, ginger cake and toasted oak.
Completing the trio with a vibrant and tropical finish is The Glenlivet Distillery Reserve Collection 22 Year Old first fill American barrel, which is packed full of citrus flavour.
Linda Brown, Brand Home Manager at The Glenlivet commented:“The rare collection celebrates the very best the distillery and Speyside has to offer and is a testament to the rich, bold flavours our makers can achieve. The Distillery Reserve Collection offers something truly unique in terms of taste, quality and experience.”
You can order from the theglenlivet.com site. |
https://www.spin.ph/basketball/ncaa-men/lyceum-rallies-to-beat-jru-for-first-win-after-three-losses-a2437-20220406 | LYCEUM shook off its slow start and used a huge final push to come away with an 82-75 victory over Jose Rizal University on Wednesday for its first win in the NCAA Season 97 seniors basketball tournament at La Salle Greenhills.
Enoch Valdez starred for the Pirates with 21 points, 12 rebounds, and five steals as Mclaude Guadana got 14 points, three assists, and two boards for a 1-3 record.
Valdez, Guadana star for Lyceum
Valdez came alive and poured eight in the payoff period where Lyceum used a 10-2 charge to flip the game from a 73-72 deficit in the final 2:54 and earn the breakthrough victory in this campaign.
Yancy Remillascored 10 for the Pirates which fought back from an early 12-point hole, 24-12, to end the first frame.
"I'm so very happy because of yung pinakita ng mga players ko. And I'll give credit to them kasi they're the ones working hard sa practice," said coach Gilbert Malabanan.
"Hard work talaga nila when it comes to the game. Aggressive talaga sila and yun naman ang sinasabi ko sa kanila, na I want them to be aggressive offensively and defensively."
Jason Celis topped JRU with 24 points, four rebounds, two assists, and two steals, while JL Delos Santos had 14 points, six boards, five dimes, and a steal in the Heavy Bombers' fourth straight defeat.
The scores:
Lyceum 82 - Valdez 21, Guadana 14, Remulla 10, Larupay 9, Cunanan 6, Barba 6, Bravo 6, Guinto 4, Garro 3, Navarro 3, Umali 0.
JRU 75 - Celis 24, Delos Santos 14, Dionisio 14, Agbong 11, Macatangay 5, G. Gonzales 3, Jungco 2, Arenal 2, Aguilar 0, Bongay 0, Guiab 0.
Quarterscores: 12-24; 38-40; 61-61; 82-75.
We are now on Quento! Download the app to enjoy more articles and videos from SPIN.ph and other Summit Media websites. | 0 | 101,174 | 0.362281 | https://news.abs-cbn.com/sports/04/06/22/ncaa-lyceum-grabs-breakthrough-win-at-jrus-expense | 2022-04-06 07:10:00+00:00 | MANILA, Philippines -- Lyceum of the Philippines University broke into the win column of the NCAA Season 97 men's basketball tournament after a hard-fought 82-75 triumph against Jose Rizal University (JRU), Wednesday at the La Salle Greenhills Gym.
Enoch Valdez led the way in Lyceum's breakthrough, putting up 21 points, 12 rebounds, and five steals while scoring clutch baskets in the final three minutes. Rookie McLaude Guadana had 14 points, and Yancy Remulla also put up a double-double with 10 points and 11 rebounds.
Veteran point guard Renzo Navarro had just three points in the game, but dished out five assists, including the pass that led to Valdez's go-ahead layup with 2:45 to play. His uncontested bucket in transition put the Pirates on top, 74-73.
Navarro then fed Remulla for a layup that made it 76-73 with 2:11 to go, before Valdez again scored on the break for a 78-73 count with 1:43 left.
A triple by Chester Jungco breathed some life into JRU, but free throws by Valdez allowed the Pirates to stay in control.
"I'm so very happy because of 'yung pinakita ng mga players ko. And I'll give credit to them, kasi they're the ones working hard sa practice, and hard work talaga nila when it comes to the game," Lyceum coach Gilbert Malabanan said.
"Aggressive talaga sila, and 'yun naman ang sinasabi ko sa kanila, na I want them to be aggressive, offensively and defensively," he added.
The Pirates improved to 1-3 in the season, while the Heavy Bombers dropped to 0-4.
Squandered in the loss was a 24-point effort from JRU's Jason Celis. Marwin Dionisio added 14 points and 10 rebounds in a losing effort.
The scores:
LPU (82) -- Valdez 21, Guadaña 14, Remulla 10, Larupay 9, Cunanan 6, Barba 6, Bravo 6, Guinto 4, Garro 3, Navarro 3, Umali 0.
JRU (75) -- Celis 24, Delos Santos 14, Dionisio 14, Agbong 11, Macatangay 5, Gonzales 3, Jungco 2, Arenal 2, Aguilar 0, Bongay 0, Guiab 0.
Quarterscores: 12-24, 38-40, 61-61, 82-75 |
https://www.spin.ph/basketball/ncaa-men/lyceum-rallies-to-beat-jru-for-first-win-after-three-losses-a2437-20220406 | LYCEUM shook off its slow start and used a huge final push to come away with an 82-75 victory over Jose Rizal University on Wednesday for its first win in the NCAA Season 97 seniors basketball tournament at La Salle Greenhills.
Enoch Valdez starred for the Pirates with 21 points, 12 rebounds, and five steals as Mclaude Guadana got 14 points, three assists, and two boards for a 1-3 record.
Valdez, Guadana star for Lyceum
Valdez came alive and poured eight in the payoff period where Lyceum used a 10-2 charge to flip the game from a 73-72 deficit in the final 2:54 and earn the breakthrough victory in this campaign.
Yancy Remillascored 10 for the Pirates which fought back from an early 12-point hole, 24-12, to end the first frame.
"I'm so very happy because of yung pinakita ng mga players ko. And I'll give credit to them kasi they're the ones working hard sa practice," said coach Gilbert Malabanan.
"Hard work talaga nila when it comes to the game. Aggressive talaga sila and yun naman ang sinasabi ko sa kanila, na I want them to be aggressive offensively and defensively."
Jason Celis topped JRU with 24 points, four rebounds, two assists, and two steals, while JL Delos Santos had 14 points, six boards, five dimes, and a steal in the Heavy Bombers' fourth straight defeat.
The scores:
Lyceum 82 - Valdez 21, Guadana 14, Remulla 10, Larupay 9, Cunanan 6, Barba 6, Bravo 6, Guinto 4, Garro 3, Navarro 3, Umali 0.
JRU 75 - Celis 24, Delos Santos 14, Dionisio 14, Agbong 11, Macatangay 5, G. Gonzales 3, Jungco 2, Arenal 2, Aguilar 0, Bongay 0, Guiab 0.
Quarterscores: 12-24; 38-40; 61-61; 82-75.
We are now on Quento! Download the app to enjoy more articles and videos from SPIN.ph and other Summit Media websites. | 1 | 129,853 | 0.401787 | https://www.tempo.com.ph/2022/04/06/valdez-navarro-star-for-lyceums-1st-win/ | 2022-04-06 09:54:13+00:00 | By REYNALD MAGALLON
Enoch Valdez provided the spark as Lyceum outlasted Jose Rizal University, 82-75, in the NCAA Season 97 yesterday at the La Salle Green Hills Gym in Mandaluyong.
The Pirates proved to be the much hungrier team, rallying from a 12-point deficit to prevail over the Heavy Bombers in the battle of the cellar-dwellers.
The win was Lyceum’s first in four games while the Bombers dropped to a 0-4 hole.
Valdez was at the forefront of the attack, providing boundless of energy to finish with a double-double effort of 21 points and 12 rebounds. He was the catalyst of the 9-2 finishing run inside the final five minutes of the game to create the separation.
McLaude Guadana, who missed the potential game-winner in Lyceum’s narrow 70-69 win against Emilio Aguinaldo College last Saturday, bounced back with a career game of 14 points while Remulla added 10 markers and 11 boards.
Renzo Navarro orchestrated the back-breaking rally, issuing crucial assists first on Valdez that allowed the Pirates to retake the lead, 74-73, before finding a cutting Yancy Remulla for a layup in the next play to stretch the lead to three with 2:10 left in the game.
Valdez then scored the final points of the match to put the nail on the coffin against the Heavy Bombers, spoiling a stellar 24-point performance from Jason Celiz after struggling with just six points in their 67-53 loss to the San Beda Red Lions last Sunday.
JL Delos Santos and Marvin Dionisio added 14-points apiece but all went down the drain as JRU fell to 0-4.
The scores:
LPU 82 ‒ Valdez 21, Guadaña 14, Remulla 10, Larupay 9, Cunanan 6, Barba 6, Bravo 6, Guinto 4, Garro 3, Navarro 3, Umali 0.
JRU 75 ‒ Celis 24, Delos Santos 14, Dionisio 14, Agbong 11, Macatangay 5, Gonzales 3, Jungco 2, Arenal 2, Aguilar 0, Bongay 0, Guiab 0.
Quarters: 12-24, 38-40, 61-61, 82-75. |
https://www.spin.ph/basketball/ncaa-men/lyceum-rallies-to-beat-jru-for-first-win-after-three-losses-a2437-20220406 | LYCEUM shook off its slow start and used a huge final push to come away with an 82-75 victory over Jose Rizal University on Wednesday for its first win in the NCAA Season 97 seniors basketball tournament at La Salle Greenhills.
Enoch Valdez starred for the Pirates with 21 points, 12 rebounds, and five steals as Mclaude Guadana got 14 points, three assists, and two boards for a 1-3 record.
Valdez, Guadana star for Lyceum
Valdez came alive and poured eight in the payoff period where Lyceum used a 10-2 charge to flip the game from a 73-72 deficit in the final 2:54 and earn the breakthrough victory in this campaign.
Yancy Remillascored 10 for the Pirates which fought back from an early 12-point hole, 24-12, to end the first frame.
"I'm so very happy because of yung pinakita ng mga players ko. And I'll give credit to them kasi they're the ones working hard sa practice," said coach Gilbert Malabanan.
"Hard work talaga nila when it comes to the game. Aggressive talaga sila and yun naman ang sinasabi ko sa kanila, na I want them to be aggressive offensively and defensively."
Jason Celis topped JRU with 24 points, four rebounds, two assists, and two steals, while JL Delos Santos had 14 points, six boards, five dimes, and a steal in the Heavy Bombers' fourth straight defeat.
The scores:
Lyceum 82 - Valdez 21, Guadana 14, Remulla 10, Larupay 9, Cunanan 6, Barba 6, Bravo 6, Guinto 4, Garro 3, Navarro 3, Umali 0.
JRU 75 - Celis 24, Delos Santos 14, Dionisio 14, Agbong 11, Macatangay 5, G. Gonzales 3, Jungco 2, Arenal 2, Aguilar 0, Bongay 0, Guiab 0.
Quarterscores: 12-24; 38-40; 61-61; 82-75.
We are now on Quento! Download the app to enjoy more articles and videos from SPIN.ph and other Summit Media websites. | 2 | 140,408 | 0.449701 | https://www.spin.ph/basketball/mac-guadana-fires-eight-in-4th-to-steer-lyceum-to-2nd-win-a2437-20220731 | 2022-07-31 07:55:44+00:00 | LYCEUM nailed its second win in the Filoil EcoOil Preseason Cup, holding off Jose Rizal University, 80-73, on Sunday in San Juan.
Mac Guadana sparked the Pirates' telling 9-0 run to turn a close 61-59 lead to a 70-59 advantage with 6:02 left to play. Lyceum stretched its lead to as big as 14 points, 77-63.
See National U stretches UCBL streak to three with win over Adamson
The Heavy Bombers cut the lead down to six, 77-71, after an Agem Miranda bucket with 45.1 ticks left, but Guadana canned a dagger step back three with 22.4 seconds remaining to seal the win.
It capped off his 13-point, 7-assist performance as he scored eight points in the fourth period to help Lyceum improve to 2-0 in Group B.
"Medyo nagkaroon ng diskusyunan kanina at nara-rattle sila nung nakakabalik na yung JRU eh. But we just enjoyed the game. Pag nage-enjoy kami sa game, doon nawawala yung pressure," said coach Gilbert Malabanan.
JM Bravo paced the Pirates with 17 points, eight rebounds, and three assists, while John Barba chimed in 11 points and three boards.
Miranda carried JRU with 15 points, six rebounds, three assists, and three steals, but his efforts weren't enough to stop his side from sliding to its third straight loss.
The Scores:
LPU 80 -- Bravo 17, Guadana 13, Bravo 11, Penafiel 9, Umali 6, Larupay 4, Culanay 3, Aviles 3, Omandac 3, Caduyac 3, Navarro 2, Cunanan 2, Montano 2, Venoya 2, Villegas 0.
JRU 73 -- Miranda 15, Sy 10, Guiab 9, Medina 8, Gonzales 7, Arenal 6, Celis 6, Dela Rosa 5, Villarin 3, Delos Santos 2, De Leon 2, Bongay 0, Abaoag 0.
Quarters: 21-20, 36-32, 59-55, 80-73.
We are now on Quento! Download the app to enjoy more articles and videos from SPIN.ph and other Summit Media websites. |
https://www.dailymail.co.uk/news/article-10691501/Babies-lifted-40ft-ground-arms-men-tied-poles-Hindu-festival-Video.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | Raising babies! Moment infants are lifted 40ft off the ground in the arms of men tied to poles at Hindu festival in India
- Footage shows row of four men holding babies attached to two connected poles
- Ceremony is known as Thookkam and takes place every year at Sree Bhadrakali
- Onlookers cheer as men reach the heigh of trajectory and are paraded around
This is the moment newborn babies being carried by men are hoisted 40 feet into the air on poles during a Hindu ritual in India.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu.
Footage shows a row of four devotees, each holding a baby, wearing traditional costume attached to two interconnected poles.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu
Footage shows a row of four men, each holding a baby, wearing traditional costume attached to two interconnected poles
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time.
Onlookers cheer as the devotees reach the height of their trajectory and are then wheeled down a street in a parade.
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets.
Childless couples regularly come to the temple to offer prayers in the hope of being falling pregnant.
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time
Onlookers cheer as the men reach the height of their trajectory and are then wheeled down a street in a parade
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets
If they then do fall pregnant, the couples return to the holy site to fulfil their vow to the deity Bhadrakali Amman by offering their babies up to participate in the festival and show their thanks.
Thookkam is an offering that is held at the Bhadrakali temple in Kollemcode in the Kanyakumari district in Tamilnadu during the month of Meenam (late March to late April).
Every year more than a thousand newborn babies are lifted by the men tied to a 40-foot pole and taken for a ride around the temple.
The festival is celebrated annually for 10 days and Thookkam is on the final day of the festival. | 0 | 44,261 | 0.178549 | https://www.newsbreak.com/news/2564521502249/raising-babies-moment-infants-are-lifted-40ft-off-the-ground-in-the-arms-of-men-tied-to-poles-at-hindu-festival-in-india | 2022-04-08 13:42:46+00:00 | Raising babies! Moment infants are lifted 40ft off the ground in the arms of men tied to poles at Hindu festival in India
This is the moment newborn babies being carried by men are hoisted 40 feet into the air on poles during a Hindu ritual in India.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu.
Footage shows a row of four devotees, each holding a baby, wearing traditional costume attached to two interconnected poles.
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time.
Onlookers cheer as the devotees reach the height of their trajectory and are then wheeled down a street in a parade.
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets.
Childless couples regularly come to the temple to offer prayers in the hope of being falling pregnant.
If they then do fall pregnant, the couples return to the holy site to fulfil their vow to the deity Bhadrakali Amman by offering their babies up to participate in the festival and show their thanks.
Thookkam is an offering that is held at the Bhadrakali temple in Kollemcode in the Kanyakumari district in Tamilnadu during the month of Meenam (late March to late April).
Every year more than a thousand newborn babies are lifted by the men tied to a 40-foot pole and taken for a ride around the temple.
The festival is celebrated annually for 10 days and Thookkam is on the final day of the festival. |
https://www.dailymail.co.uk/news/article-10691501/Babies-lifted-40ft-ground-arms-men-tied-poles-Hindu-festival-Video.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | Raising babies! Moment infants are lifted 40ft off the ground in the arms of men tied to poles at Hindu festival in India
- Footage shows row of four men holding babies attached to two connected poles
- Ceremony is known as Thookkam and takes place every year at Sree Bhadrakali
- Onlookers cheer as men reach the heigh of trajectory and are paraded around
This is the moment newborn babies being carried by men are hoisted 40 feet into the air on poles during a Hindu ritual in India.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu.
Footage shows a row of four devotees, each holding a baby, wearing traditional costume attached to two interconnected poles.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu
Footage shows a row of four men, each holding a baby, wearing traditional costume attached to two interconnected poles
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time.
Onlookers cheer as the devotees reach the height of their trajectory and are then wheeled down a street in a parade.
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets.
Childless couples regularly come to the temple to offer prayers in the hope of being falling pregnant.
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time
Onlookers cheer as the men reach the height of their trajectory and are then wheeled down a street in a parade
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets
If they then do fall pregnant, the couples return to the holy site to fulfil their vow to the deity Bhadrakali Amman by offering their babies up to participate in the festival and show their thanks.
Thookkam is an offering that is held at the Bhadrakali temple in Kollemcode in the Kanyakumari district in Tamilnadu during the month of Meenam (late March to late April).
Every year more than a thousand newborn babies are lifted by the men tied to a 40-foot pole and taken for a ride around the temple.
The festival is celebrated annually for 10 days and Thookkam is on the final day of the festival. | 1 | 108,433 | 0.976237 | https://www.news18.com/amp/news/world/indonesia-hindu-climb-active-volcano-sacrifice-crops-livestock-ancient-ritual-5386267.html | 2022-06-16 17:48:52+00:00 | Thousands of Hindu worshippers climbed an active volcano in Indonesia on Thursday to throw offerings from crops to livestock down its smouldering crater in a centuries-old religious ceremony.
Every year people from the Tengger tribe gather from villages in the highlands around Mount Bromo to trek to its peak to cast goats, chickens, fruit, flowers and vegetables into its crater as part of the Yadnya Kasada festival.
A chain of worshippers, some lugging goats on their backs, trekked to the edge of the crater in hope of pleasing their Hindu gods while bringing prosperity and good fortune to the communities of the Tenggerese, an indigenous group in eastern Java.
“Despite the pandemic, I still come up here every year bringing crops (to be thrown into the crater) to express gratitude to the gods and the ancestors," Wawan, one of the worshippers, told AFP. Wawan had earlier launched offerings of chicken and crops into the volcanic cauldron while wishing for good health and fortune on top of the mountain famed for its stunning sunrise views.
Some villagers not part of the Tengger tribe stood on the crater’s steep slopes armed with nets in a bid to snatch the offerings out of the air before they disappeared into the smokey void. It is not part of the ritual, but some members of the local population have the frugal urge not to let the offerings go to waste.
Thursday’s ritual was the third Yadnya Kasada ceremony since the Covid-19 pandemic hit Indonesia, but it did not deter worshippers from again carrying out their yearly sacrifice.
Bambang Suprapto, head of the area’s Hindu community association, said the annual ritual had to continue as it “cannot be held in another place" or virtually. But access to the crater during the ritual was limited to worshippers and tourists were barred in line with the government’s Covid-19 guidance, he added.
The festival dates back to the 15th-century legends of the Javanese Hindu Majapahit kingdom’s princess Roro Anteng and her husband. Unable to bear children after years of marriage, the couple begged the gods for help.
Their prayers were answered and they were promised 25 children, as long as they agreed to sacrifice their youngest child by throwing him into Mount Bromo. Legend has it their son willingly jumped into the volcano to guarantee the prosperity of the Tengger people.
The sacrifice tradition continues to this day, although the Tengger tribe sacrifices their harvest and farm animals instead of humans.
As local community chief Bambang lobbed his batch of crops into the volcanic crater, he prayed for harmonious relations between humans and God, nature, and their fellow human beings. “If we take care of nature, it will take care of us as well," he said.
Read all the Latest News , Breaking News , watch Top Videos and Live TV here. |
https://www.dailymail.co.uk/news/article-10691501/Babies-lifted-40ft-ground-arms-men-tied-poles-Hindu-festival-Video.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | Raising babies! Moment infants are lifted 40ft off the ground in the arms of men tied to poles at Hindu festival in India
- Footage shows row of four men holding babies attached to two connected poles
- Ceremony is known as Thookkam and takes place every year at Sree Bhadrakali
- Onlookers cheer as men reach the heigh of trajectory and are paraded around
This is the moment newborn babies being carried by men are hoisted 40 feet into the air on poles during a Hindu ritual in India.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu.
Footage shows a row of four devotees, each holding a baby, wearing traditional costume attached to two interconnected poles.
The ceremony, known as Thookkam, takes place every year at Sree Bhadrakali Temple in Kollemcode in the state of Tamil Nadu
Footage shows a row of four men, each holding a baby, wearing traditional costume attached to two interconnected poles
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time.
Onlookers cheer as the devotees reach the height of their trajectory and are then wheeled down a street in a parade.
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets.
Childless couples regularly come to the temple to offer prayers in the hope of being falling pregnant.
Other people partaking in the ritual then hoist the men up into the air while they kick their legs in time
Onlookers cheer as the men reach the height of their trajectory and are then wheeled down a street in a parade
The ritual goes on into the night as different men holding different babies take turns being hoisted up and paraded through the streets
If they then do fall pregnant, the couples return to the holy site to fulfil their vow to the deity Bhadrakali Amman by offering their babies up to participate in the festival and show their thanks.
Thookkam is an offering that is held at the Bhadrakali temple in Kollemcode in the Kanyakumari district in Tamilnadu during the month of Meenam (late March to late April).
Every year more than a thousand newborn babies are lifted by the men tied to a 40-foot pole and taken for a ride around the temple.
The festival is celebrated annually for 10 days and Thookkam is on the final day of the festival. | 2 | 109,153 | 0.976249 | https://www.news18.com/news/world/indonesia-hindu-climb-active-volcano-sacrifice-crops-livestock-ancient-ritual-5386267.html | 2022-06-16 17:51:09+00:00 | Thousands of Hindu worshippers climbed an active volcano in Indonesia on Thursday to throw offerings from crops to livestock down its smouldering crater in a centuries-old religious ceremony.
Every year people from the Tengger tribe gather from villages in the highlands around Mount Bromo to trek to its peak to cast goats, chickens, fruit, flowers and vegetables into its crater as part of the Yadnya Kasada festival.
A chain of worshippers, some lugging goats on their backs, trekked to the edge of the crater in hope of pleasing their Hindu gods while bringing prosperity and good fortune to the communities of the Tenggerese, an indigenous group in eastern Java.
“Despite the pandemic, I still come up here every year bringing crops (to be thrown into the crater) to express gratitude to the gods and the ancestors,” Wawan, one of the worshippers, told AFP. Wawan had earlier launched offerings of chicken and crops into the volcanic cauldron while wishing for good health and fortune on top of the mountain famed for its stunning sunrise views.
Some villagers not part of the Tengger tribe stood on the crater’s steep slopes armed with nets in a bid to snatch the offerings out of the air before they disappeared into the smokey void. It is not part of the ritual, but some members of the local population have the frugal urge not to let the offerings go to waste.
Thursday’s ritual was the third Yadnya Kasada ceremony since the Covid-19 pandemic hit Indonesia, but it did not deter worshippers from again carrying out their yearly sacrifice.
Bambang Suprapto, head of the area’s Hindu community association, said the annual ritual had to continue as it “cannot be held in another place” or virtually. But access to the crater during the ritual was limited to worshippers and tourists were barred in line with the government’s Covid-19 guidance, he added.
The festival dates back to the 15th-century legends of the Javanese Hindu Majapahit kingdom’s princess Roro Anteng and her husband. Unable to bear children after years of marriage, the couple begged the gods for help.
Their prayers were answered and they were promised 25 children, as long as they agreed to sacrifice their youngest child by throwing him into Mount Bromo. Legend has it their son willingly jumped into the volcano to guarantee the prosperity of the Tengger people.
The sacrifice tradition continues to this day, although the Tengger tribe sacrifices their harvest and farm animals instead of humans.
As local community chief Bambang lobbed his batch of crops into the volcanic crater, he prayed for harmonious relations between humans and God, nature, and their fellow human beings. “If we take care of nature, it will take care of us as well,” he said.
Read all the Latest News , Breaking News , watch Top Videos and Live TV here. |
https://auto.economictimes.indiatimes.com/amp/news/aftermarket/blusmart-launches-intercity-rides-on-evs-from-delhi-ncr-to-chandigarh-jaipur/90683931 | BluSmart launches intercity rides on EVs from Delhi-NCR to Chandigarh, Jaipur
The intercity rides are available for Blu Prive members, a BluSmart loyalty programme. The company plans to make it available for all its customers in a few months, the company said.
New Delhi: With an aim to bust the fear around range anxiety, The electric ride-hailing platform BluSmart Mobility on Wednesday launched intercity rides from Delhi-NCR to Chandigarh and to Jaipur in the premium electric SUV MG ZS EV.
BluSmart said that with the launch of these intercity rides, it aims to cover long distance routes with EVs and create charging infrastructure along major national highways for private and public EV owners so as to promote EV adoption.
Anmol Jaggi, co-founder and CEO, BluSmart Mobility, said, “EVs have a reputation of being able to commute only within the city. With our intercity launch, we are busting the myth around range anxiety and making intercity commute possible with an electric car. This is only the start of our expansion.”
“In a parallel vision with government reforms, with ride-hailing 2.0, BluSmart plans to expand its horizon to different cities by developing charging infrastructure and expanding our fleet,” he said.
BluSmart operates a fleet of over 1000 electric cars in Delhi-NCR with OEMs like Tata Motors, MG Motor and Mahindra & Mahindra. The company said that so far it has completed over 1 million all-electric trips.
According to the statement, the BluSmart Mobility will use the fresh capital to purchase 3,000 all-electric cars to expand its EV fleet. From the sanctioned loan of INR 267.67 crores, the first tranche of INR 35.70 has been disbursed by IREDA to the company.
Under this proposed partnership, the customers of TVS electric vehicles will get access to the charging network of Jio-bp, which is also open to other vehicles, TVS Motor Company said. | 0 | 15,049 | 0.224258 | https://auto.economictimes.indiatimes.com/news/aftermarket/blusmart-launches-intercity-rides-on-evs-from-delhi-ncr-to-chandigarh-jaipur/90683931 | 2022-04-06 11:53:09+00:00 | ET Auto privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET Auto.
BluSmart launches intercity rides on EVs from Delhi-NCR to Chandigarh, Jaipur
The intercity rides are available for Blu Prive members, a BluSmart loyalty programme. The company plans to make it available for all its customers in a few months, the company said.
New Delhi: With an aim to bust the fear around range anxiety, The electric ride-hailing platform BluSmart Mobility on Wednesday launched intercity rides from Delhi-NCR to Chandigarh and to Jaipur in the premium electric SUV MG ZS EV.
Aimed at busting range anxiety, “the intercity rides are available for Blu Prive members, a BluSmart loyalty programme. The company plans to make it available for all its customers in a few months,” it said in a statement.
BluSmart said that with the launch of these intercity rides, it aims to cover long distance routes with EVs and create charging infrastructure along major national highways for private and public EV owners so as to promote EV adoption.
Anmol Jaggi, co-founder and CEO, BluSmart Mobility, said, “EVs have a reputation of being able to commute only within the city. With our intercity launch, we are busting the myth around range anxiety and making intercity commute possible with an electric car. This is only the start of our expansion.”
“In a parallel vision with government reforms, with ride-hailing 2.0, BluSmart plans to expand its horizon to different cities by developing charging infrastructure and expanding our fleet,” he said.
BluSmart operates a fleet of over 1000 electric cars in Delhi-NCR with OEMs like Tata Motors, MG Motor and Mahindra & Mahindra. The company said that so far it has completed over 1 million all-electric trips.
According to the statement, the BluSmart Mobility will use the fresh capital to purchase 3,000 all-electric cars to expand its EV fleet. From the sanctioned loan of INR 267.67 crores, the first tranche of INR 35.70 has been disbursed by IREDA to the company.
Under this proposed partnership, the customers of TVS electric vehicles will get access to the charging network of Jio-bp, which is also open to other vehicles, TVS Motor Company said.
Car production is expected to be affected for the rest of 2022 because of the semiconductor supply crunch. For the two-wheeler segment, the rural recovery is still remote and the market for commuter motorcycles is yet to recover from the second COVID wave. Meanwhile, the commercial vehicle and the tractor segments are showing some signs of recovery.
The company launched its maiden scooter Simple One back in August 2021 and will begin deliveries only by June but is prepared for 1 lakh bookings by then to be serviced by the end of 2022. Given Bhavish Aggarwal's struggles at Ola Electric with ramp up and deliveries to customers, Simple's Suhas Rajkumar is going slow and steady opting for caution knowing that for a three year old startup, he cannot afford to have his scooters stutter on the roads. |
https://auto.economictimes.indiatimes.com/amp/news/aftermarket/blusmart-launches-intercity-rides-on-evs-from-delhi-ncr-to-chandigarh-jaipur/90683931 | BluSmart launches intercity rides on EVs from Delhi-NCR to Chandigarh, Jaipur
The intercity rides are available for Blu Prive members, a BluSmart loyalty programme. The company plans to make it available for all its customers in a few months, the company said.
New Delhi: With an aim to bust the fear around range anxiety, The electric ride-hailing platform BluSmart Mobility on Wednesday launched intercity rides from Delhi-NCR to Chandigarh and to Jaipur in the premium electric SUV MG ZS EV.
BluSmart said that with the launch of these intercity rides, it aims to cover long distance routes with EVs and create charging infrastructure along major national highways for private and public EV owners so as to promote EV adoption.
Anmol Jaggi, co-founder and CEO, BluSmart Mobility, said, “EVs have a reputation of being able to commute only within the city. With our intercity launch, we are busting the myth around range anxiety and making intercity commute possible with an electric car. This is only the start of our expansion.”
“In a parallel vision with government reforms, with ride-hailing 2.0, BluSmart plans to expand its horizon to different cities by developing charging infrastructure and expanding our fleet,” he said.
BluSmart operates a fleet of over 1000 electric cars in Delhi-NCR with OEMs like Tata Motors, MG Motor and Mahindra & Mahindra. The company said that so far it has completed over 1 million all-electric trips.
According to the statement, the BluSmart Mobility will use the fresh capital to purchase 3,000 all-electric cars to expand its EV fleet. From the sanctioned loan of INR 267.67 crores, the first tranche of INR 35.70 has been disbursed by IREDA to the company.
Under this proposed partnership, the customers of TVS electric vehicles will get access to the charging network of Jio-bp, which is also open to other vehicles, TVS Motor Company said. | 1 | 113,187 | 0.295654 | https://indianexpress.com/article/business/companies/blusmart-mobility-launches-ev-intercity-rides-from-delhi-ncr-to-chandigarh-jaipur-7855622/ | 2022-04-06 08:25:18+00:00 | Electric ride-hailing platform BluSmart Mobility on Wednesday launched its first EV intercity rides from Delhi NCR to Chandigarh and Delhi NCR to Jaipur.
The company said that it will offer MG ZS EV to its customers for these intercity rides.
BluSmart Mobility informed that the intercity rides are currently available for Blu Prive members, a loyalty program by the company and said that it plans to make it available for all its customers in a few months.
The ride hailing company said that it has been setting up charging infrastructure in Delhi NCR to aid EV fleets. With the launch of intercity ride, BluSmart aims to debunk the range anxiety and create charging infra along major national highways for private and public EV owners so as to promote EV adoption, it said.
“EVs have a reputation of being able to commute only within the city. With our intercity launch, we are busting the myth around range anxiety and making intercity commute possible with an electric car. This is only the start of our expansion. In a parallel vision with government reforms, with ride-hailing 2.0, BluSmart plans to expand its horizon to different cities by developing charging infrastructure and expanding our fleet,” said Anmol Jaggi, Co-Founder and CEO at BluSmart Mobility.
Currently, BluSmart Mobility operates a fleet of 1000+ electric cars in Delhi NCR ranging from Tata, MG and Mahindra. It said that it ensures no ride cancellations and no surge pricing.
The company said that it has completed over 1 million all-electric trips so far and has covered more than 35 million clean km since launch.
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards. |
https://auto.economictimes.indiatimes.com/amp/news/aftermarket/blusmart-launches-intercity-rides-on-evs-from-delhi-ncr-to-chandigarh-jaipur/90683931 | BluSmart launches intercity rides on EVs from Delhi-NCR to Chandigarh, Jaipur
The intercity rides are available for Blu Prive members, a BluSmart loyalty programme. The company plans to make it available for all its customers in a few months, the company said.
New Delhi: With an aim to bust the fear around range anxiety, The electric ride-hailing platform BluSmart Mobility on Wednesday launched intercity rides from Delhi-NCR to Chandigarh and to Jaipur in the premium electric SUV MG ZS EV.
BluSmart said that with the launch of these intercity rides, it aims to cover long distance routes with EVs and create charging infrastructure along major national highways for private and public EV owners so as to promote EV adoption.
Anmol Jaggi, co-founder and CEO, BluSmart Mobility, said, “EVs have a reputation of being able to commute only within the city. With our intercity launch, we are busting the myth around range anxiety and making intercity commute possible with an electric car. This is only the start of our expansion.”
“In a parallel vision with government reforms, with ride-hailing 2.0, BluSmart plans to expand its horizon to different cities by developing charging infrastructure and expanding our fleet,” he said.
BluSmart operates a fleet of over 1000 electric cars in Delhi-NCR with OEMs like Tata Motors, MG Motor and Mahindra & Mahindra. The company said that so far it has completed over 1 million all-electric trips.
According to the statement, the BluSmart Mobility will use the fresh capital to purchase 3,000 all-electric cars to expand its EV fleet. From the sanctioned loan of INR 267.67 crores, the first tranche of INR 35.70 has been disbursed by IREDA to the company.
Under this proposed partnership, the customers of TVS electric vehicles will get access to the charging network of Jio-bp, which is also open to other vehicles, TVS Motor Company said. | 2 | 17,419 | 0.586687 | https://www.businesstoday.in/latest/corporate/story/ev-cab-firm-blusmart-raises-usd-50-mn-plans-to-expand-fleet-to-over-5000-cars-334794-2022-05-24 | 2022-05-24 06:30:24+00:00 | Electric vehicle ride-hailing platform BluSmart has raised $25 million in a Series A1 round. It is a follow-up to the Series A funding round that closed in September 2021. This brings the total round of its Series A investment to $50.7 million. The company said that this is one of the largest Series A fundraise in ride-hailing and smart mobility space globally.
BluSmart’s $25 million in the Series A1 round comprised $15 million of equity capital and a venture debt of $10 million. The equity round was led by BP Ventures and Green Frontier Capital with participation from existing investors, while the venture debt round saw participation from Stride Ventures, Alteria Capital, BlackSoil and UCIC.
The company plans to use the funding to scale up its all-electric ride-hailing fleet to over 5,000 EVs and expand its network of EV Superhubs across Delhi-NCR.
Co-founder and CEO Anmol Jaggi said, “BluSmart has been able to scale 25x since launch backed by its founding tenets of innovative supply side differentiation (backed by institutional EV financing), customer centric business model (zero ride denials and zero surge pricing) and full stack EV ecosystem approach (fully electric ride-hailing fleet backed by large scale EV infrastructure). BluSmart is creating inclusive and equitable economic opportunities for driver partners who can drive and earn without the hassles of asset ownership.”
Jaggi added that BluSmart is building the next generation EV ride-hailing service and EV charging infrastructure, making it India’s largest integrated and full-stack EV ecosystem solutions provider.
The company said that it is committed to decarbonise mobility in Indian mega cities. It recently added long-range EVs and started its all-electric intercity service from Delhi-NCR to Jaipur and Chandigarh. It also has its presence in all the domestic and international terminals at the Delhi IGI Airport.
BluSmart currently operates across Delhi-NCR. It said that it has completed 1.6 million zero-emission trips, covering 50 million clean kms.
Also read: Ather Energy raises $128 mn led by state-owned NIIFL, Hero MotoCorp
Also read: Ola Electric CMO, Varun Dubey quits amidst slew of fresh exits
Copyright©2022 Living Media India Limited. For reprint rights: Syndications Today |
https://www.news-medical.net/news/20220406/2411M-for-North-Carolina-work-based-rehab-raises-concerns.aspx | An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym, and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing, and meals are free to participants. And TROSA doesn't bill insurance. Instead, residents work for about two years in TROSA's many businesses, including a moving company, thrift store, and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96% of individuals remain sober and 91% are employed a year later, the program's latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It's the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25% of participants complete the program — a figure TROSA leaders confirmed.
"If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], 'I don't think you all should do this,'" said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. "You can't look at the small number of people who had success and say this works. It's not the majority."
The dispute over TROSA's funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
"Because essentially they're running businesses off of people's uncompensated labor, there is a built-in funding mechanism," he said. "If the state doesn't have to pay full freight to run a program … that might be a reason to like it."
TROSA's annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30% of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA's request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program's self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
"The good thing about TROSA: They raised most of their own funds," she said in a phone interview.
It's reasonable that residents don't get paid for their work, she added, since they're already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
But being a bargain doesn't necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
"The work-based element is essential to recovery," Artin said. "We're teaching people how to live."
Toward the end of residents' two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging work experiences
TROSA's model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was "a blessing."
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA's thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. "It was meaningful work that also taught me a lot of good job skills," he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they're buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master's in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38% of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. "The next day, they told me I had to get back to work," he claimed.
That's when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it's no thanks to TROSA, he said.
"They're taking advantage of people at their low points in life," he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents' experience. In general, CEO Artin wrote in an email, "when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk."
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program's 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It's been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the "gold standard" for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they've discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they'd consider injectable buprenorphine, but it's costly for their mostly uninsured participants.
"People choose to come here because it is a behavior modification program," said Lisa Finlay, lead clinical counselor at TROSA. "They know that we don't offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using."
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling, and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40% of residential programs surveyed in the U.S. didn't offer opioid use disorder medications and 20% actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training, and to learn coping skills. Roberts recalled one patient saying to her: "I need to go to residential treatment and I need this medication because I fear I'll die."
"That’s really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature," she said. "And that you know there are very few places in the state that offer that."
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they're the best way to combat the opioid crisis. Some medical and legal experts have said it's in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
"The goal isn't just to get people into treatment; it's to get people doing better," he said. "You want to make sure that you're using the money effectively."
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it's an effective program, he said, "I also have concerns from what I learned about TROSA's approach to treating opioid addiction in particular. I'd like to see TROSA consider what their current practices are." | 0 | 14,363 | 0.057535 | https://www.wunc.org/health/2022-04-06/11m-north-carolina-rehab-work-requirements-medication-restrictions-concerns-nchealthnews | 2022-04-06 11:48:21+00:00 | An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing and meals are free to participants. And TROSA doesn’t bill insurance. Instead, residents work for about two years in TROSA’s many businesses, including a moving company, thrift store and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96 percent of individuals remain sober and 91 percent are employed a year later, the program’s latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It’s the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25 percent of participants complete the program — a figure TROSA leaders confirmed.
“If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], ‘I don’t think you all should do this,’” said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. “You can’t look at the small number of people who had success and say this works. It’s not the majority.”
The dispute over TROSA’s funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
“Because essentially they’re running businesses off of people’s uncompensated labor, there is a built-in funding mechanism,” he said. “If the state doesn’t have to pay full freight to run a program ... that might be a reason to like it.”
TROSA’s annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30 percent of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA’s request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program’s self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
“The good thing about TROSA: They raised most of their own funds,” she said in a phone interview.
It’s reasonable that residents don’t get paid for their work, she added, since they’re already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
“Because essentially they’re running businesses off of people’s uncompensated labor, there is a built-in funding mechanism."
But being a bargain doesn’t necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
“The work-based element is essential to recovery,” Artin said. “We’re teaching people how to live.”
Toward the end of residents’ two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging work experiences
TROSA’s model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was “a blessing.”
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA’s thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. “It was meaningful work that also taught me a lot of good job skills,” he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they’re buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master’s in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38 percent of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. “The next day, they told me I had to get back to work,” he claimed.
That’s when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it’s no thanks to TROSA, he said.
“They’re taking advantage of people at their low points in life,” he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents’ experience. In general, CEO Artin wrote in an email, “when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk.”
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program’s 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It’s been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the “gold standard” for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they’ve discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they’d consider injectable buprenorphine, but it’s costly for their mostly uninsured participants.
“People choose to come here because it is a behavior modification program,” said Lisa Finlay, lead clinical counselor at TROSA. “They know that we don’t offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using.”
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40 percent of residential programs surveyed in the U.S. didn’t offer opioid use disorder medications and 20 percent actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training and to learn coping skills. Roberts recalled one patient saying to her: “I need to go to residential treatment and I need this medication because I fear I’ll die.”
“That's really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature,” she said. “And that you know there are very few places in the state that offer that.”
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they’re the best way to combat the opioid crisis.
“I also have concerns from what I learned about TROSA’s approach to treating opioid addiction in particular."
Some medical and legal experts have said it’s in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
“The goal isn’t just to get people into treatment; it’s to get people doing better,” he said. “You want to make sure that you’re using the money effectively.”
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it’s an effective program, he said, “I also have concerns from what I learned about TROSA’s approach to treating opioid addiction in particular. I’d like to see TROSA consider what their current practices are.”
North Carolina Health News is an independent, nonpartisan, not-for-profit, statewide news organization dedicated to covering all things health care in North Carolina.
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation. |
https://www.news-medical.net/news/20220406/2411M-for-North-Carolina-work-based-rehab-raises-concerns.aspx | An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym, and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing, and meals are free to participants. And TROSA doesn't bill insurance. Instead, residents work for about two years in TROSA's many businesses, including a moving company, thrift store, and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96% of individuals remain sober and 91% are employed a year later, the program's latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It's the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25% of participants complete the program — a figure TROSA leaders confirmed.
"If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], 'I don't think you all should do this,'" said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. "You can't look at the small number of people who had success and say this works. It's not the majority."
The dispute over TROSA's funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
"Because essentially they're running businesses off of people's uncompensated labor, there is a built-in funding mechanism," he said. "If the state doesn't have to pay full freight to run a program … that might be a reason to like it."
TROSA's annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30% of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA's request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program's self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
"The good thing about TROSA: They raised most of their own funds," she said in a phone interview.
It's reasonable that residents don't get paid for their work, she added, since they're already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
But being a bargain doesn't necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
"The work-based element is essential to recovery," Artin said. "We're teaching people how to live."
Toward the end of residents' two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging work experiences
TROSA's model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was "a blessing."
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA's thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. "It was meaningful work that also taught me a lot of good job skills," he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they're buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master's in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38% of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. "The next day, they told me I had to get back to work," he claimed.
That's when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it's no thanks to TROSA, he said.
"They're taking advantage of people at their low points in life," he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents' experience. In general, CEO Artin wrote in an email, "when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk."
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program's 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It's been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the "gold standard" for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they've discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they'd consider injectable buprenorphine, but it's costly for their mostly uninsured participants.
"People choose to come here because it is a behavior modification program," said Lisa Finlay, lead clinical counselor at TROSA. "They know that we don't offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using."
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling, and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40% of residential programs surveyed in the U.S. didn't offer opioid use disorder medications and 20% actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training, and to learn coping skills. Roberts recalled one patient saying to her: "I need to go to residential treatment and I need this medication because I fear I'll die."
"That’s really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature," she said. "And that you know there are very few places in the state that offer that."
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they're the best way to combat the opioid crisis. Some medical and legal experts have said it's in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
"The goal isn't just to get people into treatment; it's to get people doing better," he said. "You want to make sure that you're using the money effectively."
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it's an effective program, he said, "I also have concerns from what I learned about TROSA's approach to treating opioid addiction in particular. I'd like to see TROSA consider what their current practices are." | 1 | 131,327 | 0.189272 | https://www.physiciansweekly.com/11m-for-north-carolina-work-based-rehab-raises-concerns/ | 2022-04-06 10:03:07+00:00 | DURHAM, N.C. — An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym, and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing, and meals are free to participants. And TROSA doesn’t bill insurance. Instead, residents work for about two years in TROSA’s many businesses, including a moving company, thrift store, and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96% of individuals remain sober and 91% are employed a year later, the program’s latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It’s the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25% of participants complete the program — a figure TROSA leaders confirmed.
“If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], ‘I don’t think you all should do this,’” said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. “You can’t look at the small number of people who had success and say this works. It’s not the majority.”
The dispute over TROSA’s funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as Treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
“Because essentially they’re running businesses off of people’s uncompensated labor, there is a built-in funding mechanism,” he said. “If the state doesn’t have to pay full freight to run a program … that might be a reason to like it.”
TROSA’s annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30% of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA’s request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program’s self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
“The good thing about TROSA: They raised most of their own funds,” she said in a phone interview.
It’s reasonable that residents don’t get paid for their work, she added, since they’re already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
But being a bargain doesn’t necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
“The work-based element is essential to recovery,” Artin said. “We’re teaching people how to live.”
Toward the end of residents’ two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging Work Experiences
TROSA’s model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was “a blessing.”
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA’s thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. “It was meaningful work that also taught me a lot of good job skills,” he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they’re buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master’s in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38% of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. “The next day, they told me I had to get back to work,” he claimed.
That’s when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it’s no thanks to TROSA, he said.
“They’re taking advantage of people at their low points in life,” he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents’ experience. In general, CEO Artin wrote in an email, “when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk.”
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program’s 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication Hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It’s been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the “gold standard” for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they’ve discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they’d consider injectable buprenorphine, but it’s costly for their mostly uninsured participants.
“People choose to come here because it is a behavior modification program,” said Lisa Finlay, lead clinical counselor at TROSA. “They know that we don’t offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using.”
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling, and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40% of residential programs surveyed in the U.S. didn’t offer opioid use disorder medications and 20% actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training, and to learn coping skills. Roberts recalled one patient saying to her: “I need to go to residential treatment and I need this medication because I fear I’ll die.”
“That’s really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature,” she said. “And that you know there are very few places in the state that offer that.”
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they’re the best way to combat the opioid crisis. Some medical and legal experts have said it’s in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
“The goal isn’t just to get people into treatment; it’s to get people doing better,” he said. “You want to make sure that you’re using the money effectively.”
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it’s an effective program, he said, “I also have concerns from what I learned about TROSA’s approach to treating opioid addiction in particular. I’d like to see TROSA consider what their current practices are.”
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).
By Aneri Pattani and Taylor Knopf, NC Health NewsKaiser Health News is a nonprofit news service covering health issues. It is an editorially independent program of the Kaiser Family Foundation, which is not affiliated with Kaiser Permanente. |
https://www.news-medical.net/news/20220406/2411M-for-North-Carolina-work-based-rehab-raises-concerns.aspx | An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym, and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing, and meals are free to participants. And TROSA doesn't bill insurance. Instead, residents work for about two years in TROSA's many businesses, including a moving company, thrift store, and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96% of individuals remain sober and 91% are employed a year later, the program's latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It's the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25% of participants complete the program — a figure TROSA leaders confirmed.
"If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], 'I don't think you all should do this,'" said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. "You can't look at the small number of people who had success and say this works. It's not the majority."
The dispute over TROSA's funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
"Because essentially they're running businesses off of people's uncompensated labor, there is a built-in funding mechanism," he said. "If the state doesn't have to pay full freight to run a program … that might be a reason to like it."
TROSA's annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30% of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA's request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program's self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
"The good thing about TROSA: They raised most of their own funds," she said in a phone interview.
It's reasonable that residents don't get paid for their work, she added, since they're already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
But being a bargain doesn't necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
"The work-based element is essential to recovery," Artin said. "We're teaching people how to live."
Toward the end of residents' two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging work experiences
TROSA's model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was "a blessing."
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA's thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. "It was meaningful work that also taught me a lot of good job skills," he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they're buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master's in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38% of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. "The next day, they told me I had to get back to work," he claimed.
That's when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it's no thanks to TROSA, he said.
"They're taking advantage of people at their low points in life," he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents' experience. In general, CEO Artin wrote in an email, "when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk."
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program's 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It's been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the "gold standard" for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they've discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they'd consider injectable buprenorphine, but it's costly for their mostly uninsured participants.
"People choose to come here because it is a behavior modification program," said Lisa Finlay, lead clinical counselor at TROSA. "They know that we don't offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using."
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling, and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40% of residential programs surveyed in the U.S. didn't offer opioid use disorder medications and 20% actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training, and to learn coping skills. Roberts recalled one patient saying to her: "I need to go to residential treatment and I need this medication because I fear I'll die."
"That’s really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature," she said. "And that you know there are very few places in the state that offer that."
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they're the best way to combat the opioid crisis. Some medical and legal experts have said it's in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
"The goal isn't just to get people into treatment; it's to get people doing better," he said. "You want to make sure that you're using the money effectively."
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it's an effective program, he said, "I also have concerns from what I learned about TROSA's approach to treating opioid addiction in particular. I'd like to see TROSA consider what their current practices are." | 2 | 102,173 | 0.189272 | https://khn.org/news/article/trosa-north-carolina-drug-opioid-work-rehab-funding-concerns/ | 2022-04-06 17:52:58+00:00 | DURHAM, N.C. — An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself. Triangle Residential Options for Substance Abusers, better known as TROSA, hosts roughly 400 people a day on a campus with rows of housing units, cafeterias, a full gym, and a barbershop.
The program, which began in 1994, is uniquely designed: Treatment, housing, and meals are free to participants. And TROSA doesn’t bill insurance. Instead, residents work for about two years in TROSA’s many businesses, including a moving company, thrift store, and lawn care service. Program leaders say the work helps residents overcome addiction and train for future jobs. Of those who graduate, 96% of individuals remain sober and 91% are employed a year later, the program’s latest report claims.
Impressed with such statistics, state lawmakers recently allotted $11 million for TROSA to expand its model to Winston-Salem. It’s the largest amount in the state budget targeted to a single treatment provider and comes on the heels of $6 million North Carolina previously provided for its expansion, as well as $3.2 million TROSA has received in state and federal funds annually for several years.
This latest influx of taxpayer dollars — coming at a time when overdose deaths are surging and each dollar spent on treatment is crucial — is drawing criticism. Advocates, researchers, and some former employees and participants of TROSA say the program takes advantage of participants by making them work without pay and puts their lives at risk by restricting the use of certain medications for opioid use disorder. Although those who graduate may do well, only 25% of participants complete the program — a figure TROSA leaders confirmed.
“If I had known about this funding, I would have been the first person on the mic to [tell lawmakers], ‘I don’t think you all should do this,’” said K.C. Freeman, who interned at TROSA in 2018 and later spent two months on staff in the medical department. “You can’t look at the small number of people who had success and say this works. It’s not the majority.”
The dispute over TROSA’s funding comes amid national conversations about how to allocate billions of dollars available after landmark opioid settlements with drug companies. Two flashpoints in the North Carolina debate may provide a window into heated conversations to come. First: Are work-based rehabs legal or ethical? And second: Should every facility that receives public funding allow participants to use all medications for opioid use disorder?
Work as Treatment
Work-based rehabs are widespread across the country. The investigative news outlet Reveal identified at least 300 such facilities, including some that place participants in dangerous jobs at oil refineries or dairy farms with no training and exploit workers to bolster profits.
Many of these programs use a portion of their revenue to sustain the rehab and offer residents free housing or meals. That can make them attractive to state legislators, said Noah Zatz, a UCLA law professor who specializes in employment and labor law.
“Because essentially they’re running businesses off of people’s uncompensated labor, there is a built-in funding mechanism,” he said. “If the state doesn’t have to pay full freight to run a program … that might be a reason to like it.”
TROSA’s annual reports indicate more than half of its multimillion-dollar budget is funded through its businesses at which residents work, as well as goods and services that are donated to the program. About 30% of its funding comes from government grants and contracts.
Although TROSA and its leaders report no significant campaign donations, they spend upward of $75,000 a year on lobbying. In presentations, they often share a 2017 study — conducted by an independent research institute at TROSA’s request — which found TROSA saves the state nearly $7.5 million annually in criminal justice and emergency care costs.
The program’s self-financing aspect is part of its appeal for North Carolina Sen. Joyce Krawiec, a Republican who represents part of Forsyth County, where TROSA is building its new site.
“The good thing about TROSA: They raised most of their own funds,” she said in a phone interview.
It’s reasonable that residents don’t get paid for their work, she added, since they’re already receiving free treatment and housing. Other rehabs can be prohibitively expensive for many families, so TROSA provides a much-needed option.
But being a bargain doesn’t necessarily make it legal, Zatz and other labor experts said. A previous U.S. Supreme Court ruling suggests nonprofits that run businesses without paying employees could violate the Fair Labor Standards Act.
But TROSA administrators say they are not an employer; they are a therapeutic community. Clear policies guard against the exploitation of anyone, said Keith Artin, president and CEO. The jobs provide residents with structure and an opportunity to change their behaviors.
“The work-based element is essential to recovery,” Artin said. “We’re teaching people how to live.”
Toward the end of residents’ two-year stays, TROSA assists them in job-hunting and allows them to live on campus for several months while they work at a newfound job and build savings.
Diverging Work Experiences
TROSA’s model has widespread support among lawmakers and families affected by addiction. Benjamin Weston said it was “a blessing.”
Weston said he started using cocaine as a teenager and struggled with addiction for years. At 22, he entered TROSA. He said he was grateful for two years of free treatment.
After brief assignments in TROSA’s thrift store and moving company, Weston transitioned to the development office, where he solicited donations from local businesses. “It was meaningful work that also taught me a lot of good job skills,” he said.
Since graduating in 2016, Weston has worked in development for Hope Connection International, a nonprofit his mother started to support survivors of abuse and addiction.
Other graduates interviewed for this article talked about using the moving skills or commercial driving licenses they gained to obtain full-time jobs. Some said they’re buying houses and starting families — successes they credit to their experience in the program.
But not every resident finds the work model therapeutic. Several described working 10 to 16 hours a day, six days a week, in physically demanding moving or lawn care businesses. Several said there was little time for therapy and, with only a handful of counselors for hundreds of residents, wait times for a session could span weeks.
Freeman, the former TROSA employee who has a master’s in social work, said he thought residents rarely had an opportunity to process the trauma that made them use drugs in the first place. Although Freeman did not counsel clients — his role at TROSA focused on ordering and stocking medications — he said he noticed many graduates returned repeatedly to the program, struggling to stay away from substances once they left campus.
Richard Osborne first heard of TROSA while incarcerated on drug and theft-related charges. Like 38% of TROSA residents, he chose to attend the program as a condition of his probation.
One day in 2017, Osborne and other residents working with the moving company were unloading large boards of plywood from a trailer, when a board fell and smashed him against the trailer, he said. His vision became blurry and he worried about having a concussion, he said.
As he remembers it, no one suggested medical care. “The next day, they told me I had to get back to work,” he claimed.
That’s when Osborne said he decided to leave.
Today, Osborne, 31, said he has not used drugs in about four years, holds a steady job, and has a loving family. But it’s no thanks to TROSA, he said.
“They’re taking advantage of people at their low points in life,” he said. The moving company brings in $4 million a year, yet residents who work for it are not even allowed to keep tips, he added.
TROSA leaders confirmed the tips policy but said they could not comment on an individual residents’ experience. In general, CEO Artin wrote in an email, “when a resident is injured we ensure that they receive immediate medical attention and would never knowingly put a resident at risk.”
As a nonprofit, TROSA funnels revenue from its businesses back into the treatment program, he added.
The program’s 2020 tax documents show its top five employees combined earned over $750,000 in salary and benefits.
Medication Hesitancy
TROSA provides psychiatric care through a contract with Duke Health and offers group or individual counseling to residents who request it. The program employs four full-time counselors and partners with local providers who donate physical therapy, dental care, and other medical services.
But TROSA does not provide access to some of the most effective treatments for opioid use disorder: methadone and buprenorphine. Both medications activate opioid receptors in the brain and reduce opioid withdrawal and cravings. It’s been well documented that these medications greatly reduce the risk of opioid overdose death, and the FDA-approved drugs are considered the “gold standard” for treatment.
Right now, TROSA leaders say the only medication for opioid use disorder the program offers is naltrexone, an injectable medication that works differently than the other two because it requires patients to fully detox to be effective. Because of this, some experts are hesitant to use it, saying it puts people at higher risk of overdose death.
About one-third of TROSA participants report opioids are their primary drug of choice.
TROSA leaders said they’ve discussed adding the other addiction treatment medications but face logistical barriers. All medications at TROSA are self-administered, and leaders worry about diversion of oral methadone and buprenorphine, which are classified as controlled substances. They say they’d consider injectable buprenorphine, but it’s costly for their mostly uninsured participants.
“People choose to come here because it is a behavior modification program,” said Lisa Finlay, lead clinical counselor at TROSA. “They know that we don’t offer buprenorphine or those medications. We have people who have tried those medications in the past and believe that they actually led them back to using.”
Evidence suggests that people using medications for opioid use disorder have the best outcomes when they have access to other recovery support services, such as housing, employment, counseling, and a community. But while clinicians across the country have embraced these medications, leaders of residential treatment programs founded in the more traditional 12-step, abstinence-based recovery model have pushed back.
Some old-school recovery leaders claim the use of medications is simply replacing one drug with another, which has created stigma around this form of treatment.
A 2020 study found that about 40% of residential programs surveyed in the U.S. didn’t offer opioid use disorder medications and 20% actively discouraged people from using them. In North Carolina, there are 62 licensed long-term residential treatment facilities, according to the SAMHSA treatment locator, and fewer than half accept patients who take these medications. Only 12 facilities are licensed to prescribe buprenorphine.
This has resulted in tough conversations with patients for Kate Roberts, a clinical social worker on a UNC Health team that treats people with severe IV drug-related infections. Once patients are stabilized, many start buprenorphine, she said. Some say they want to go to a residential program for structure, job training, and to learn coping skills. Roberts recalled one patient saying to her: “I need to go to residential treatment and I need this medication because I fear I’ll die.”
“That’s really heartbreaking to hear a patient clearly articulate what it is that they need … which is in line with the [research] literature,” she said. “And that you know there are very few places in the state that offer that.”
Doctors and public health experts nationwide are pushing for lawmakers to fund rehab facilities that allow these medications, saying they’re the best way to combat the opioid crisis. Some medical and legal experts have said it’s in violation of the Americans with Disabilities Act to deny recovery services such as housing to people using medications for opioid use disorder. Health experts say that funding abstinence-based addiction programs could also inadvertently cause more overdoses if people leave the program and return to using drugs with a much lower tolerance, especially as fentanyl is rampant in the street drug supply.
These conversations will become only more important as opioid settlement funds arrive, said Bradley Stein, director of the national Rand Opioid Policy Center.
“The goal isn’t just to get people into treatment; it’s to get people doing better,” he said. “You want to make sure that you’re using the money effectively.”
The conversations have begun in North Carolina. When Rep. Graig Meyer (D-Durham) tweeted his support for TROSA late last year, clinicians reached out to him explaining their concerns about the program not allowing participants to use methadone or buprenorphine.
Although Meyer still believes it’s an effective program, he said, “I also have concerns from what I learned about TROSA’s approach to treating opioid addiction in particular. I’d like to see TROSA consider what their current practices are.” |
https://www.forbes.com/sites/brendarichardson/2022/04/06/home-sellers-have-great-expectations-in-a-hot-housing-market/ | Spring is in the air and home buyers and sellers are coming out of hibernation. New survey data by Realtor.com shows that homeowners are gearing up to sell this spring and summer. According to the report, 64% of prospective 2022 sellers anticipate doing so within the next six months and with high expectations for making a profit.
Still, the potential uptick in newly-listed homes indicates some much-needed relief could be on the horizon for buyers – especially first-timers. Today’s sellers expect to ask for relatively affordable prices and include a higher share of Millennials than last spring, suggesting that more Americans plan to upgrade from their starter homes.
“The start of the spring 2022 real estate season comes on the heels of a historic pandemic-defined period, which saw Americans respond to health concerns and government-induced quarantines by seeking shelter in homes,” said George Ratiu, senior economist and manager of economic research at Realtor.com.
He explained that monetary policy injected an unprecedented dose of financial liquidity into capital markets, leading to record-breaking low mortgage rates in 2021.
Ratiu said, “In the process, housing markets—already struggling with over a decade of under-building—responded with double-digit price increases, which continued from last year into March 2022, with the median-priced home reaching $405,000. Moreover, in a market heavily skewed in sellers’ favor, homeowners have been able to be picky with competing offers, each one waiving contingencies and concessions in order to stand out, with winners generally bringing a full cash offer to the closing table.”
The survey of 3,000 consumers, which was conducted online in February, also asked about the experiences of recent sellers, who said determining the right time to list was the longest stage of the process.
“Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home,” said Ratiu. “While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge – particularly for those also buying in today’s fast-paced market.”
Ratiu said homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this spring and summer.
“Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home,” he explained. “At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers’ budgets, underscoring the long-term need for more affordable inventory.”
Survey data suggests some relief is on the horizon for Americans grappling with one of the worst housing shortages of all-time. Almost two-thirds (64%) of prospective 2022 sellers anticipate listing a home within the next six months.
Whether these sellers follow through with their plans will be key to the forecasted 2022 inventory recovery and critical for buyers hoping to find a home before mortgage rates climb even further. In a positive sign that homeowners are serious about listing, many sellers are already getting their homes ready. However, they are doing so with great expectations of the current market, which means buyers should prepare for sellers asking for high offer prices, quick closes, waived contingencies and more.
- The majority of 2022 prospective sellers plan to list within the next six months, with 9% already listed and the remaining getting ready to list within the next 30 days (11%), one to three months (24%) or four to six months (20%).
- Compared to those who planned to list last spring, this year’s prospective sellers have higher expectations of the hot housing market, including asking for more than their home is worth (42% versus 29%) and refusing to pay for repairs or improvements (28% versus 24%).
- When asked why they are planning to list in 2022, surveyed sellers’ top reason was wanting to profit off the current market, tied with their home no longer meeting their families needs (each at 31%).
- Homeowners’ motivating factors behind moving also reflect the impact of pandemic trends, such as wanting different features after spending so much time at home (15%) and no longer needing to live near their office (14%).
With the oldest Millennials already 40 years old, these homeowners are playing an important role in adding to the supply of starter homes. Millennials represent nearly half (49%) of sellers who plan to list within the next six months, and many anticipate selling at relatively affordable prices. This is welcome news for first-time buyers, who face fierce competition for limited available starter homes. Combined with rising affordability issues as home prices and mortgage rates climb, survey data offers some hope for first-time buyers, based on:
- More Millennials plan to list within the next six months than in March 2021 (75% versus 66%), and account for a higher share of all 2022 prospective sellers (42% versus 26%).
- In a further sign that older Millennials are moving on up from their starter homes, the share of surveyed Millennials who have sold a home before was nearly as high as the overall rate (61% versus 64%).
- Millennials have plenty of financial motivation to stick to their plans, with top reasons for selling reflecting the pressures of rising inflation and economic uncertainties. Compared to all survey respondents, higher shares of Gen Y sellers want a more affordable home (34% versus 21%) and need the sale money as soon as possible (14% versus 11%).
- In a potential sign of more starter homes coming onto the market, the majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000 to $500,000 (22%).
The Covid housing market has largely favored sellers, and many who recently sold were able to take advantage of bidding wars, fast closings, waived contingencies, inspections, appraisals and more.
At the same time, sellers’ experiences highlight the importance of preparation, especially as buyer demand is beginning to moderate. Even among recent sellers who found success, the majority took steps to get their home ready to list, such as making repairs, cleaning and decluttering. Although many sellers were able to list quickly, 41% said the process took longer than they anticipated.
- Over half (53%) of sellers spent less than a month preparing their home for listing, while another 26% said the process took one to three months.
- Forty-one percent of recent sellers said getting their home ready to list took longer than they expected. Determining the right time to enter the market took longer than any step of the home prep process, with 38% of respondents reporting that this decision took more than three months.
- Among steps successful sellers took to prepare their home for listing, top responses included repairs and updates (59%) and cleaning and decluttering (67%). While minor cosmetic updates were the top repairs sellers made before listing, at 53% of respondents, nearly as many fully repainted interiors and replaced flooring (47% each).
The majority (80%) of recent sellers sold at or above their asking price. Other top benefits of the competitive market included: buyers forgoing repair concessions (28%), offers within a week (27%) and waived contingencies such as inspections (25%). | 0 | 20,277 | 0.350946 | https://dsnews.com/daily-dose/04-13-2022/survey-majority | 2022-04-15 11:23:07+00:00 | As part of “Listapalooza,” Realtor.com has released a slew of new data showing that potential sellers should think about preparing their home to sell now, during the time leading up to the traditional market frenzy that occurs starting in late spring to the end of summer.
According to Realtor.com, 64% of prospective sellers anticipate doing so within the next six months, and expectations are high for record profits on their potential sales.
Still, the expected uptick in newly-listed homes indicates that much-needed relief could be on the horizon for buyers, especially first-time homebuyers as more Millennials are preparing to sell their starter homes and move up in the market.
This data comes from a survey commissioned by Realtor.com and conducted by HarrisX, a market research firm. HarrisX interviewed collected the responses of 3,000 individuals from Feb. 16-18 of this year. The demographics of the sample was chosen to be roughly representative of the demographics of the nation as a whole.
The survey also found that of the 3,000 consumers that responded to the survey, the determination on when to list their house was the longest stage of the home selling process.
"Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home. While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge—particularly for those also buying in today's fast-paced market," said George Ratiu, Senior Economist and Manager of Economic Research at Realtor.com. "Homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this Spring and Summer. Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home. At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers' budgets, underscoring the long-term need for more affordable inventory."
Homeowners are ready to take advantage of the spring and summer buying seasons
Again, the survey data indicates that the near-record low amount of inventory the market is currently seeing will improve in the next six months as 64% of prospective sellers anticipate selling within the next six months.
Potential sellers also indicated that they are getting their properties ready for sale with the expectations that currents trends will continue, which means high offer prices, quick closes, waived appraisals or inspections, and more.
- The majority of 2022 prospective sellers plan to list within the next six months, with 9% already listed and the remaining getting ready to list within the next 30 days (11%), 1-3 months (24%) or 4-6 months (20%).
- Compared to those who planned to list last Spring, this year's prospective sellers have higher expectations of the hot housing market, including asking for more than their home is worth (42% vs. 29%) and refusing to pay for repairs or improvements (28% vs. 24%).
- When asked why they're planning to list in 2022, surveyed sellers' top reason was wanting to profit off the current market, tied with their home no longer meeting their families needs (each at 31%).
- Homeowners' motivating factors behind moving also reflect the impact of pandemic trends, such as wanting different features after spending so much time at home (15%) and no longer needing to live near their office (14%).
Millennials are moving on up, signaling more starter homes for first-time buyers
As the oldest Millennials are now pushing 40-years-old, these homeowners play a key role in adding starter-home inventory to the market. Millennials represented 49% of sellers who plan to list within the next six months. This should be welcome news for first-time buyers who typically buy these starter homes, but they should still expect fierce competition for these homes.
When combined with rising affordability concerns as both home prices and interest rates climb, the survey offered hope for first-time homebuyers based on:
- More millennials plan to list within the next six months than in March 2021 (75% vs. 66%), and account for a higher share of all 2022 prospective sellers (42.0% vs. 26.0%).
- In a further sign that older millennials are moving on up from their starter homes, the share of surveyed millennials who have sold a home before was nearly as high as the overall rate (61% vs. 64%).
- Millennials have plenty of financial motivation to stick to their plans, with top reasons for selling reflecting the pressures of rising inflation and economic uncertainties. Compared to all survey respondents, higher shares of Gen Y sellers want a more affordable home (34% vs. 21%) and need the sale money ASAP (14% vs. 11%).
- In a potential sign of more starter homes coming onto the market, the majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000-$500,000 (22%).
Recent experiences highlight the importance of preparation, even in a seller's market
Over the last two years, the housing market throughout the course of the COVID-19 pandemic has largely favored sellers, not buyers. In order to prepare for a sale, buyers are increasingly making repairs, cleaning, and decluttering in preparation for showing the home to buyers.
Although many sellers are able to list their homes quickly, 41% of those that have reported that the listing process took longer than they had planned for one reason or another.
- Over half (53%) of sellers spent less than a month preparing their home for listing, while another 26% said the process took 1-3 months.
- Forty-one percent of recent sellers said getting their home ready to list took longer than they expected. Determining the right time to enter the market took longer than any step of the home prep process, with 38% of respondents reporting that this decision took more than 3 months.
- Among steps successful sellers took to prepare their home for listing, top responses included repairs and updates (59%) and cleaning and decluttering (67%). While minor cosmetic updates were the top repair sellers made before listing, at 53% of respondents, nearly as many fully repainted interiors and replaced flooring (47% each).
- The majority (80%) of recent sellers sold at or above their asking price. Other top benefits of the competitive market included: buyers forgoing repair concessions (28%), offers within a week (27%), and waived contingencies like inspections (25%).
Listapalooza, was created by Realtor.com earlier this year, branding the week they traditionally release and analyze data predicting when the best week for sellers to list their houses will be. This year, that week was determined to be April 10-16 due to predictions of high buyer demand, strong home prices, quick sales, and less competition.
Designed around a marketing campaign, the week features the release of survey data, insights, and resources to help sellers prepare for the process and understand their options. It was also named a “national holiday” by the National Day Archives, a website that tracks and promotes events such as “Talk Like a Pirate Day” (Sept. 19) or National Cat Day (Oct. 29). |
https://www.forbes.com/sites/brendarichardson/2022/04/06/home-sellers-have-great-expectations-in-a-hot-housing-market/ | Spring is in the air and home buyers and sellers are coming out of hibernation. New survey data by Realtor.com shows that homeowners are gearing up to sell this spring and summer. According to the report, 64% of prospective 2022 sellers anticipate doing so within the next six months and with high expectations for making a profit.
Still, the potential uptick in newly-listed homes indicates some much-needed relief could be on the horizon for buyers – especially first-timers. Today’s sellers expect to ask for relatively affordable prices and include a higher share of Millennials than last spring, suggesting that more Americans plan to upgrade from their starter homes.
“The start of the spring 2022 real estate season comes on the heels of a historic pandemic-defined period, which saw Americans respond to health concerns and government-induced quarantines by seeking shelter in homes,” said George Ratiu, senior economist and manager of economic research at Realtor.com.
He explained that monetary policy injected an unprecedented dose of financial liquidity into capital markets, leading to record-breaking low mortgage rates in 2021.
Ratiu said, “In the process, housing markets—already struggling with over a decade of under-building—responded with double-digit price increases, which continued from last year into March 2022, with the median-priced home reaching $405,000. Moreover, in a market heavily skewed in sellers’ favor, homeowners have been able to be picky with competing offers, each one waiving contingencies and concessions in order to stand out, with winners generally bringing a full cash offer to the closing table.”
The survey of 3,000 consumers, which was conducted online in February, also asked about the experiences of recent sellers, who said determining the right time to list was the longest stage of the process.
“Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home,” said Ratiu. “While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge – particularly for those also buying in today’s fast-paced market.”
Ratiu said homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this spring and summer.
“Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home,” he explained. “At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers’ budgets, underscoring the long-term need for more affordable inventory.”
Survey data suggests some relief is on the horizon for Americans grappling with one of the worst housing shortages of all-time. Almost two-thirds (64%) of prospective 2022 sellers anticipate listing a home within the next six months.
Whether these sellers follow through with their plans will be key to the forecasted 2022 inventory recovery and critical for buyers hoping to find a home before mortgage rates climb even further. In a positive sign that homeowners are serious about listing, many sellers are already getting their homes ready. However, they are doing so with great expectations of the current market, which means buyers should prepare for sellers asking for high offer prices, quick closes, waived contingencies and more.
- The majority of 2022 prospective sellers plan to list within the next six months, with 9% already listed and the remaining getting ready to list within the next 30 days (11%), one to three months (24%) or four to six months (20%).
- Compared to those who planned to list last spring, this year’s prospective sellers have higher expectations of the hot housing market, including asking for more than their home is worth (42% versus 29%) and refusing to pay for repairs or improvements (28% versus 24%).
- When asked why they are planning to list in 2022, surveyed sellers’ top reason was wanting to profit off the current market, tied with their home no longer meeting their families needs (each at 31%).
- Homeowners’ motivating factors behind moving also reflect the impact of pandemic trends, such as wanting different features after spending so much time at home (15%) and no longer needing to live near their office (14%).
With the oldest Millennials already 40 years old, these homeowners are playing an important role in adding to the supply of starter homes. Millennials represent nearly half (49%) of sellers who plan to list within the next six months, and many anticipate selling at relatively affordable prices. This is welcome news for first-time buyers, who face fierce competition for limited available starter homes. Combined with rising affordability issues as home prices and mortgage rates climb, survey data offers some hope for first-time buyers, based on:
- More Millennials plan to list within the next six months than in March 2021 (75% versus 66%), and account for a higher share of all 2022 prospective sellers (42% versus 26%).
- In a further sign that older Millennials are moving on up from their starter homes, the share of surveyed Millennials who have sold a home before was nearly as high as the overall rate (61% versus 64%).
- Millennials have plenty of financial motivation to stick to their plans, with top reasons for selling reflecting the pressures of rising inflation and economic uncertainties. Compared to all survey respondents, higher shares of Gen Y sellers want a more affordable home (34% versus 21%) and need the sale money as soon as possible (14% versus 11%).
- In a potential sign of more starter homes coming onto the market, the majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000 to $500,000 (22%).
The Covid housing market has largely favored sellers, and many who recently sold were able to take advantage of bidding wars, fast closings, waived contingencies, inspections, appraisals and more.
At the same time, sellers’ experiences highlight the importance of preparation, especially as buyer demand is beginning to moderate. Even among recent sellers who found success, the majority took steps to get their home ready to list, such as making repairs, cleaning and decluttering. Although many sellers were able to list quickly, 41% said the process took longer than they anticipated.
- Over half (53%) of sellers spent less than a month preparing their home for listing, while another 26% said the process took one to three months.
- Forty-one percent of recent sellers said getting their home ready to list took longer than they expected. Determining the right time to enter the market took longer than any step of the home prep process, with 38% of respondents reporting that this decision took more than three months.
- Among steps successful sellers took to prepare their home for listing, top responses included repairs and updates (59%) and cleaning and decluttering (67%). While minor cosmetic updates were the top repairs sellers made before listing, at 53% of respondents, nearly as many fully repainted interiors and replaced flooring (47% each).
The majority (80%) of recent sellers sold at or above their asking price. Other top benefits of the competitive market included: buyers forgoing repair concessions (28%), offers within a week (27%) and waived contingencies such as inspections (25%). | 1 | 55,121 | 0.412948 | https://www.theintelligencer.com/news/article/64-of-2022-prospective-home-sellers-plan-to-list-17062028.php | 2022-04-07 14:35:18+00:00 | Of prospective 2022 home sellers, 64% anticipate selling within the next six months, with high expectations for making a profit, according to a report from Realtor.com. Sellers expect to ask for relatively affordable prices and include a higher share of millennials than last Spring, suggesting that more Americans plan to upgrade from their starter homes, Realtor.com stated.
The Realtor.com survey included 3,000 customers and also asked about the experiences of recent sellers, who said determining the right time to list was the longest stage of the process.
"Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home," George Ratiu, senior economist and manager of economic research at Realtor.com said in a statement. "While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge – particularly for those also buying in today's fast-paced market."
"Homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this Spring and Summer," Ratiu continued. "Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home. At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers' budgets, underscoring the long-term need for more affordable inventory."
Key to the forecasted 2022 inventory recovery and critical for buyers hoping to find a home before mortgage rates climb even further is well prospective sellers follow through with their plans. Many sellers are already preparing their homes, Realtor.com found, however, they're doing so with "great expectations" of the current market, which means buyers should prepare for sellers asking for high offer prices, quick home closes, waived contingencies and more.
Among 2022 prospective sellers, 9% already listed and the remaining are getting ready to list in the next 30 days (11%), 1-3 months (24%) or 4-6 months (20%).
This year's prospective sellers also have higher expectations of the housing market, including asking for more than their home is worth (42% vs. 29%) and refusing to pay for repairs or improvements (28% vs. 24%). Surveyed sellers' top reason for planning to list in 2022 was profiting off the current market, tied with homes no longer meeting family needs (each at 31%), the report found.
Millennials represent nearly half (49%) of sellers who plan to list within the next six months, with many anticipating selling at relatively affordable prices, Realtor.com wrote. More millennials plan to list within the next six months than in March 2021 (75% vs. 66%) and account for a higher share of all 2022 prospective sellers (42% vs. 26%).
The majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000-$500,000 (22%), the report found.
The majority of recent sellers took steps to get their home ready to list, like making repairs (with 59% of successful sellers reporting they took the step) and cleaning and decluttering (67%). Among recent sellers, 41% said the process took longer than they originally anticipated, the report found. More than half (53%) of sellers spent less than a month preparing their home for listing while another 26% said the process took 1-3 months.
Minor cosmetic updates were the top repair made before listing at 53% of respondents while 47% reported fully repainting interiors and another 47% replacing flooring.
The majority (80%) of recent sellers sold at or above their asking price while 28% of buyers reported foregoing repair concessions, with other benefits of the current market being offers within a week (27%) and waived contingencies like inspections (25%).
The survey was conducted online in the United States from Feb. 16 to 18 among 3,000 adults. The results reflect a nationally representative sample of U.S. adults. Results were weighted for age by gender, region, race/ethnicity, and income where necessary to align them with their actual proportions in the population. |
https://www.forbes.com/sites/brendarichardson/2022/04/06/home-sellers-have-great-expectations-in-a-hot-housing-market/ | Spring is in the air and home buyers and sellers are coming out of hibernation. New survey data by Realtor.com shows that homeowners are gearing up to sell this spring and summer. According to the report, 64% of prospective 2022 sellers anticipate doing so within the next six months and with high expectations for making a profit.
Still, the potential uptick in newly-listed homes indicates some much-needed relief could be on the horizon for buyers – especially first-timers. Today’s sellers expect to ask for relatively affordable prices and include a higher share of Millennials than last spring, suggesting that more Americans plan to upgrade from their starter homes.
“The start of the spring 2022 real estate season comes on the heels of a historic pandemic-defined period, which saw Americans respond to health concerns and government-induced quarantines by seeking shelter in homes,” said George Ratiu, senior economist and manager of economic research at Realtor.com.
He explained that monetary policy injected an unprecedented dose of financial liquidity into capital markets, leading to record-breaking low mortgage rates in 2021.
Ratiu said, “In the process, housing markets—already struggling with over a decade of under-building—responded with double-digit price increases, which continued from last year into March 2022, with the median-priced home reaching $405,000. Moreover, in a market heavily skewed in sellers’ favor, homeowners have been able to be picky with competing offers, each one waiving contingencies and concessions in order to stand out, with winners generally bringing a full cash offer to the closing table.”
The survey of 3,000 consumers, which was conducted online in February, also asked about the experiences of recent sellers, who said determining the right time to list was the longest stage of the process.
“Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home,” said Ratiu. “While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge – particularly for those also buying in today’s fast-paced market.”
Ratiu said homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this spring and summer.
“Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home,” he explained. “At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers’ budgets, underscoring the long-term need for more affordable inventory.”
Survey data suggests some relief is on the horizon for Americans grappling with one of the worst housing shortages of all-time. Almost two-thirds (64%) of prospective 2022 sellers anticipate listing a home within the next six months.
Whether these sellers follow through with their plans will be key to the forecasted 2022 inventory recovery and critical for buyers hoping to find a home before mortgage rates climb even further. In a positive sign that homeowners are serious about listing, many sellers are already getting their homes ready. However, they are doing so with great expectations of the current market, which means buyers should prepare for sellers asking for high offer prices, quick closes, waived contingencies and more.
- The majority of 2022 prospective sellers plan to list within the next six months, with 9% already listed and the remaining getting ready to list within the next 30 days (11%), one to three months (24%) or four to six months (20%).
- Compared to those who planned to list last spring, this year’s prospective sellers have higher expectations of the hot housing market, including asking for more than their home is worth (42% versus 29%) and refusing to pay for repairs or improvements (28% versus 24%).
- When asked why they are planning to list in 2022, surveyed sellers’ top reason was wanting to profit off the current market, tied with their home no longer meeting their families needs (each at 31%).
- Homeowners’ motivating factors behind moving also reflect the impact of pandemic trends, such as wanting different features after spending so much time at home (15%) and no longer needing to live near their office (14%).
With the oldest Millennials already 40 years old, these homeowners are playing an important role in adding to the supply of starter homes. Millennials represent nearly half (49%) of sellers who plan to list within the next six months, and many anticipate selling at relatively affordable prices. This is welcome news for first-time buyers, who face fierce competition for limited available starter homes. Combined with rising affordability issues as home prices and mortgage rates climb, survey data offers some hope for first-time buyers, based on:
- More Millennials plan to list within the next six months than in March 2021 (75% versus 66%), and account for a higher share of all 2022 prospective sellers (42% versus 26%).
- In a further sign that older Millennials are moving on up from their starter homes, the share of surveyed Millennials who have sold a home before was nearly as high as the overall rate (61% versus 64%).
- Millennials have plenty of financial motivation to stick to their plans, with top reasons for selling reflecting the pressures of rising inflation and economic uncertainties. Compared to all survey respondents, higher shares of Gen Y sellers want a more affordable home (34% versus 21%) and need the sale money as soon as possible (14% versus 11%).
- In a potential sign of more starter homes coming onto the market, the majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000 to $500,000 (22%).
The Covid housing market has largely favored sellers, and many who recently sold were able to take advantage of bidding wars, fast closings, waived contingencies, inspections, appraisals and more.
At the same time, sellers’ experiences highlight the importance of preparation, especially as buyer demand is beginning to moderate. Even among recent sellers who found success, the majority took steps to get their home ready to list, such as making repairs, cleaning and decluttering. Although many sellers were able to list quickly, 41% said the process took longer than they anticipated.
- Over half (53%) of sellers spent less than a month preparing their home for listing, while another 26% said the process took one to three months.
- Forty-one percent of recent sellers said getting their home ready to list took longer than they expected. Determining the right time to enter the market took longer than any step of the home prep process, with 38% of respondents reporting that this decision took more than three months.
- Among steps successful sellers took to prepare their home for listing, top responses included repairs and updates (59%) and cleaning and decluttering (67%). While minor cosmetic updates were the top repairs sellers made before listing, at 53% of respondents, nearly as many fully repainted interiors and replaced flooring (47% each).
The majority (80%) of recent sellers sold at or above their asking price. Other top benefits of the competitive market included: buyers forgoing repair concessions (28%), offers within a week (27%) and waived contingencies such as inspections (25%). | 2 | 26,967 | 0.518389 | https://www.finanzen.at/nachrichten/aktien/new-realtor-com-survey-finds-64percent-of-2022-sellers-plan-to-list-by-summers-end-1031335866 | 2022-04-07 12:26:08+00:00 | New Realtor.com® Survey Finds 64% of 2022 Sellers Plan to List by Summer's End
Realtor.com® Listapalooza – the best time to list – is now a national holiday, according to National Day Archives
SANTA CLARA, Calif., April 6, 2022 /PRNewswire/ -- As the final countdown begins to Realtor.com® Listapalooza (April 10-16), a new national holiday, the company today released survey data that shows homeowners are gearing up to sell this Spring and Summer. According to the report, 64% of prospective 2022 sellers anticipate doing so within the next six months, and with high expectations for making a profit. Still, the potential uptick in newly-listed homes indicates some much-needed relief could be on the horizon for buyers – especially first-timers. Today's sellers expect to ask for relatively affordable prices and include a higher share of millennials than last Spring, suggesting that more Americans plan to upgrade from their starter homes.
The Realtor.com® survey of 3,000 consumers, which was conducted online by HarrisX in February 2022, also asked about the experiences of recent sellers, who said determining the right time to list was the longest stage of the process.
"Our survey data illustrates the importance of helping empower homeowners to take control of the listing process, by providing information about market conditions, prices and seasonal trends, like the best dates to list your home. While sellers are expected to hold the upper hand in 2022, navigating the listing process remains a challenge – particularly for those also buying in today's fast-paced market," said George Ratiu, Senior Economist & Manager of Economic Research at Realtor.com®. "Homeowners who are ready to move forward with pandemic-delayed plans will find plenty of opportunity this Spring and Summer. Although accelerating inflation is leading to higher housing costs and living expenses, many buyers remain interested in finding a home. At the same time, recent housing trends suggest demand is beginning to moderate as higher mortgage rates push monthly payments out of some buyers' budgets, underscoring the long-term need for more affordable inventory."
Homeowners are ready to take advantage of the Spring and Summer buying seasons
Survey data suggests some relief is on the horizon for Americans grappling with one of the worst housing shortages of all-time. Almost two-thirds (64%) of prospective 2022 sellers anticipate listing a home within the next six months. Whether these sellers follow-through with their plans will be key to the forecasted 2022 inventory recovery and critical for buyers hoping to find a home before mortgage rates climb even further. In a positive sign that homeowners are serious about listing, many sellers are already getting their home ready. However, they're doing so with great expectations of the current market, which means buyers should prepare for sellers asking for high offer prices, quick closes, waived contingencies and more.
- The majority of 2022 prospective sellers plan to list within the next six months, with 9% already listed and the remaining getting ready to list within the next 30 days (11%), 1-3 months (24%) or 4-6 months (20%).
- Compared to those who planned to list last Spring, this year's prospective sellers have higher expectations of the hot housing market, including asking for more than their home is worth (42% vs. 29%) and refusing to pay for repairs or improvements (28% vs. 24%).
- When asked why they're planning to list in 2022, surveyed sellers' top reason was wanting to profit off the current market, tied with their home no longer meeting their families needs (each at 31%).
- Homeowners' motivating factors behind moving also reflect the impact of pandemic trends, such as wanting different features after spending so much time at home (15%) and no longer needing to live near their office (14%).
Millennials are moving on up, signaling more starter homes for first-time buyers
With the oldest millennials already 40-years-old, these homeowners are playing an important role in adding to the supply of starter homes. Millennials represent nearly half (49%) of sellers who plan to list within the next six months and many anticipate selling at relatively affordable prices. This is welcome news for first-time buyers, who face fierce competition for limited available starter homes. Combined with rising affordability issues as home prices and mortgage rates climb, survey data offers some hope for first-time buyers, based on:
- More millennials plan to list within the next six months than in March 2021 (75% vs. 66%), and account for a higher share of all 2022 prospective sellers (42.0% vs. 26.0%).
- In a further sign that older millennials are moving on up from their starter homes, the share of surveyed millennials who have sold a home before was nearly as high as the overall rate (61% vs. 64%).
- Millennials have plenty of financial motivation to stick to their plans, with top reasons for selling reflecting the pressures of rising inflation and economic uncertainties. Compared to all survey respondents, higher shares of Gen Y sellers want a more affordable home (34% vs. 21%) and need the sale money ASAP (14% vs. 11%).
- In a potential sign of more starter homes coming onto the market, the majority of 2022 prospective sellers expect to list in relatively affordable price ranges: $350,000 or less (43%) and $351,000-$500,000 (22%).
Recent experiences highlight the importance of preparation, even in a seller's market
The COVID housing market has largely favored sellers and many who recently sold were able to take advantage of bidding wars, fast closings, waived contingencies, inspections and appraisals, and more. At the same time, sellers' experiences highlight the importance of preparation, especially as buyer demand is beginning to moderate. Even among recent sellers who found success, the majority took steps to get their home ready to list, such as making repairs, cleaning and decluttering. Additionally, although many sellers were able to list quickly, 41% said the process took longer than they originally anticipated.
- Over half (53%) of sellers spent less than a month preparing their home for listing, while another 26% said the process took 1-3 months.
- Forty-one percent of recent sellers said getting their home ready to list took longer than they expected. Determining the right time to enter the market took longer than any step of the home prep process, with 38% of respondents reporting that this decision took more than 3 months.
- Among steps successful sellers took to prepare their home for listing, top responses included repairs and updates (59%) and cleaning and decluttering (67%). While minor cosmetic updates were the top repair sellers made before listing, at 53% of respondents, nearly as many fully repainted interiors and replaced flooring (47% each).
- The majority (80%) of recent sellers sold at or above their asking price. Other top benefits of the competitive market included: buyers forgoing repair concessions (28%), offers within a week (27%), and waived contingencies like inspections (25%).
Methodology
This Realtor.com® survey was conducted online within the United States from February 16-18, 2022 among 3,000 adults in the United States by HarrisX. The sampling margin of error of this poll is plus or minus 1.8 percentage points. The results reflect a nationally representative sample of U.S. adults. Results were weighted for age by gender, region, race/ethnicity, and income where necessary to align them with their actual proportions in the population.
About Realtor.com®
Realtor.com® makes buying, selling, renting and living in homes easier and more rewarding for everyone. Realtor.com® pioneered the world of digital real estate more than 25 years ago, and today through its website and mobile apps offers a marketplace where people can learn about their options, trust in the transparency of information provided to them, and get services and resources that are personalized to their needs. Using proprietary data science and machine learning technology, Realtor.com® pairs buyers and sellers with local agents in their market, helping take the guesswork out of buying and selling a home. For professionals, Realtor.com® is a trusted provider of consumer connections and branding solutions that help them succeed in today's on-demand world. Realtor.com® is operated by News Corp [Nasdaq: NWS, NWSA] [ASX: NWS, NWSLV] subsidiary Move, Inc. For more information, visit Realtor.com®.
Media Contact
rachel.conner@move.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-realtorcom-survey-finds-64-of-2022-sellers-plan-to-list-by-summers-end-301518509.html
SOURCE Realtor.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren! |
https://www.forbes.com/sites/forbestechcouncil/2022/04/06/recognizing-the-untapped-potential-of-decentralized-clinical-trials/ | Jiang Li, Ph.D., is the Founder and CEO of Vivalink, Inc.
Politicians love the adage “Never let a good crisis go to waste”—a rallying cry for finding silver linings in tumultuous times. In a post-pandemic world, the healthcare field might be missing exactly that kind of opportunity by failing to explore the full potential of decentralized clinical trials (DCTs). DCTs provided a lifeline for disease treatment and drug development when many clinical facilities were so riddled with Covid-19 it was unsafe to continue in-person activities.
Learning More About DCTs
DCTs—studies of treatments or medications done with participants who aren’t in a single location and may never enter a hospital—have been used for many years, but the pandemic made them a vital part of continuing care and drug development. Providing access to clinical trial participation for a more diverse population was already a goal for many healthcare clinicians, but the pandemic spotlighted both the need and the opportunity for trials in this format.
Circumstances made DCTs a necessity, but an examination of their effectiveness during the pandemic laid the groundwork for refinements and improvements—if the potential is fully embraced. Moving forward and making the best use of DCT techniques will require investments in technology, data quality and potential applications. Lessons from the pandemic and earlier should be put into practice to help design more refined, effective trials in the future. Pursuing these aims could ease the burden on participants and tell researchers more about possible clinical applications.
When should a DCT be used?
There’s wide variation in DCTs, as there is in traditional clinical trials, and they aren’t appropriate solutions for every scenario. When it makes clinical, logistical and financial sense, a DCT can provide real-world data reflecting how a patient is affected beyond a specific clinical endpoint. For this discussion, the focus is on drug development trials and the post-pandemic potential for even more effective evaluations of new medications.
Because completely decentralized trials aren’t viable for every case, it may be worth finding situations in which the benefits include greater patient diversity, convenience and compliance. Some researchers point to the potential benefits of new study designs so that by reconsidering study endpoints for safety and efficacy, it might be easier to probe for functional outcomes rather than simply objective academic outcomes. In other words, the study design can factor in how patients fare in their homes, rather than clinical settings, and each participant can be evaluated individually and tracked as to how their results affect a trial endpoint.
DCTs facilitate a practical, patient-oriented set of endpoints to provide a more longitudinal view of the patient’s status. Instead of periodic glimpses, we can see a full picture through continuous data transmission from the remote monitoring technology used to move a trial out of a hospital setting. For example, rather than getting sporadic data points regarding arthritis patient A during visits to a clinical trial location, it’s possible to know that they’re moving up and down stairs more after starting a trial drug and to examine his progression over time.
A close examination of remote monitoring data can allow for a more refined analysis of the patient’s condition. For example, a study can compare the patient to their own data points. Researchers’ access to continuous data can allow them to track individual and study-wide trends more easily.
This approach marks a sea change for an industry that traditionally relies on conventional clinical research and trials—methods that, in some cases, date back to the 1940s. Although the reasoning behind a trial may vary widely depending on the intent and the phase of development, there are reasons to support decentralizing the process.
Shifting The Paradigm
Expanding the thinking on what remote patient monitoring (RPM) and DCTs can achieve with regard to collecting ambulatory data requires innovation in interpretation and collaboration, which could better serve both participants and the industry. The entire industry must embrace the idea of shifting the paradigm—even if just for some trials—from the in-clinic experience to the real-world experience and from a hard and fast objective biomarker to a more functional biomarker.
Addressing the cost is obviously a consideration. Research results show that in traditional clinical trials, patient recruitment and retention are two major issues that can delay development. Those delays, in turn, increase the overall cost. The number of patients needed to establish treatment effects is another major influence on estimated cost, followed by the number of clinic visits required for screening, treatment and assessment.
Given those costs, we can infer that DCTs are inherently more cost-effective and certainly less expensive. Even if the decentralized option isn’t an all-or-nothing proposition, combining some traditional elements with some decentralized aspects offers an opportunity to attain quality, continuous data. This, then, provides the necessary information to shift how we approach some trials to a more viable model.
What’s the next step? As an industry, we must leverage the best infrastructure to accomplish our ultimate goal, including making fit-for-purpose remote sensors and being strategic about their locations. We must be assiduous about how we gather, analyze, handle and present data. By expanding the thinking on what RPM and DCTs can do in the collection of ambulatory data and innovation in interpretation and collaboration, we can better serve both trial participants and the industry.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify? | 0 | 53,338 | 0.702811 | https://www.wfmz.com/news/pr_newswire/pr_newswire_health/centerwatch-announces-three-data-trends-you-must-consider-when-developing-your-decentralized-clinical-trial-strategy/article_48ec43a2-b0ae-550b-9a86-c43797ec6ce1.html | 2022-05-10 04:18:59+00:00 | Decentralized clinical trial strategy lacking? Free webinar shows how to update yours to stay compliant, drive better outcomes.
FALLS CHURCH, Va., May 10, 2022 /PRNewswire-PRWeb/ -- Three Data Trends You Must Consider when Developing
Your Decentralized Clinical Trial Strategy
A Free CenterWatch Webinar, Sponsored by Medable, Inc.
Tuesday, May 17, 2022, 11:00 a.m.-12:00 p.m. EDT
https://cwinfo.centerwatch.com/cw-web22517-three-data-trends
The push for rapid adoption of decentralized clinical trials (DCT) is coming from all sides: the pandemic, technology and legislation.
Clinical trial professionals can support enhanced DCT designs to drive better trial outcomes while decreasing the overall burden on sites and patients with this free webinar.
Attendees will learn how to capture quality, real-time data from participants with greater ease and convenience, empowering them to scale their global trials and boost diversity in anticipation of legislation like the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act.
Ching Tian, Medable's senior vice president, strategy and solutions, and Sherry Volk, eClinical Solutions' principal portfolio lead, will explain the three key trends shaping the industry now, so attendees can update their clinical data strategy and create more useful DCT designs with:
- An understanding of the approach that cross-functional clinical teams should take as to incorporate DCT designs into more trials
- Best practices and strategies for design, handling and optimizing data collection and management using DCT and modern platforms for data review and management
- New techniques and understanding to maximize the value of DCT data
With DTC here to stay, the way clinical trial teams capture and use real-time data is more important than ever. This free webinar will make it easier.
Webinar Details:
Three Data Trends You Must Consider when Developing
Your Decentralized Clinical Trial Strategy
A Free CenterWatch Webinar, Sponsored by Medable, Inc.
Tuesday, May 17, 2022, 11:00 a.m.-12:00 p.m. EDT
https://cwinfo.centerwatch.com/cw-web22517-three-data-trends
Tuition:
Free
Easy Ways to Order:
Online: https://cwinfo.centerwatch.com/cw-web22517-three-data-trends
By phone: 888.838.5578 or 703.538.7600
About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.
Media Contact
Michelle Butler, CenterWatch, 703-538-7665, mbutler@fdanews.com
SOURCE CenterWatch |
https://www.forbes.com/sites/forbestechcouncil/2022/04/06/recognizing-the-untapped-potential-of-decentralized-clinical-trials/ | Jiang Li, Ph.D., is the Founder and CEO of Vivalink, Inc.
Politicians love the adage “Never let a good crisis go to waste”—a rallying cry for finding silver linings in tumultuous times. In a post-pandemic world, the healthcare field might be missing exactly that kind of opportunity by failing to explore the full potential of decentralized clinical trials (DCTs). DCTs provided a lifeline for disease treatment and drug development when many clinical facilities were so riddled with Covid-19 it was unsafe to continue in-person activities.
Learning More About DCTs
DCTs—studies of treatments or medications done with participants who aren’t in a single location and may never enter a hospital—have been used for many years, but the pandemic made them a vital part of continuing care and drug development. Providing access to clinical trial participation for a more diverse population was already a goal for many healthcare clinicians, but the pandemic spotlighted both the need and the opportunity for trials in this format.
Circumstances made DCTs a necessity, but an examination of their effectiveness during the pandemic laid the groundwork for refinements and improvements—if the potential is fully embraced. Moving forward and making the best use of DCT techniques will require investments in technology, data quality and potential applications. Lessons from the pandemic and earlier should be put into practice to help design more refined, effective trials in the future. Pursuing these aims could ease the burden on participants and tell researchers more about possible clinical applications.
When should a DCT be used?
There’s wide variation in DCTs, as there is in traditional clinical trials, and they aren’t appropriate solutions for every scenario. When it makes clinical, logistical and financial sense, a DCT can provide real-world data reflecting how a patient is affected beyond a specific clinical endpoint. For this discussion, the focus is on drug development trials and the post-pandemic potential for even more effective evaluations of new medications.
Because completely decentralized trials aren’t viable for every case, it may be worth finding situations in which the benefits include greater patient diversity, convenience and compliance. Some researchers point to the potential benefits of new study designs so that by reconsidering study endpoints for safety and efficacy, it might be easier to probe for functional outcomes rather than simply objective academic outcomes. In other words, the study design can factor in how patients fare in their homes, rather than clinical settings, and each participant can be evaluated individually and tracked as to how their results affect a trial endpoint.
DCTs facilitate a practical, patient-oriented set of endpoints to provide a more longitudinal view of the patient’s status. Instead of periodic glimpses, we can see a full picture through continuous data transmission from the remote monitoring technology used to move a trial out of a hospital setting. For example, rather than getting sporadic data points regarding arthritis patient A during visits to a clinical trial location, it’s possible to know that they’re moving up and down stairs more after starting a trial drug and to examine his progression over time.
A close examination of remote monitoring data can allow for a more refined analysis of the patient’s condition. For example, a study can compare the patient to their own data points. Researchers’ access to continuous data can allow them to track individual and study-wide trends more easily.
This approach marks a sea change for an industry that traditionally relies on conventional clinical research and trials—methods that, in some cases, date back to the 1940s. Although the reasoning behind a trial may vary widely depending on the intent and the phase of development, there are reasons to support decentralizing the process.
Shifting The Paradigm
Expanding the thinking on what remote patient monitoring (RPM) and DCTs can achieve with regard to collecting ambulatory data requires innovation in interpretation and collaboration, which could better serve both participants and the industry. The entire industry must embrace the idea of shifting the paradigm—even if just for some trials—from the in-clinic experience to the real-world experience and from a hard and fast objective biomarker to a more functional biomarker.
Addressing the cost is obviously a consideration. Research results show that in traditional clinical trials, patient recruitment and retention are two major issues that can delay development. Those delays, in turn, increase the overall cost. The number of patients needed to establish treatment effects is another major influence on estimated cost, followed by the number of clinic visits required for screening, treatment and assessment.
Given those costs, we can infer that DCTs are inherently more cost-effective and certainly less expensive. Even if the decentralized option isn’t an all-or-nothing proposition, combining some traditional elements with some decentralized aspects offers an opportunity to attain quality, continuous data. This, then, provides the necessary information to shift how we approach some trials to a more viable model.
What’s the next step? As an industry, we must leverage the best infrastructure to accomplish our ultimate goal, including making fit-for-purpose remote sensors and being strategic about their locations. We must be assiduous about how we gather, analyze, handle and present data. By expanding the thinking on what RPM and DCTs can do in the collection of ambulatory data and innovation in interpretation and collaboration, we can better serve both trial participants and the industry.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify? | 1 | 48,717 | 0.74202 | https://www.globenewswire.com/news-release/2022/05/26/2451326/0/en/Global-Decentralized-Clinical-Trials-DCTs-Market-valued-at-US-8-8-billion-2021-is-set-to-witness-a-healthy-growth-rate-of-10-to-reach-US-14-2-billion-by-2026.html | 2022-05-26 13:43:56+00:00 | Brussels, Belgium, May 26, 2022 (GLOBE NEWSWIRE) --
Description:
Decentralized clinical trials (DCT) employ a method of conducting clinical trials where parts or all of the trial happen outside a traditional physical clinic or trial site. Clinical trial studies are conducted via telemedicine, mobile/local healthcare providers & digital/mobile technologies.
Covid-19 Spurs Adoption of Decentralized Clinical Trials Market
Covid-19 adversely impacted health services internationally and the clinical industry was no different. More than 2000 trials registered on ClinicalTrials.gov were terminated because of the challenges of doing clinical research during the Covid-19 pandemic. Covid-19 adversely impacted participant recruitment, retention, the safety of trial subjects, protocol compliance, and highlighted the need for safe, reliable, and secure remote capabilities, which in turn led to a renewed focus on digitization.
In the wake of the Covid-19 pandemic, decentralized clinical trials (DCT) emerged as an important tool using which patients can be recruited remotely, physician visits/patient consent can take place via telemedicine, and mobile technology can be used for remote data collection.
“The Covid-19 pandemic compelled several sponsors to incorporate virtual elements such as telemedicine, remote electronic medical record access for monitors, and virtual monitoring of data & study documentation into their trials.” - Senior Director, Leading DCT Solution Provider, United States
Regulatory Hurdles Likely to Hamper Adoption of Decentralized Clinical Trials Market
Clinical trial regulations have not kept pace with the digital tools used for decentralized trials. For instance, for wearable devices, there is a need to create an ecosystem where data from different devices and technologies are standardized, validated, and exchanged without data integrity issues.
Regulatory agencies follow a variety of approaches to DCTs, but currently, there is no international standard. The DCT regulatory landscape is continuously changing, and hence clinical-trial sponsors need to align their studies with the most up-to-date guidelines. For multi-regional clinical trials, there is a need to recognize the increased regulations and limited possibilities for variation in research methods. A customized strategy and consideration for complexity in the clinical trial design are required for all global clinical trials that implement decentralization.
Growing Adoption and Financial Backing of DCTs by Pharmaceutical, Medical Device Companies, and Contract Research Organizations (CROs)
In recent years, due to Covid-19, there has been an increase in the use of the DCT model by the pharmaceutical, medical device companies and contract research organizations (CROs):
- To reduce contact, improve the patient experience and keep studies on track during the Covid-19 pandemic.
- Due to the growing trend toward more patient-centric trials.
- The formation of industry stakeholder groups to facilitate collaboration and research.
- The possibility of reducing trial time and costs. Cost savings arising from diverse sources, including fewer sites (i.e., less investigator fees and costs for patient visits, and other site costs), less patient travel costs, and less site monitoring and management fees.
Moreover, funding from big pharma companies to virtual clinical trial specialists is likely to boost the decentralized clinical trials market. For instance, in August 2020, Science 37, an American clinical research company that specializes in decentralized clinical trials, secured $40 million in funding from Novartis, Amgen, Sanofi, PPD, and Google’s VC arm.
The global decentralized clinical trials market is a booming market that is expected to gain further momentum in the coming years due to its ability to harness technological developments to improve the efficiency, participant experience, and generalisability of clinical studies.
Competitive Landscape Analysis: Decentralized Clinical Trials Market
The decentralized clinical trials market is marked by the presence of players such as ICON, Parexel, IQVIA, Covance, Thermo Fisher, LEO Innovation Lab, Huma, Medidata (part of Dassault), Oracle, CRF Health, Medable, Signant Health, and Clinical Ink, among others.
Explore Detailed Insights on Decentralized Clinical Trials Market @ https://meditechinsights.com/decentralized-clinical-trials-market/
About Medi-Tech Insights:
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
Contact Us:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com |
https://www.forbes.com/sites/forbestechcouncil/2022/04/06/recognizing-the-untapped-potential-of-decentralized-clinical-trials/ | Jiang Li, Ph.D., is the Founder and CEO of Vivalink, Inc.
Politicians love the adage “Never let a good crisis go to waste”—a rallying cry for finding silver linings in tumultuous times. In a post-pandemic world, the healthcare field might be missing exactly that kind of opportunity by failing to explore the full potential of decentralized clinical trials (DCTs). DCTs provided a lifeline for disease treatment and drug development when many clinical facilities were so riddled with Covid-19 it was unsafe to continue in-person activities.
Learning More About DCTs
DCTs—studies of treatments or medications done with participants who aren’t in a single location and may never enter a hospital—have been used for many years, but the pandemic made them a vital part of continuing care and drug development. Providing access to clinical trial participation for a more diverse population was already a goal for many healthcare clinicians, but the pandemic spotlighted both the need and the opportunity for trials in this format.
Circumstances made DCTs a necessity, but an examination of their effectiveness during the pandemic laid the groundwork for refinements and improvements—if the potential is fully embraced. Moving forward and making the best use of DCT techniques will require investments in technology, data quality and potential applications. Lessons from the pandemic and earlier should be put into practice to help design more refined, effective trials in the future. Pursuing these aims could ease the burden on participants and tell researchers more about possible clinical applications.
When should a DCT be used?
There’s wide variation in DCTs, as there is in traditional clinical trials, and they aren’t appropriate solutions for every scenario. When it makes clinical, logistical and financial sense, a DCT can provide real-world data reflecting how a patient is affected beyond a specific clinical endpoint. For this discussion, the focus is on drug development trials and the post-pandemic potential for even more effective evaluations of new medications.
Because completely decentralized trials aren’t viable for every case, it may be worth finding situations in which the benefits include greater patient diversity, convenience and compliance. Some researchers point to the potential benefits of new study designs so that by reconsidering study endpoints for safety and efficacy, it might be easier to probe for functional outcomes rather than simply objective academic outcomes. In other words, the study design can factor in how patients fare in their homes, rather than clinical settings, and each participant can be evaluated individually and tracked as to how their results affect a trial endpoint.
DCTs facilitate a practical, patient-oriented set of endpoints to provide a more longitudinal view of the patient’s status. Instead of periodic glimpses, we can see a full picture through continuous data transmission from the remote monitoring technology used to move a trial out of a hospital setting. For example, rather than getting sporadic data points regarding arthritis patient A during visits to a clinical trial location, it’s possible to know that they’re moving up and down stairs more after starting a trial drug and to examine his progression over time.
A close examination of remote monitoring data can allow for a more refined analysis of the patient’s condition. For example, a study can compare the patient to their own data points. Researchers’ access to continuous data can allow them to track individual and study-wide trends more easily.
This approach marks a sea change for an industry that traditionally relies on conventional clinical research and trials—methods that, in some cases, date back to the 1940s. Although the reasoning behind a trial may vary widely depending on the intent and the phase of development, there are reasons to support decentralizing the process.
Shifting The Paradigm
Expanding the thinking on what remote patient monitoring (RPM) and DCTs can achieve with regard to collecting ambulatory data requires innovation in interpretation and collaboration, which could better serve both participants and the industry. The entire industry must embrace the idea of shifting the paradigm—even if just for some trials—from the in-clinic experience to the real-world experience and from a hard and fast objective biomarker to a more functional biomarker.
Addressing the cost is obviously a consideration. Research results show that in traditional clinical trials, patient recruitment and retention are two major issues that can delay development. Those delays, in turn, increase the overall cost. The number of patients needed to establish treatment effects is another major influence on estimated cost, followed by the number of clinic visits required for screening, treatment and assessment.
Given those costs, we can infer that DCTs are inherently more cost-effective and certainly less expensive. Even if the decentralized option isn’t an all-or-nothing proposition, combining some traditional elements with some decentralized aspects offers an opportunity to attain quality, continuous data. This, then, provides the necessary information to shift how we approach some trials to a more viable model.
What’s the next step? As an industry, we must leverage the best infrastructure to accomplish our ultimate goal, including making fit-for-purpose remote sensors and being strategic about their locations. We must be assiduous about how we gather, analyze, handle and present data. By expanding the thinking on what RPM and DCTs can do in the collection of ambulatory data and innovation in interpretation and collaboration, we can better serve both trial participants and the industry.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify? | 2 | 31,725 | 0.756427 | https://www.pharmalive.com/using-decentralized-approaches-to-unleash-the-power-of-real-world-evidence-in-long-term-follow-up-studies/ | 2022-08-09 22:51:41+00:00 | Using decentralized approaches to unleash the power of real-world evidence in long-term follow-up studies
By Gordon Cummins
There has been no shortage of words written during the past year on the potential benefits of applying decentralized approaches to randomized controlled trials (RCT) — especially in the realms of accelerating patient enrollment, improving retention and diversity, and generally getting investigational compounds to market faster for those who need them most. And with good reason. These approaches continue to show great results.
We also know that decentralized clinical trials are not just short-term novelty tactics for coping with COVID, but they represent a fundamental shift in the way clinical research is conducted that will far outlast the pandemic. In fact, our own research reveals that, in 2022, and for the first time, more sponsors and CROs are running agile, or hybrid, clinical trials (featuring at least some decentralized components) than are planning to run traditional clinical trials.
And that’s great for accelerating and improving RCT research. But what about long-term follow-up (LTFU) studies? Can decentralized and agile approaches also be applied to LTFUs and the collection of real-world evidence (RWE)? What does that look like, who’s interested in pursuing it, and what are the perceived benefits and pitfalls?
In the world of biopharmaceutical research, there are two distinct audiences of sponsors interested in harnessing the power of decentralized-driven LTFUs. The first is the study team, or the clinical operations, who are thinking about how to implement this type of design, extending the main study and transitioning into an LTFU. The second comprises the core RWE and health outcomes economics research (HEOR) teams, whose interest in data sets generally goes beyond that of a standard LTFU protocol.
Why clinical operations execs care
The core value propositions for the first group, the “clin ops” folks, are similar to those making the case for using decentralized approaches in the main clinical studies — namely, that the use of DCT components eases the burden on patients, providers, and sites, which, in turn, improves retention rates and provides better, more reliable data sets.
In some cases, LTFU studies are mandated by the FDA, as is often the case in the oncology space. In fact, any trial that is investigating CAR T-cell therapy is required by FDA to do between a five- and a 15-year LTFU. In other cases, there might be more of an agreement with FDA — or even just an internal rationale at the sponsor — to evaluate such things as long-term safety. Either way, sponsors and regulators alike are trying to figure out what is the most efficient manner of implementing LTFUs.
Long-term challenges
LTFU studies are not without challenges, of course. We hear from the market that patients, providers, and study sites have each questioned the value of participating in LTFUs, from time to time. The chief reason on the provider/site side is financial. Since these are not interventional or investigational types of studies, then the financial compensation is not as strong as for traditional clinical trials. Let’s say providers are seeing in their practices maybe three to five patients a year, and according to the study design, most of these visits are standard of care, collected maybe once or twice a year, with maybe some additional patient-reported outcomes (PROs) on the patient side. For this typical scenario, the clinician might make $500 a year at the most. So, for sporadic data collection at that level of reimbursement, it can become more of a nuisance to the provider than a value proposition.
Plus, for sites, the sheer duration of some of these studies can be off-putting — it’s not unheard of to work on studies of maybe 30 years, and some of the more apprehensive sites might be wondering if they’ll even be in business in 15 or 20 years.
Major life events
Patients may have similar reservations regarding the duration of LTFUs, especially when it comes to potential scenarios around major life changes. “What happens when I move from New York to California?” they may ask. So. the patient’s perceived burden may become greater. In this example, either the patient will have to pay out of pocket to travel, which means that they’re probably going to discontinue participation in the study, or the sponsor will have to cover the patient’s additional costs — again, for a once- or twice-a-year in-person visit.
Therefore, the classic core value propositions of DCTs hold strong, in terms of eliminating geographic barriers and reducing the burden — and the long-term concerns — of patients, providers, and traditional clinical trial sites.
The patient is, of course, paid a stipend, or reimbursed for the activity that they are requested to do, so the design, endpoints, and frequency become important. If the approach is to look at patients’ medical records, say, every quarter or twice a year, and we’re going to ask them to fill out a questionnaire once or twice a year, they would only get reimbursed for the questionnaire, which might be worth as little as $50 or $100 a year. So, we have to ensure that the study design is going to provide them with value, too.
The diversity issue
It has been well-documented that “regular” randomized clinical trials are not diverse enough and rarely reflect the patient populations for the treatments they are investigating. The rapid adoption of DCTs and agile clinical trials have been shown to improve diversity in these main studies (by three times across the board, according to our own experiences), but because the LTFU is predicated on the composition of the patients in the main study, the challenge on the diversity side is that, purely by the nature of the design, we can’t go out and find a new set of more-diverse patients.
And so, while there is no quick-fire solution to the diversity issue, as clinical trials become more diverse through adopting decentralized approaches, intrinsically, so will LTFUs. In other words, we expect to see in LTFUs a continuation of the improvements regarding the diversity of participants that we are currently experiencing in regular clinical trials with DCT elements.
RWE: Going beyond the study data
On the RWE side, there are a couple of major value propositions in doing LTFU studies that deploy DCT components.
Firstly, this is an opportunity to develop a customized, longitudinal data set — or longitudinal patient population — beyond the confines of the study protocol. Let’s take an example where the LTFU is focused on primary endpoints for safety, and there are also some PROs. Given that we are prospectively engaging with patients, we have a robust level of personally identifiable information, or P.I.I., and one major thing we can do is tokenize that information and bring in additional data outside of the protocol.
So, now we can start to look at longitudinal data, whether it’s medical claims, pharmacy, additional labs, genomics, or other data types that would provide value for different audiences within the sponsor organization — but outside of the study team. Functions can include RWE, HR, market access, payer reimbursement, and any number of these types of stakeholders. Again, this is an opportunity for the sponsor to create customized longitudinal datasets, which represent true value for the RWE team.
If the LTFU is mandated, we can point to the information we have collected for purposes of regulatory requirements. And then later, in the protocol, we can always outline the additional endpoints that we will be exploring, such as healthcare utilization and costs.
As we look at how to execute LTFU studies for maximum success, what we find is one of the best practices is to execute a “warm handoff” or “warm transition,” from the main study to the LTFU. For every patient, the final visit of the main study becomes the first visit of the LTFU, or the first transition into the decentralized model, in other words.
What happens is the patient and the main study investigator have a conversation on that last main study visit, and there’s a smoother transition as a result. Because, with a decentralized approach, if you’re going from the main study into the LTFU, there has to be some proactive contact to engage the patient. Without it, there would be a much lower uptake.
Patient engagement is key
If there is any pushback of taking a decentralized approach to LTFUs, it’s that it might be perceived to lack in-person contact. If that were true, patients would be far less likely to be retained in LTFUs. But it’s important that LTFU designs take into account the crucial need to engage with the patient for the duration of the study. This may include notifications, one-on-one outreaches, and other appropriate tactics, as well as more of a human engagement approach, where clinical research coordinators (CRCs) call patients to, effectively, see how they are doing. Because, again, from the perspective of the patient in a 5 to 15-year study, there needs to be some loopback to the patient in terms of the value they’re providing to the study.
From the sponsor perspective, one perceived challenge is that sites or investigators from the main study might not be interested in, or open to, adopting DCT approaches for the LTFU — having just treated a patient for the duration of main study, they may question having to hand them over to another organization for a virtual LTFU. But the benefits of deploying decentralized models, particularly pertaining to the tearing down of geographic barriers, is overriding, and consequently, we’re seeing that a lot more sites and investigators are interested in having DCT components for LTFUs. It’s worth noting that such decentralized study models should also be able to accommodate individual investigators who want to continue working with specific patients in the LTFU.
Efficiency and agility
Also key, of course, is the fact that the sponsor wants to get the LTFU study up and running and completed in the most efficient manner possible. So, from the sponsor standpoint, it might seem daunting to continually engage with, say, 100 sites over the course of 5 to 15 years. Purely from an efficiency standpoint, then, sponsors would prefer to have 100% of sites transition to virtual models. In reality, this would depend upon a number of factors, such as the condition of the patient population and the endpoints of the study. So, an agile clinical trial design—comprising a mix of traditional and decentralized approaches—would appear to be the way forward, in most cases.
If the investigator or the patient wants to continue with their current treating relationship in the LTFU, then the decentralized model needs to be flexible enough to accommodate it. And, assuming you get it right, you’re also taking a giant step toward listening and adhering to the personal preferences of the patients.
As for the ROI of using DCT approaches to drive LTFUs, an analysis that was done for multiple sponsors, based on how much it would cost to keep sites open, showed a cumulative breakeven point early in the study duration (e.g., year 4), with positive savings for the sponsor from the fourth year.
At the end of the day, LTFU studies represent some of the “easiest” areas for the adoption of decentralization approaches, because all stakeholders—the sponsor, the sites, the patients, the providers—benefit greatly. It is the ultimate win-win. And so, as a result, I see a huge increase in demand ahead. |
https://www.prnewswire.com/news-releases/the-worldwide-user-research-repositories-software-industry-is-expected-to-reach-364-million-by-2028-301517697.html | DUBLIN, April 5, 2022 /PRNewswire/ -- The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX data requires to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and collaborate it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
The user research repositories software market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into cloud-based and on-premises. Based on application, the user research repositories software market is segmented into government, retail and e-commerce, healthcare and life sciences, BFSI, transportation and logistics, telecom and IT, manufacturing, and others. Geographically, the market is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, Singapore, and the Rest of APAC), Middle East and Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South America (Brazil, Argentina, and the Rest of SAM).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. User Research Repositories Software Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 MEA
4.2.5 SAM
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. User Research Repositories Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing adoption of software to Streamline Research Process
5.1.2 Rising Demand from UX-Centric Tech Start-ups
5.2 Key Market Restraints
5.2.1 Concerns Related to Privacy and Data Access
5.3 Key Market Opportunities
5.3.1 Rise in User's Digital Experience Data
5.4 Future Trends
5.4.1 Use of AI and Automated Analytics
5.5 Impact Analysis of Drivers And Restraints
6. User Research Repositories Software - Global Market Analysis
6.1 Global User Research Repositories Software Market Overview
6.2 Global User Research Repositories Software Market Revenue Forecast and Analysis
6.3 Market Positioning - Five Key Players
7. User Research Repositories Software Market Analysis - By Type
7.1 Overview
7.2 User Research Repositories Software Market, By Type (2020 and 2028)
7.3 Cloud-based
7.3.1 Overview
7.3.2 Cloud-based: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
7.4 On-Premises
7.4.1 Overview
7.4.2 On-Premises: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8. User Research Repositories Software Market Analysis - By Application
8.1 Overview
8.2 User Research Repositories Software Market, By Application (2020 and 2028)
8.3 Government
8.3.1 Overview
8.3.2 Government: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.4 Retail and eCommerce
8.4.1 Overview
8.4.2 Retail and eCommerce: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.5 Healthcare and Life Sciences
8.5.1 Overview
8.5.2 Healthcare and Life Sciences: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.6 BFSI
8.6.1 Overview
8.6.2 BFSI: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.7 Transportation and Logistics
8.7.1 Overview
8.7.2 Transportation and Logistics: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.8 Telecom and IT
8.8.1 Overview
8.8.2 Telecom and IT: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.9 Manufacturing
8.9.1 Overview
8.9.2 Manufacturing: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
9. User Research Repositories Software Market - Geographic Analysis
10. User Research Repositories Software Market - Covid-19 Impact Analysis
10.1 Overview
10.2 North America: Impact Assessment of Covid-19 Pandemic
10.3 Europe: Impact Assessment of Covid-19 Pandemic
10.4 Asia Pacific: Impact Assessment of Covid-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of Covid-19 Pandemic
10.6 South America Impact Assessment of Covid-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Merger and Acquisition
11.4 New Development
12. Company Profiles
12.1 Crayon Bits, LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Usertimes Solutions GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tetra Insights, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savio Technology Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Reveall B.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Productboard, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 UserZoom
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dovetail Research Pty. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Condens Insights GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Aurelius Lab, LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/1awuut
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets | 0 | 70,214 | 0 | https://www.wfmz.com/news/pr_newswire/pr_newswire_technology/the-worldwide-user-research-repositories-software-industry-is-expected-to-reach-364-million-by-2028/article_e8c0d622-3065-54ff-8399-09b84fcaff34.html | 2022-04-05 16:50:42+00:00 | DUBLIN, April 5, 2022 /PRNewswire/ -- The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX data requires to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and collaborate it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
The user research repositories software market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into cloud-based and on-premises. Based on application, the user research repositories software market is segmented into government, retail and e-commerce, healthcare and life sciences, BFSI, transportation and logistics, telecom and IT, manufacturing, and others. Geographically, the market is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, Singapore, and the Rest of APAC), Middle East and Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South America (Brazil, Argentina, and the Rest of SAM).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. User Research Repositories Software Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 MEA
4.2.5 SAM
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. User Research Repositories Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing adoption of software to Streamline Research Process
5.1.2 Rising Demand from UX-Centric Tech Start-ups
5.2 Key Market Restraints
5.2.1 Concerns Related to Privacy and Data Access
5.3 Key Market Opportunities
5.3.1 Rise in User's Digital Experience Data
5.4 Future Trends
5.4.1 Use of AI and Automated Analytics
5.5 Impact Analysis of Drivers And Restraints
6. User Research Repositories Software - Global Market Analysis
6.1 Global User Research Repositories Software Market Overview
6.2 Global User Research Repositories Software Market Revenue Forecast and Analysis
6.3 Market Positioning - Five Key Players
7. User Research Repositories Software Market Analysis - By Type
7.1 Overview
7.2 User Research Repositories Software Market, By Type (2020 and 2028)
7.3 Cloud-based
7.3.1 Overview
7.3.2 Cloud-based: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
7.4 On-Premises
7.4.1 Overview
7.4.2 On-Premises: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8. User Research Repositories Software Market Analysis - By Application
8.1 Overview
8.2 User Research Repositories Software Market, By Application (2020 and 2028)
8.3 Government
8.3.1 Overview
8.3.2 Government: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.4 Retail and eCommerce
8.4.1 Overview
8.4.2 Retail and eCommerce: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.5 Healthcare and Life Sciences
8.5.1 Overview
8.5.2 Healthcare and Life Sciences: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.6 BFSI
8.6.1 Overview
8.6.2 BFSI: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.7 Transportation and Logistics
8.7.1 Overview
8.7.2 Transportation and Logistics: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.8 Telecom and IT
8.8.1 Overview
8.8.2 Telecom and IT: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.9 Manufacturing
8.9.1 Overview
8.9.2 Manufacturing: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
9. User Research Repositories Software Market - Geographic Analysis
10. User Research Repositories Software Market - Covid-19 Impact Analysis
10.1 Overview
10.2 North America: Impact Assessment of Covid-19 Pandemic
10.3 Europe: Impact Assessment of Covid-19 Pandemic
10.4 Asia Pacific: Impact Assessment of Covid-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of Covid-19 Pandemic
10.6 South America Impact Assessment of Covid-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Merger and Acquisition
11.4 New Development
12. Company Profiles
12.1 Crayon Bits, LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Usertimes Solutions GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tetra Insights, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savio Technology Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Reveall B.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Productboard, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 UserZoom
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dovetail Research Pty. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Condens Insights GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Aurelius Lab, LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/1awuut
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/the-worldwide-user-research-repositories-software-industry-is-expected-to-reach-364-million-by-2028-301517697.html
SOURCE Research and Markets |
https://www.prnewswire.com/news-releases/the-worldwide-user-research-repositories-software-industry-is-expected-to-reach-364-million-by-2028-301517697.html | DUBLIN, April 5, 2022 /PRNewswire/ -- The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX data requires to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and collaborate it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
The user research repositories software market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into cloud-based and on-premises. Based on application, the user research repositories software market is segmented into government, retail and e-commerce, healthcare and life sciences, BFSI, transportation and logistics, telecom and IT, manufacturing, and others. Geographically, the market is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, Singapore, and the Rest of APAC), Middle East and Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South America (Brazil, Argentina, and the Rest of SAM).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. User Research Repositories Software Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 MEA
4.2.5 SAM
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. User Research Repositories Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing adoption of software to Streamline Research Process
5.1.2 Rising Demand from UX-Centric Tech Start-ups
5.2 Key Market Restraints
5.2.1 Concerns Related to Privacy and Data Access
5.3 Key Market Opportunities
5.3.1 Rise in User's Digital Experience Data
5.4 Future Trends
5.4.1 Use of AI and Automated Analytics
5.5 Impact Analysis of Drivers And Restraints
6. User Research Repositories Software - Global Market Analysis
6.1 Global User Research Repositories Software Market Overview
6.2 Global User Research Repositories Software Market Revenue Forecast and Analysis
6.3 Market Positioning - Five Key Players
7. User Research Repositories Software Market Analysis - By Type
7.1 Overview
7.2 User Research Repositories Software Market, By Type (2020 and 2028)
7.3 Cloud-based
7.3.1 Overview
7.3.2 Cloud-based: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
7.4 On-Premises
7.4.1 Overview
7.4.2 On-Premises: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8. User Research Repositories Software Market Analysis - By Application
8.1 Overview
8.2 User Research Repositories Software Market, By Application (2020 and 2028)
8.3 Government
8.3.1 Overview
8.3.2 Government: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.4 Retail and eCommerce
8.4.1 Overview
8.4.2 Retail and eCommerce: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.5 Healthcare and Life Sciences
8.5.1 Overview
8.5.2 Healthcare and Life Sciences: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.6 BFSI
8.6.1 Overview
8.6.2 BFSI: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.7 Transportation and Logistics
8.7.1 Overview
8.7.2 Transportation and Logistics: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.8 Telecom and IT
8.8.1 Overview
8.8.2 Telecom and IT: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.9 Manufacturing
8.9.1 Overview
8.9.2 Manufacturing: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
9. User Research Repositories Software Market - Geographic Analysis
10. User Research Repositories Software Market - Covid-19 Impact Analysis
10.1 Overview
10.2 North America: Impact Assessment of Covid-19 Pandemic
10.3 Europe: Impact Assessment of Covid-19 Pandemic
10.4 Asia Pacific: Impact Assessment of Covid-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of Covid-19 Pandemic
10.6 South America Impact Assessment of Covid-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Merger and Acquisition
11.4 New Development
12. Company Profiles
12.1 Crayon Bits, LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Usertimes Solutions GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tetra Insights, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savio Technology Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Reveall B.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Productboard, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 UserZoom
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dovetail Research Pty. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Condens Insights GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Aurelius Lab, LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/1awuut
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets | 1 | 2,981 | 0.028292 | https://www.globenewswire.com/news-release/2022/04/06/2417369/28124/en/Outlook-on-the-User-Research-Repositories-Software-Global-Market-to-2028-Rise-in-User-s-Digital-Experience-Data-Presents-Opportunities.html | 2022-04-06 10:52:15+00:00 | Dublin, April 06, 2022 (GLOBE NEWSWIRE) -- The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX data requires to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and collaborate it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
The user research repositories software market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into cloud-based and on-premises. Based on application, the user research repositories software market is segmented into government, retail and e-commerce, healthcare and life sciences, BFSI, transportation and logistics, telecom and IT, manufacturing, and others. Geographically, the market is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, Singapore, and the Rest of APAC), Middle East and Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South America (Brazil, Argentina, and the Rest of SAM).
Crayon Bits, LLC; Usertimes Solutions GmbH; Tetra Insights, Inc.; Savio Technology Inc.; Reveall B.V.; Productboard, Inc.; UserZoom; Dovetail Research Pty. Ltd.; Condens Insights GmbH; and Aurelius Lab, LLC. are among the key players operating in the global user research repositories software market and profiled in the market study.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. User Research Repositories Software Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 MEA
4.2.5 SAM
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. User Research Repositories Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing adoption of software to Streamline Research Process
5.1.2 Rising Demand from UX-Centric Tech Start-ups
5.2 Key Market Restraints
5.2.1 Concerns Related to Privacy and Data Access
5.3 Key Market Opportunities
5.3.1 Rise in User's Digital Experience Data
5.4 Future Trends
5.4.1 Use of AI and Automated Analytics
5.5 Impact Analysis of Drivers And Restraints
6. User Research Repositories Software - Global Market Analysis
6.1 Global User Research Repositories Software Market Overview
6.2 Global User Research Repositories Software Market Revenue Forecast and Analysis
6.3 Market Positioning - Five Key Players
7. User Research Repositories Software Market Analysis - By Type
7.1 Overview
7.2 User Research Repositories Software Market, By Type (2020 and 2028)
7.3 Cloud-based
7.3.1 Overview
7.3.2 Cloud-based: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
7.4 On-Premises
7.4.1 Overview
7.4.2 On-Premises: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8. User Research Repositories Software Market Analysis - By Application
8.1 Overview
8.2 User Research Repositories Software Market, By Application (2020 and 2028)
8.3 Government
8.3.1 Overview
8.3.2 Government: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.4 Retail and eCommerce
8.4.1 Overview
8.4.2 Retail and eCommerce: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.5 Healthcare and Life Sciences
8.5.1 Overview
8.5.2 Healthcare and Life Sciences: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.6 BFSI
8.6.1 Overview
8.6.2 BFSI: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.7 Transportation and Logistics
8.7.1 Overview
8.7.2 Transportation and Logistics: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.8 Telecom and IT
8.8.1 Overview
8.8.2 Telecom and IT: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.9 Manufacturing
8.9.1 Overview
8.9.2 Manufacturing: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
9. User Research Repositories Software Market - Geographic Analysis
10. User Research Repositories Software Market - Covid-19 Impact Analysis
10.1 Overview
10.2 North America: Impact Assessment of Covid-19 Pandemic
10.3 Europe: Impact Assessment of Covid-19 Pandemic
10.4 Asia Pacific: Impact Assessment of Covid-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of Covid-19 Pandemic
10.6 South America Impact Assessment of Covid-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Merger and Acquisition
11.4 New Development
12. Company Profiles
12.1 Crayon Bits, LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Usertimes Solutions GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tetra Insights, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savio Technology Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Reveall B.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Productboard, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 UserZoom
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dovetail Research Pty. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Condens Insights GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Aurelius Lab, LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/juv2ao
Attachment |
https://www.prnewswire.com/news-releases/the-worldwide-user-research-repositories-software-industry-is-expected-to-reach-364-million-by-2028-301517697.html | DUBLIN, April 5, 2022 /PRNewswire/ -- The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX data requires to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and collaborate it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
The user research repositories software market is segmented on the basis of type, application, and geography. Based on type, the market is bifurcated into cloud-based and on-premises. Based on application, the user research repositories software market is segmented into government, retail and e-commerce, healthcare and life sciences, BFSI, transportation and logistics, telecom and IT, manufacturing, and others. Geographically, the market is broadly segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, Singapore, and the Rest of APAC), Middle East and Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South America (Brazil, Argentina, and the Rest of SAM).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Key Topics Covered:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. User Research Repositories Software Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 MEA
4.2.5 SAM
4.3 Ecosystem Analysis
4.4 Expert Opinions
5. User Research Repositories Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing adoption of software to Streamline Research Process
5.1.2 Rising Demand from UX-Centric Tech Start-ups
5.2 Key Market Restraints
5.2.1 Concerns Related to Privacy and Data Access
5.3 Key Market Opportunities
5.3.1 Rise in User's Digital Experience Data
5.4 Future Trends
5.4.1 Use of AI and Automated Analytics
5.5 Impact Analysis of Drivers And Restraints
6. User Research Repositories Software - Global Market Analysis
6.1 Global User Research Repositories Software Market Overview
6.2 Global User Research Repositories Software Market Revenue Forecast and Analysis
6.3 Market Positioning - Five Key Players
7. User Research Repositories Software Market Analysis - By Type
7.1 Overview
7.2 User Research Repositories Software Market, By Type (2020 and 2028)
7.3 Cloud-based
7.3.1 Overview
7.3.2 Cloud-based: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
7.4 On-Premises
7.4.1 Overview
7.4.2 On-Premises: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8. User Research Repositories Software Market Analysis - By Application
8.1 Overview
8.2 User Research Repositories Software Market, By Application (2020 and 2028)
8.3 Government
8.3.1 Overview
8.3.2 Government: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.4 Retail and eCommerce
8.4.1 Overview
8.4.2 Retail and eCommerce: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.5 Healthcare and Life Sciences
8.5.1 Overview
8.5.2 Healthcare and Life Sciences: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.6 BFSI
8.6.1 Overview
8.6.2 BFSI: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.7 Transportation and Logistics
8.7.1 Overview
8.7.2 Transportation and Logistics: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.8 Telecom and IT
8.8.1 Overview
8.8.2 Telecom and IT: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.9 Manufacturing
8.9.1 Overview
8.9.2 Manufacturing: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: User Research Repositories Software Market - Revenue and Forecast to 2028 (USD Million)
9. User Research Repositories Software Market - Geographic Analysis
10. User Research Repositories Software Market - Covid-19 Impact Analysis
10.1 Overview
10.2 North America: Impact Assessment of Covid-19 Pandemic
10.3 Europe: Impact Assessment of Covid-19 Pandemic
10.4 Asia Pacific: Impact Assessment of Covid-19 Pandemic
10.5 Middle East & Africa: Impact Assessment of Covid-19 Pandemic
10.6 South America Impact Assessment of Covid-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Merger and Acquisition
11.4 New Development
12. Company Profiles
12.1 Crayon Bits, LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Usertimes Solutions GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Tetra Insights, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savio Technology Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Reveall B.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Productboard, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 UserZoom
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dovetail Research Pty. Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Condens Insights GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Aurelius Lab, LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/1awuut
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets | 2 | 98,612 | 0.126256 | https://www.benzinga.com/pressreleases/22/04/b26422519/global-user-research-repositories-software-market-forecast-to-2028-covid-19-impact-and-analysis-re | 2022-08-23 12:47:03+00:00 | The "User Research Repositories Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application (Government, Retail and eCommerce, Healthcare and Life Sciences, BFSI, Transportation and Logistics, Telecom and IT, Manufacturing, and Others)" report has been added to ResearchAndMarkets.com's offering.
The user research repositories software market is expected to grow from US$ 106.04 million in 2020 to US$ 364.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.
Growing digitalization and rising internet penetration worldwide influence businesses to accelerate their digital transformation and take necessary steps to deliver an engaging Digital Experience (DX). Nearly half of the tech companies comment that improving customer experience and satisfaction were among the leading factors to start a digital transformation. Large enterprises offering digital experiences, such as Amazon and Google, rely on a considerable amount of customer feedback data that provides a foundation for improving their digital product.
The UX requires data to be easily accessible to all stakeholders engaged in product development to streamline the process of user research. The user research repositories software provides a platform to store the vast pool of customer/user-based data and share it with product developers, marketers, and researchers to deduce useful insight using analytics tools. The growing need to keep the user experience at the priority of product development has resulted in an increase in the amount of feedbacks and surveys taken from the customers. Therefore, the advent of a vast amount of research data pertaining to user's digital experience is creating ample opportunities for key players in the user research repositories software market.
Progress in COVID-19 vaccination programs and businesses reopening is fuelling the demand for user research repository software in the coming years. While the first half of 2020 witnessed reduced sales revenue due to the lockdown and halted operations of several industries, online sales were surged significantly in the second half of 2020. Market players are investing in customer experience management technologies to boost sales and generate revenues. There is an increasing trend of using artificial intelligence, cloud technology, edge computing, machine learning, and IoT technology in North America. Further, the advent of 5G technology, combined with IoT, is expected to create lucrative opportunities in maximizing efficiency and minimizing wastage of resources across various industry verticals. Thus, post the COVID-19 pandemic, the user research repositories software market is expected grow at a significant pace.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global User Research Repositories market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global User Research Repositories market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Market Dynamics
Drivers
- Growing adoption of software to Streamline Research Process
- Rising Demand from UX-Centric Tech Start-ups
Restraints
- Concerns Related to Privacy and Data Access
Opportunities
- Rise in User's Digital Experience Data
Future Trends
- Use of AI and Automated Analytics
Companies Mentioned
- Crayon Bits, LLC
- Usertimes Solutions GmbH
- Tetra Insights, Inc.
- Savio Technology Inc.
- Reveall B.V.
- Productboard, Inc.
- UserZoom
- Dovetail Research Pty. Ltd.
- Condens Insights GmbH
- Aurelius Lab, LLC
For more information about this report visit https://www.researchandmarkets.com/r/z84hy5
View source version on businesswire.com: https://www.businesswire.com/news/home/20220401005301/en/
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria. |
https://www.thehindu.com/news/cities/Tiruchirapalli/govt-departments-not-to-extend-services-to-helmetless-two-wheeler-riders-in-karur-district/article65296206.ece/amp/ | Govt. departments not to extend services to helmetless two-wheeler riders in Karur district
KARUR April 06, 2022 17:41 ISTWearing helmets mandatory for buying liquor, refuelling from April 18
Seeking to ensure strict compliance of the helmet rule, the district administration has announced that two-wheeler riders without helmets would not be extended any service by government and private agencies / institutions in the district from April 18.
Two-wheeler riders without helmets would not be able to buy liquor at TASMAC outlets and petrol at fuel stations, District Collector T. Prabhushankar has announced.
Seeking to initiate coordinated efforts in this direction, Mr.Prabhushankar chaired a consultative meeting with various government department and private institutions, including educational institutions, public sector organisations and petroleum dealers, on Tuesday and requested their cooperation in ensuring strict compliance.
Speaking at the meeting, Mr. Prabhushankar expressed concern that Karur district was witnessing a high number of fatalities caused by road accidents involving two-wheeler riders. In almost all cases, the deaths were due to two-wheeler riders not wearing helmets.
“In an attempt save precious lives, we have planned to launch a coordinated movement to enforce the helmet rule strictly in the district. Accordingly, two wheeler riders will not be extended any service by government departments, including the District Collectorate, PSUs, hotels, textile and jewellery shops, fuel stations and industries from April 18,” Mr. Prabhushankar said.
All establishments had been instructed to put up signboards in front of their premises to this effect. Signboards would be placed at all Tasmac liquor shops informing customers of the decision.
Fuel stations had been instructed not refuel two-wheelers if the riders were not wearing helmets. Children riding two-wheelers would not be allowed to refuel at the fuel stations. Fuel stations had also been instructed to ensure drivers of four-wheelers wore seat belts, he added.
Pointing out that a majority of employees of private establishments were two-wheeler riders, Mr. Prabhushankar urged owners of the establishments not to permit employees coming to work on two-wheelers without wearing helmets.
Revenue Divisional Officers had been instructed to inspect shops selling helmets and ensure that they sold only ISI certified head gear. Sub-standard products would be seized, he said. | 0 | 21,169 | 0.099261 | https://www.thehindu.com/news/cities/Tiruchirapalli/govt-departments-not-to-extend-services-to-helmetless-two-wheeler-riders-in-karur-district/article65296206.ece | 2022-04-06 12:22:16+00:00 | Govt. departments not to extend services to helmetless two-wheeler riders in Karur district
Wearing helmets mandatory for buying liquor, refuelling from April 18
Seeking to ensure strict compliance of the helmet rule, the district administration has announced that two-wheeler riders without helmets would not be extended any service by government and private agencies / institutions in the district from April 18.
Two-wheeler riders without helmets would not be able to buy liquor at TASMAC outlets and petrol at fuel stations, District Collector T. Prabhushankar has announced.
Seeking to initiate coordinated efforts in this direction, Mr.Prabhushankar chaired a consultative meeting with various government department and private institutions, including educational institutions, public sector organisations and petroleum dealers, on Tuesday and requested their cooperation in ensuring strict compliance.
Speaking at the meeting, Mr. Prabhushankar expressed concern that Karur district was witnessing a high number of fatalities caused by road accidents involving two-wheeler riders. In almost all cases, the deaths were due to two-wheeler riders not wearing helmets.
“In an attempt save precious lives, we have planned to launch a coordinated movement to enforce the helmet rule strictly in the district. Accordingly, two wheeler riders will not be extended any service by government departments, including the District Collectorate, PSUs, hotels, textile and jewellery shops, fuel stations and industries from April 18,” Mr. Prabhushankar said.
All establishments had been instructed to put up signboards in front of their premises to this effect. Signboards would be placed at all Tasmac liquor shops informing customers of the decision.
Fuel stations had been instructed not refuel two-wheelers if the riders were not wearing helmets. Children riding two-wheelers would not be allowed to refuel at the fuel stations. Fuel stations had also been instructed to ensure drivers of four-wheelers wore seat belts, he added.
Pointing out that a majority of employees of private establishments were two-wheeler riders, Mr. Prabhushankar urged owners of the establishments not to permit employees coming to work on two-wheelers without wearing helmets.
Revenue Divisional Officers had been instructed to inspect shops selling helmets and ensure that they sold only ISI certified head gear. Sub-standard products would be seized, he said.
- Comments will be moderated by The Hindu editorial team.
- Comments that are abusive, personal, incendiary or irrelevant cannot be published.
- Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
- We may remove hyperlinks within comments.
- Please use a genuine email ID and provide your name, to avoid rejection. |
https://www.thehindu.com/news/cities/Tiruchirapalli/govt-departments-not-to-extend-services-to-helmetless-two-wheeler-riders-in-karur-district/article65296206.ece/amp/ | Govt. departments not to extend services to helmetless two-wheeler riders in Karur district
KARUR April 06, 2022 17:41 ISTWearing helmets mandatory for buying liquor, refuelling from April 18
Seeking to ensure strict compliance of the helmet rule, the district administration has announced that two-wheeler riders without helmets would not be extended any service by government and private agencies / institutions in the district from April 18.
Two-wheeler riders without helmets would not be able to buy liquor at TASMAC outlets and petrol at fuel stations, District Collector T. Prabhushankar has announced.
Seeking to initiate coordinated efforts in this direction, Mr.Prabhushankar chaired a consultative meeting with various government department and private institutions, including educational institutions, public sector organisations and petroleum dealers, on Tuesday and requested their cooperation in ensuring strict compliance.
Speaking at the meeting, Mr. Prabhushankar expressed concern that Karur district was witnessing a high number of fatalities caused by road accidents involving two-wheeler riders. In almost all cases, the deaths were due to two-wheeler riders not wearing helmets.
“In an attempt save precious lives, we have planned to launch a coordinated movement to enforce the helmet rule strictly in the district. Accordingly, two wheeler riders will not be extended any service by government departments, including the District Collectorate, PSUs, hotels, textile and jewellery shops, fuel stations and industries from April 18,” Mr. Prabhushankar said.
All establishments had been instructed to put up signboards in front of their premises to this effect. Signboards would be placed at all Tasmac liquor shops informing customers of the decision.
Fuel stations had been instructed not refuel two-wheelers if the riders were not wearing helmets. Children riding two-wheelers would not be allowed to refuel at the fuel stations. Fuel stations had also been instructed to ensure drivers of four-wheelers wore seat belts, he added.
Pointing out that a majority of employees of private establishments were two-wheeler riders, Mr. Prabhushankar urged owners of the establishments not to permit employees coming to work on two-wheelers without wearing helmets.
Revenue Divisional Officers had been instructed to inspect shops selling helmets and ensure that they sold only ISI certified head gear. Sub-standard products would be seized, he said. | 1 | 75,503 | 0.566403 | https://www.newindianexpress.com/states/tamil-nadu/2022/apr/15/no-ration-no-drink-as-karur-tightens-helmet-rule-2442144.html | 2022-04-16 06:23:30+00:00 | No ration, no drink as Karur tightens helmet rule
Officials, who ride two-wheelers to government offices without wearing helmets, will be marked absent, says a circular issued by collector Dr T Prabhushankar.
Published: 15th April 2022 05:33 AM | Last Updated: 15th April 2022 05:33 AM | A+A A-
KARUR: Starting Monday, government offices in Karur district will be off limits for motorists riding without helmets as the district administration is launching ‘No Helmet, No Service’ movement to deny all essential services to violators.
Officials, who ride two-wheelers to government offices without wearing helmets, will be marked absent, says a circular issued by collector Dr T Prabhushankar. Karur district has the highest fatality rate of 36.6% in road accidents in Tamil Nadu as per the Accident Severity Index.
Petrol stations were told not to dispense fuel to vehicles of violators who don’t use helmets or wear seatbelts in cars. While ration shops will deny violators essential commodities, Tasmac shops will not sell them liquor. Private grocers and shopkeepers have also been told to implement the no-service rule strictly.
Two-wheeler riders will be denied entry into government offices if they come without helmets. Entry of violators into government offices will be monitored through CCTV cameras by dedicated personnel assigned for the purpose.
Heads of departments have been given clear instructions on implementing the initiative at government offices. Speaking to TNIE, Karur District Forest Officer (DFO) Saravanan said, “The Collector has sent a circular asking us to ensure all officials who use two-wheelers wear helmets.”
Only 2-3% wear helmet: Survey
“After assessing the accidents reported in Karur district during our regular road safety meetings, we found that over 50% of them involved two-wheelers. While fatalities are high as most victims had not worn helmets, accidents also lead to acute disability,” collector Prabhushankar said.
“Wearing a helmet is the easiest solution to end road fatalities. Our team conducted a baseline survey at 50 places across the district and found that only 2% to 3% of the motorists wore a helmet. With this regulatory and educative initiative, we expect the numbers to gradually increase,” the collector said.
Last Tuesday, awareness programmes were conducted in schools to inculcate the importance of wearing helmet among schoolchildren. The students were also encouraged to write an emotional letter to their parents on wearing helmets. The district administration has planned to take the safety message to adults with the help of students across the district.
Karur tops in deaths, cams will monitor violators
Karur district has the highest fatality rate of 36.6% in road accidents in Tamil Nadu as per the Accident Severity Index. Entry of violators into government offices will be monitored through CCTV cameras by dedicated personnel |
https://www.thehindu.com/news/cities/Tiruchirapalli/govt-departments-not-to-extend-services-to-helmetless-two-wheeler-riders-in-karur-district/article65296206.ece/amp/ | Govt. departments not to extend services to helmetless two-wheeler riders in Karur district
KARUR April 06, 2022 17:41 ISTWearing helmets mandatory for buying liquor, refuelling from April 18
Seeking to ensure strict compliance of the helmet rule, the district administration has announced that two-wheeler riders without helmets would not be extended any service by government and private agencies / institutions in the district from April 18.
Two-wheeler riders without helmets would not be able to buy liquor at TASMAC outlets and petrol at fuel stations, District Collector T. Prabhushankar has announced.
Seeking to initiate coordinated efforts in this direction, Mr.Prabhushankar chaired a consultative meeting with various government department and private institutions, including educational institutions, public sector organisations and petroleum dealers, on Tuesday and requested their cooperation in ensuring strict compliance.
Speaking at the meeting, Mr. Prabhushankar expressed concern that Karur district was witnessing a high number of fatalities caused by road accidents involving two-wheeler riders. In almost all cases, the deaths were due to two-wheeler riders not wearing helmets.
“In an attempt save precious lives, we have planned to launch a coordinated movement to enforce the helmet rule strictly in the district. Accordingly, two wheeler riders will not be extended any service by government departments, including the District Collectorate, PSUs, hotels, textile and jewellery shops, fuel stations and industries from April 18,” Mr. Prabhushankar said.
All establishments had been instructed to put up signboards in front of their premises to this effect. Signboards would be placed at all Tasmac liquor shops informing customers of the decision.
Fuel stations had been instructed not refuel two-wheelers if the riders were not wearing helmets. Children riding two-wheelers would not be allowed to refuel at the fuel stations. Fuel stations had also been instructed to ensure drivers of four-wheelers wore seat belts, he added.
Pointing out that a majority of employees of private establishments were two-wheeler riders, Mr. Prabhushankar urged owners of the establishments not to permit employees coming to work on two-wheelers without wearing helmets.
Revenue Divisional Officers had been instructed to inspect shops selling helmets and ensure that they sold only ISI certified head gear. Sub-standard products would be seized, he said. | 2 | 70,811 | 0.685962 | https://www.deshdoot.com/deshdoot-times/helmet-compulsion-for-pillion-rider-from-today | 2022-04-02 09:13:27+00:00 | NASHIK: From today (April 2), the helmet rule to become more stringent in Nashik as the pillion rider compulsorily will have to wear a helmet along with the bike rider. Assistant Commissioner (Traffic) Sitaram Gaikwad informed in a circular that the drive will be launched from today on important squares, signals and traffic points in the city.
Police Commissioner Deepak Pandey has decided to enforce the helmet rule with an added compulsion, to prevent accident deaths of two-wheeler riders which has become a cause of concern. In that connection, campaigns such as counselling for two-wheelers without helmets; No helmets, No petrol; No helmets, No cooperation; followed by punitive action were being implemented.
Under the initiative, from 9th September 2021 to 30th November 2021, altogether 5456 males and 476 females, totalling 5932 helmetless two-wheeler riders were counselled at Nashik First. So far 47299 helmetless two-wheeler riders have been counselled by setting up counselling centres at 12 places in Nashik city. Also, from January 18, 2022, till now, 14116 helmetless riders were fined Rs. 75 lakh 83 thousand 500.
From today (April 2), within the limits of the Commissionerate of Police, it has been made compulsory for two-wheeler riders and pillion riders to wear helmets. A circular issued by the traffic department has appealed to motorcyclists to use helmets for their own safety and save their time and financial burden by adhering to the traffic rules. |
https://www.leicestermercury.co.uk/whats-on/food-drink/walkers-launches-crunchiest-loudest-wotsits-6912350 | Everyone loves to crunch a crisp don’t they? Well if you're one of the many who do, it’s good news as Wotsits have launched what they say is their crunchiest - and loudest - crisps ever.
Now available across the nation, Walkers launched their Wotsits Crunchy crisps this week, giving snack connoisseurs - including vegetarians - the super crunch they’ve been looking for. They may look like ordinary Wotsits, but these have been made with a bit of a twist.
The Leicester food manufacturer claims that the new crunchier crisps will give snackers a new sensory experience. They’ve also claimed that the snacks, which come in Really Cheesy and Flamin’ Hot varieties, are louder than any other Wotsit on the market.
READ MORE:Famous faces reveal their favourite Walkers crisps flavours
Katherine Cook from Walkers said: “We know so many people across the UK love Wotsits, both the melty originals and Giants, so not only did we make our new Wotsits crunchier, we also made them louder. No matter if snack lovers love to melt or crunch their Wotsits, they can now do both with the addition of Wotsits Crunchy Really Cheesy and Flamin’ Hot snacks… can you handle them?!”
The newest addition to the Wotsit family comes just a month after Walkers confirmed the long-awaited return of Prawn Cocktail Wotsits. That was after a 20-year hiatus and numerous campaigns to bring the much-loved flavour back onto the shelves.
Wotsits Crunchy Really Cheesy and Flamin’ Hot are available in a 140g sharing bag, with individual 60g bags to launch at a later date. They can be found at all major UK supermarkets. | 0 | 13,500 | 0.562558 | https://www.walesonline.co.uk/whats-on/shopping/snack-fans-joy-regular-wotsits-23650721 | 2022-04-10 11:52:58+00:00 | One of Britain's best-loved snacks has had a makeover. Iconic puffed corn Wotsits, produced by Walkers, has been given extra crunch in a new twist.
New Wotsits Crunchy are an new variation of the popular cheesy-flavoured puffed snack that has been a favourite for years. The new variety is now available in supermarkets nationwide in two tasty flavours – Really Cheesy and Flamin’ Hot.
Wotsits Crunchy is the latest addition to the Wotsits family and follows hot on the heels of Wotsits Prawn Cocktail Giants, which sent snack fans into meltdown when it relaunched earlier this year.
Katherine Cook, from Walkers, said: “We know so many people across the UK love Wotsits, both the melty originals and Giants, so not only did we make our new Wotsits crunchier, we also made them louder. No matter if snack lovers love to melt or crunch their Wotsits, they can now do both with the addition of Wotsits Crunchy Really Cheesy and Flamin’ Hot snacks.”
Wotsits Crunchy Really Cheesy and Flamin’ Hot are available now at all major UK supermarkets in a 140g sharing bag format. Wotsits Crunchy are baked not fried, contain no preservatives and are suitable for vegetarians.
For more stories from where you live, visit InYourArea. |
https://www.leicestermercury.co.uk/whats-on/food-drink/walkers-launches-crunchiest-loudest-wotsits-6912350 | Everyone loves to crunch a crisp don’t they? Well if you're one of the many who do, it’s good news as Wotsits have launched what they say is their crunchiest - and loudest - crisps ever.
Now available across the nation, Walkers launched their Wotsits Crunchy crisps this week, giving snack connoisseurs - including vegetarians - the super crunch they’ve been looking for. They may look like ordinary Wotsits, but these have been made with a bit of a twist.
The Leicester food manufacturer claims that the new crunchier crisps will give snackers a new sensory experience. They’ve also claimed that the snacks, which come in Really Cheesy and Flamin’ Hot varieties, are louder than any other Wotsit on the market.
READ MORE:Famous faces reveal their favourite Walkers crisps flavours
Katherine Cook from Walkers said: “We know so many people across the UK love Wotsits, both the melty originals and Giants, so not only did we make our new Wotsits crunchier, we also made them louder. No matter if snack lovers love to melt or crunch their Wotsits, they can now do both with the addition of Wotsits Crunchy Really Cheesy and Flamin’ Hot snacks… can you handle them?!”
The newest addition to the Wotsit family comes just a month after Walkers confirmed the long-awaited return of Prawn Cocktail Wotsits. That was after a 20-year hiatus and numerous campaigns to bring the much-loved flavour back onto the shelves.
Wotsits Crunchy Really Cheesy and Flamin’ Hot are available in a 140g sharing bag, with individual 60g bags to launch at a later date. They can be found at all major UK supermarkets. | 1 | 16,206 | 0.562558 | https://www.hulldailymail.co.uk/whats-on/shopping/snack-fans-joy-regular-wotsits-6932270 | 2022-04-10 12:15:09+00:00 | One of Britain's best-loved snacks has had a makeover. Iconic puffed corn Wotsits, produced by Walkers, has been given extra crunch in a new twist.
New Wotsits Crunchy are an new variation of the popular cheesy-flavoured puffed snack that has been a favourite for years. The new variety is now available in supermarkets nationwide in two tasty flavours – Really Cheesy and Flamin’ Hot.
Wotsits Crunchy is the latest addition to the Wotsits family and follows hot on the heels of Wotsits Prawn Cocktail Giants, which sent snack fans into meltdown when it relaunched earlier this year.
Katherine Cook, from Walkers, said: “We know so many people across the UK love Wotsits, both the melty originals and Giants, so not only did we make our new Wotsits crunchier, we also made them louder. No matter if snack lovers love to melt or crunch their Wotsits, they can now do both with the addition of Wotsits Crunchy Really Cheesy and Flamin’ Hot snacks.”
Wotsits Crunchy Really Cheesy and Flamin’ Hot are available now at all major UK supermarkets in a 140g sharing bag format. Wotsits Crunchy are baked not fried, contain no preservatives and are suitable for vegetarians.
For more stories from where you live, visit InYourArea. |
https://www.leicestermercury.co.uk/whats-on/food-drink/walkers-launches-crunchiest-loudest-wotsits-6912350 | Everyone loves to crunch a crisp don’t they? Well if you're one of the many who do, it’s good news as Wotsits have launched what they say is their crunchiest - and loudest - crisps ever.
Now available across the nation, Walkers launched their Wotsits Crunchy crisps this week, giving snack connoisseurs - including vegetarians - the super crunch they’ve been looking for. They may look like ordinary Wotsits, but these have been made with a bit of a twist.
The Leicester food manufacturer claims that the new crunchier crisps will give snackers a new sensory experience. They’ve also claimed that the snacks, which come in Really Cheesy and Flamin’ Hot varieties, are louder than any other Wotsit on the market.
READ MORE:Famous faces reveal their favourite Walkers crisps flavours
Katherine Cook from Walkers said: “We know so many people across the UK love Wotsits, both the melty originals and Giants, so not only did we make our new Wotsits crunchier, we also made them louder. No matter if snack lovers love to melt or crunch their Wotsits, they can now do both with the addition of Wotsits Crunchy Really Cheesy and Flamin’ Hot snacks… can you handle them?!”
The newest addition to the Wotsit family comes just a month after Walkers confirmed the long-awaited return of Prawn Cocktail Wotsits. That was after a 20-year hiatus and numerous campaigns to bring the much-loved flavour back onto the shelves.
Wotsits Crunchy Really Cheesy and Flamin’ Hot are available in a 140g sharing bag, with individual 60g bags to launch at a later date. They can be found at all major UK supermarkets. | 2 | 56,684 | 0.827219 | https://www.tesco.com/groceries/en-GB/products/312083723 | 2022-09-01 01:35:27+00:00 | We use cookies to improve your experience on our website. Please let us know your preferences.
Walkers Max Strong Hot Sauce Blaze Crisps 6X27g
- Suitable for vegetarians
Per 27g
- Energy
- 570kJ
- 136kcal
- 7%of the reference intake
- Fat
- 7.9g
- 11%of the reference intake
- Saturates
- 0.7g
- 3%of the reference intake
- Sugars
- 0.8g
- <1%of the reference intake
- Salt
- 0.18g
- 3%of the reference intake
high
medium
low
medium
of the reference intake*
Typical values per 100g: Energy 2112kJ
Product Description
- Hot Sauce Flavour Ridged Potato Crisps
- Walkers Max Strong the irresistible, deep ridged crisp packed with bold flavour - perfect with beer. Enjoy the ultimate taste experience in every bite!
- Max Spice Max Satisfaction
- Want Max Crunch? Try
- Walkers Max Double Crunch
- Packaged in a Protective Atmosphere
- Walkers, the Walkers Logo, and Max are registered trademarks.
- Walkers Max Strong is a trademark. ©2022
- Perfect with Beer
- Can You Handle the Heat?
- No Added MSG
- No Artificial Preservatives or Colours
- Suitable for Vegetarians
- Pack size: 162G
Information
Ingredients
Potatoes, Vegetable Oils (Sunflower, Rapeseed in varying proportions), Hot Sauce Seasoning [Sugar, Flavourings (contain Chilli Powder, Paprika Powder, Onion Powder), Acidity Regulators (Sodium Acetates, Citric Acid), Potassium Chloride, Salt, Colour (Paprika Extract)]
Allergy Information
- May contain: Milk, Wheat, Gluten, Barley, Soya, Celery, Mustard.
Storage
Store in a cool dry place.
Number of uses
Each inner pack contains 1 serving
Additives
- Free From Added MSG
- Free From Artificial Colours
- Free From Artificial Preservatives
Name and address
- Walkers Snack Foods Ltd.,
- PO Box 23,
- Leicester,
- LE4 8ZU,
- UK.
- EU: Walkers,
Return to
- We're Here to Help!
- www.walkers.co.uk
- Or UK 0800 274777
- ROI: 1800 509408
- Weekdays 9am-5pm
- Consumer Care
- Walkers Snack Foods Ltd.,
- PO Box 23,
- Leicester,
- LE4 8ZU,
- UK.
- EU: Walkers,
Net Contents
6 x 27g ℮
Nutrition
Using Product Information
While every care has been taken to ensure product information is correct, food products are constantly being reformulated, so ingredients, nutrition content, dietary and allergens may change. You should always read the product label and not rely solely on the information provided on the website.
If you have any queries, or you'd like advice on any Tesco brand products, please contact Tesco Customer Services, or the product manufacturer if not a Tesco brand product.
Although product information is regularly updated, Tesco is unable to accept liability for any incorrect information. This does not affect your statutory rights.
This information is supplied for personal use only, and may not be reproduced in any way without the prior consent of Tesco Stores Limited nor without due acknowledgement.
Tesco © Copyright 2022
No reviews yet
Help other customers like you
Write a reviewReviews are submitted by our customers directly through our website. We also share reviews from other retailers' websites to help you make an informed decision. |
https://www.eadt.co.uk/news/traffic/essex-a120-quadbike-rider-dies-collision-8809520 | Teenager dies after quadbike collision on A120
- Credit: Google Maps
A teenage quadbike rider has died after a serious collision on the A120 last month.
Police were called to the westbound carriageway of the road, at the A133 junction near Hare Green, shortly before 12.30pm on Sunday, March 27.
The rider of the quadbike, an 18-year-old man, was taken to hospital in a life-threatening condition.
He has now died, Essex Police confirmed.
The man's family has been informed.
Detective Sergeant Sam Nason, of Essex Police, said: "We still need people to come forward in order to help us piece together the moments before this incident took place.
"I would urge anyone who witnessed the incident or has dashcam footage of it to get in touch as soon as you can."
Most Read
- 1 Hollywood superstar John Travolta shooting film about Suffolk airbase
- 2 Man United teens Savage and Fish train with Ipswich
- 3 YouTube and Strictly stars enjoy stay at east Suffolk resort
- 4 Plans for eight new homes in Suffolk village submitted
- 5 Car catches fire on A14 slip road in west Suffolk
- 6 M&S to launch new larger store in north Essex
- 7 Weeks before sex abuse trial former Ipswich RE teacher found dead
- 8 Naked burglar found in victim's bed at house break-in
- 9 Andy Warren: My top three for Town's player-of-the-year award
- 10 Two caravans stolen from storage yard in west Suffolk town
Anyone with information related to the incident is urged to contact Essex Police, quoting incident number 504 of March 27. | 0 | 47,167 | 0.446987 | https://www.essexlive.news/news/essex-news/quad-bike-rider-18-dies-6914461 | 2022-04-06 14:16:04+00:00 | A quad bike rider has died following a crash near Hare Green. Emergency services were called shortly before 12.30pm on March 27 to the A120 Colchester-bound, near the junction with the A133 to reports of a collision.
The teenage rider was taken to hospital in a life-threatening condition. Sadly, the 18-year-old has since died of his injuries.
His family have been notified. Police have today (April 6) appealed for any witnesses to come forward.
Read More: Woman dies after A120 collision in Wix
Essex Police said: "We are now in a position to confirm a man involved in a serious collision on the A120 has sadly died. The 18-year-old quad bike rider was involved in a collision on the Colchester-bound A120 near to the junction with the A133 at Hare Green shortly before 12.30pm on Sunday 27 March.
"He was taken to hospital in a life-threatening condition but sadly has now died. His family are aware. We continue to appeal for witnesses or anyone with dashcam footage of the incident to come forward and speak to us." |
https://www.eadt.co.uk/news/traffic/essex-a120-quadbike-rider-dies-collision-8809520 | Teenager dies after quadbike collision on A120
- Credit: Google Maps
A teenage quadbike rider has died after a serious collision on the A120 last month.
Police were called to the westbound carriageway of the road, at the A133 junction near Hare Green, shortly before 12.30pm on Sunday, March 27.
The rider of the quadbike, an 18-year-old man, was taken to hospital in a life-threatening condition.
He has now died, Essex Police confirmed.
The man's family has been informed.
Detective Sergeant Sam Nason, of Essex Police, said: "We still need people to come forward in order to help us piece together the moments before this incident took place.
"I would urge anyone who witnessed the incident or has dashcam footage of it to get in touch as soon as you can."
Most Read
- 1 Hollywood superstar John Travolta shooting film about Suffolk airbase
- 2 Man United teens Savage and Fish train with Ipswich
- 3 YouTube and Strictly stars enjoy stay at east Suffolk resort
- 4 Plans for eight new homes in Suffolk village submitted
- 5 Car catches fire on A14 slip road in west Suffolk
- 6 M&S to launch new larger store in north Essex
- 7 Weeks before sex abuse trial former Ipswich RE teacher found dead
- 8 Naked burglar found in victim's bed at house break-in
- 9 Andy Warren: My top three for Town's player-of-the-year award
- 10 Two caravans stolen from storage yard in west Suffolk town
Anyone with information related to the incident is urged to contact Essex Police, quoting incident number 504 of March 27. | 1 | 39,005 | 0.488968 | https://www.chelmsfordweeklynews.co.uk/news/20048724.a120-quadbike-rider-18-dies-colchester-bound-crash/?ref=rss | 2022-04-06 13:41:23+00:00 | A TEENAGE quadbike rider has died after sustaining serious injuries following a crash on a busy main road.
Emergency services were called to an incident on the A120’s Colchester-bound carriageway near the A133 at Hare Green shortly before 12.30pm on March 27.
An 18-year-old motorist who was involved in the smash was subsequently taken to hospital in a life-threatening condition.
Essex Police have now confirmed the quad-biker has died as a result of his injuries and his family have been made aware.
Detective Sergeant Sam Nason, who is leading the investigation, said: “We need people to come forwardto help us piece together the moments before this incident.
“I would urge anyone who witnessed the incident or has dashcam footage of it to get in touch as soon as you can.”
To submit information to Essex Police visit essex.police.uk or use the 'Live Chat' button to speak to an online operator between 7am-11pm.
Alternatively, you can call 101 quoting incident number 504 of Sunday 27 March.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here |
https://www.eadt.co.uk/news/traffic/essex-a120-quadbike-rider-dies-collision-8809520 | Teenager dies after quadbike collision on A120
- Credit: Google Maps
A teenage quadbike rider has died after a serious collision on the A120 last month.
Police were called to the westbound carriageway of the road, at the A133 junction near Hare Green, shortly before 12.30pm on Sunday, March 27.
The rider of the quadbike, an 18-year-old man, was taken to hospital in a life-threatening condition.
He has now died, Essex Police confirmed.
The man's family has been informed.
Detective Sergeant Sam Nason, of Essex Police, said: "We still need people to come forward in order to help us piece together the moments before this incident took place.
"I would urge anyone who witnessed the incident or has dashcam footage of it to get in touch as soon as you can."
Most Read
- 1 Hollywood superstar John Travolta shooting film about Suffolk airbase
- 2 Man United teens Savage and Fish train with Ipswich
- 3 YouTube and Strictly stars enjoy stay at east Suffolk resort
- 4 Plans for eight new homes in Suffolk village submitted
- 5 Car catches fire on A14 slip road in west Suffolk
- 6 M&S to launch new larger store in north Essex
- 7 Weeks before sex abuse trial former Ipswich RE teacher found dead
- 8 Naked burglar found in victim's bed at house break-in
- 9 Andy Warren: My top three for Town's player-of-the-year award
- 10 Two caravans stolen from storage yard in west Suffolk town
Anyone with information related to the incident is urged to contact Essex Police, quoting incident number 504 of March 27. | 2 | 92,974 | 0.646855 | https://www.southwalesargus.co.uk/news/20611137.quad-bike-rider-killed-crash-cowbridge-road-east/?ref=rss | 2022-08-09 12:19:40+00:00 | A 34-YEAR-OLD quad bike rider has been killed in a crash.
The accident happened in Cowbridge Road East in the Canton area of Cardiff on Monday evening, South Wales Police said.
Dozens of police vehicles and ambulances were parked at the crossroads between Llandaff Road and Leckwith Road from around 5pm.
The busy street was closed for several hours while officers carried out investigations at the scene.
Detective Sergeant Debbie Hobrough said: “The collision involved a green and black Yamaha quad bike.
“Despite the best efforts of emergency services, the driver of the quad bike, a 34-year-old man, was declared deceased at the scene.
“His next of kin is aware and is being supported by officers.”
Police believe no other vehicles were involved.
Anyone who witnessed the crash or has dashcam footage that may assist is being asked to contact South Wales Police via their website or by calling Crimestoppers anonymously on 0800 555 111 quoting the reference 2200266464.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here |
https://www.theintelligencer.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. | 0 | 12,596 | 0 | https://www.ctinsider.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | 2022-04-06 11:38:36+00:00 | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. |
https://www.theintelligencer.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. | 1 | 13,115 | 0 | https://www.ourmidland.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | 2022-04-06 11:41:43+00:00 | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. |
https://www.theintelligencer.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. | 2 | 13,386 | 0 | https://www.stamfordadvocate.com/news/article/Iran-says-it-gave-long-sought-answers-to-UN-17060738.php | 2022-04-06 11:43:15+00:00 | TEHRAN, Iran (AP) — Iran on Wednesday said it supplied the United Nations’ nuclear watchdog with documents explaining the discovery of suspect enriched uranium traces, state media reported, the first acknowledgement from Tehran that it had answered the agency's long-standing demands.
The head of Iran's civilian Atomic Energy Organization, Mohammad Eslami, said Iran on March 20 had sent the requested explanations about several former undeclared sites in Iran where there was evidence of past nuclear activity.
The deadline came as part of an agreement announced last month to resolve the problem of undeclared uranium particles in Iran by June — long a source of tension between Tehran and the U.N. atomic watchdog.
The thorny issue is separate from now-stalled talks to revive Tehran's nuclear deal with world powers, which collapsed four years ago when former President Donald Trump withdrew the United States from the accord and imposed crushing sanctions on Iran. In the meantime, Iran has vastly expanded its nuclear work.
As the fate of a renewed nuclear deal hangs in the balance, long-sought answers about Iran's old but undeclared nuclear sites would improve trust and solve a major sticking point in its negotiations with the International Atomic Energy Agency. The IAEA did not immediately respond to a request for comment about Eslami's statement.
Eslami told reporters that Iran had handed over documents to the U.N. watchdog about the three requested sites in Iran, without elaborating. He expected agency inspectors to visit Iran “to review the answers" and finish a report on the subject by late June, he added.
The IAEA in 2019 first discovered the traces of man-made uranium that suggested they were once connected to Iran’s nuclear program. U.S. intelligence agencies, Western nations and the IAEA have said Iran ran an organized nuclear weapons program until 2003. Iran long has denied ever seeking nuclear weapons.
As a member of the Nuclear Nonproliferation Treaty, Iran is obligated to explain the radioactive traces and to provide assurances that they are not being used as part of a nuclear weapons program. The IAEA has staked its credibility on finding information about the sites, with its head Rafael Grossi routinely lambasting Iran for its failure to answer where the radioactive particles came from and where they are now.
Eslami on Wednesday claimed that one of the particles discovered by IAEA inspectors does not exist in Iran, without offering evidence or details. He blamed regional archenemy Israel for “sowing doubts” about the nature of Iran's nuclear program. Israel has said it believes Iran would pursue a nuclear weapon, despite Western intelligence assessments indicating otherwise.
Tehran currently enriches uranium up to 60% purity — its highest level ever and a short technical step from weapons-grade levels of 90% and far greater than the nuclear deal’s 3.67% cap.
Its stockpile of enriched uranium continues to grow as nuclear talks in Vienna flounder, worrying nuclear nonproliferation experts that Iran could be closer to the threshold of having enough material for an atomic weapon if it chose to pursue one. |
https://www.expressnews.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM | 0 | 6,376 | 0 | https://www.lakecountystar.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | 2022-04-06 11:07:50+00:00 | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM |
https://www.expressnews.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM | 1 | 7,431 | 0 | https://www.beaumontenterprise.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | 2022-04-06 11:12:26+00:00 | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM |
https://www.expressnews.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM | 2 | 7,980 | 0 | https://www.newstimes.com/business/article/RPM-International-Fiscal-Q3-Earnings-Snapshot-17060709.php | 2022-04-06 11:14:36+00:00 | MEDINA, Ohio (AP) _ RPM International Inc. (RPM) on Wednesday reported fiscal third-quarter net income of $33 million.
On a per-share basis, the Medina, Ohio-based company said it had net income of 25 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 38 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The specialty chemicals company posted revenue of $1.43 billion in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.41 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPM at https://www.zacks.com/ap/RPM |
https://www.wfmz.com/news/pr_newswire/pr_newswire_health/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them/article_4f32b473-a65f-5142-832a-24e3e9968480.html | New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
View original content:https://www.prnewswire.com/news-releases/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them-301518391.html
SOURCE Global Parents for Eczema Research | 0 | 19,871 | 0 | https://www.dakotanewsnow.com/prnewswire/2022/04/06/global-scorecard-highlights-unmet-needs-eczema-patients-worldwide-strategies-addressing-them/ | 2022-04-06 12:16:18+00:00 | New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
View original content:
SOURCE Global Parents for Eczema Research |
https://www.wfmz.com/news/pr_newswire/pr_newswire_health/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them/article_4f32b473-a65f-5142-832a-24e3e9968480.html | New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
View original content:https://www.prnewswire.com/news-releases/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them-301518391.html
SOURCE Global Parents for Eczema Research | 1 | 20,435 | 0 | https://www.nbc11news.com/prnewswire/2022/04/06/global-scorecard-highlights-unmet-needs-eczema-patients-worldwide-strategies-addressing-them/ | 2022-04-06 12:19:13+00:00 | New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
View original content:
SOURCE Global Parents for Eczema Research |
https://www.wfmz.com/news/pr_newswire/pr_newswire_health/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them/article_4f32b473-a65f-5142-832a-24e3e9968480.html | New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
View original content:https://www.prnewswire.com/news-releases/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them-301518391.html
SOURCE Global Parents for Eczema Research | 2 | 102,184 | 0.106394 | https://www.prnewswire.co.uk/news-releases/global-scorecard-highlights-unmet-needs-of-eczema-patients-worldwide-and-strategies-for-addressing-them-836474818.html | 2022-04-08 05:20:13+00:00 | Global Scorecard Highlights Unmet Needs of Eczema Patients Worldwide And Strategies for Addressing Them
New study finds low treatment satisfaction, poor control of symptoms, high psychosocial burden and shortcomings in patient centered care for eczema patients worldwide.
SANTA BARBARA, Calif., April 6, 2022 /PRNewswire/ -- The Global Patient Initiative to Improve Eczema Care (GPIIEC), a partnership of eleven patient organizations, today released a global report card of eczema patient care in eight countries: Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom. The Initiative is a global collaboration to establish a common "yardstick" to assess the responsiveness of health systems to the needs of patients and their caregivers, and to identify opportunities for improvement.
Eczema is a chronic relapsing inflammatory skin condition that impacts approximately 15% to 20% of children and 1% to 3% of adults globally, resulting in a significant patient burden and high demand on health care systems. A global survey by the GPIIEC that received over 3,200 responses found that patients in every country, and particularly those who live with moderate-to-severe eczema, are struggling to achieve long-term control of their eczema symptoms and report limited satisfaction with current treatments.
Poorly controlled eczema that can't be fully addressed by existing treatments substantially impacts patients' health-related quality of life. Based on adult patients' descriptions of their health, they would give up between 17-36 percent of their remaining life span in order to be restored to perfect health. Key drivers of this detriment in quality of life were the pain and discomfort of eczema and the mental health impacts such as anxiety and depression.
"We have work to do to improve care for people with eczema worldwide. This data helps us see the gaps and know where to focus our attention," said Marjolaine Hering, with Association Française de l'Eczéma.
Moderate-to-severe eczema is complex and chronic, demanding a high degree of patient involvement in ongoing symptom management. However, training for this role is minimal and patient input into treatment decisions is lacking in almost every country surveyed. Interestingly, shared decision making, defined as asking patients and caregivers about their priorities during a medical visit, was predictive of symptom control. This finding suggests that such involvement may improve medical care and outcomes, and serves as a target for improvement for health systems in each country.
"Through this initiative we are discovering how patients are faring in our country and worldwide and learning from the other patient organizations how to advocate for better medical care and supports for people with eczema," said Thomas Schwennesen of the Deutscher Neurodermitis Bund in Germany.
About Global Patient Initiative to Improve Eczema Care (GPIIEC)
GPIIEC is a patient organization-led effort to measure the performance of health systems in meeting the needs of people with eczema (atopic dermatitis) and their caregivers using a common methodology to allow for direct comparisons. For more information: www.improveeczemacare.org
About Global Parents for Eczema Research (GPER)
GPER is a grassroots, non-profit organization based in California whose mission is to improve quality of life and reduce suffering for children with moderate to severe eczema and their families. For more information: www.parentsforeczemaresearch.com
SOURCE Global Parents for Eczema Research |
https://www.cenlanow.com/health/us-discrimination-based-on-opioid-treatment-violates-law/ | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. | 0 | 16,570 | 0 | https://www.mytwintiers.com/news-cat/national-news/us-discrimination-based-on-opioid-treatment-violates-law/ | 2022-04-05 22:51:26+00:00 | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. |
https://www.cenlanow.com/health/us-discrimination-based-on-opioid-treatment-violates-law/ | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. | 1 | 19,430 | 0 | https://www.wytv.com/news/national-world/ap-us-news/us-discrimination-based-on-opioid-treatment-violates-law/ | 2022-04-05 23:03:52+00:00 | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. |
https://www.cenlanow.com/health/us-discrimination-based-on-opioid-treatment-violates-law/ | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. | 2 | 19,710 | 0 | https://www.wane.com/news/us-discrimination-based-on-opioid-treatment-violates-law/ | 2022-04-05 23:05:28+00:00 | A deepening opioid epidemic is prompting the U.S. Department of Justice to warn about discrimination against those who are prescribed medication to treat their addictions.
In guidelines published Tuesday, the department’s Civil Rights Division said employers, health care providers, law enforcement agencies that operate jails and others are violating the Americans with Disabilities Act if they discriminate against people for taking prescription drugs to treat opioid use disorder.
“People who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path of recovery,” Assistant Attorney General Kristen Clarke said in a statement.
The nation’s addiction overdose crisis has intensified in recent years. The U.S. Centers for Disease Control and Prevention announced last year that more than 100,000 people had died from overdoses over a 12-month period, the highest level ever recorded.
Most of the deaths are linked to opioids, which include prescription painkillers, morphine, heroin and potent laboratory-made drugs such as fentanyl that often are mixed into the supplies of other illegal drugs.
Public health experts believe that increasing the availability and acceptance of medications such as methadone and buprenorphine to treat opioid addiction is essential to curtailing the crisis. But those drugs — which are themselves opioids — have long had stigmas attached to them.
The Justice Department guidelines clarify that drug addiction is considered an impairment under the ADA. The department says they do not represent a policy change but rather clarify existing requirements.
“We know that seeking and accessing treatment is a critical part of reversing the addiction crisis and the overdose crisis,” said Kevin Roy, the chief public policy officer at the advocacy group Shatterproof. “People are going to be more likely to get treatment because of this policy, and that has the potential to reduce the number of people at risk of overdose death.”
The guidelines give examples of possible violations: A doctor’s office denying care to patients receiving treatment for opioid addiction; a town refusing to allow a treatment facility if the opposition is based on residents’ hostility toward people with addictions; a jail barring inmates from taking prescribed medication to block opioid addiction.
In February, the department sued the judicial system in Pennsylvania, alleging that some courts under its jurisdiction prohibit or limit people in court supervision programs from using medication to treat opioid use disorder. In a response, Pennsylvania officials said they had taken steps to “enhance awareness in the few, discrete judicial districts involved,”
The U.S. reached a settlement with Massachusetts courts last month over similar allegations, prompting the courts to change their practices.
The government last month also reached a settlement with Ready to Work, a Colorado agency that provides services to the homeless. It was accused of denying admission to one would-be participant because she was on medications to treat opioid use disorder. In addition to stopping the discrimination, Ready to Work was required to pay the person who complained $7,500.
The department also sent a letter in March to the Indiana State Board of Nursing over its decision to remove a nurse from a required licensing program over her use of medication to treat an addiction. A spokesperson for the board did not immediately respond to a request for comment Tuesday.
The Justice Department document notes that federal law does not protect people who are using illegal drugs. A drug rehabilitation program, for example, would not be violating the law if it kicked out a participant who routinely kept using drugs.
But the guidelines do say that a person who uses opioids legally prescribed to treat pain could not be fired because of it.
“The Justice Department is committed to using federal civil rights laws such as the ADA to safeguard people with opioid use disorder from facing discriminatory barriers as they move forward with their lives,” Clarke said. |
https://www.kxnet.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | 0 | 89,108 | 0 | https://www.wvnstv.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | 2022-04-05 18:10:25+00:00 | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. |
https://www.kxnet.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | 1 | 89,895 | 0 | https://www.cbs17.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | 2022-04-05 18:14:20+00:00 | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. |
https://www.kxnet.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | 2 | 92,984 | 0 | https://www.abc4.com/reviews/br/tools-br/best-kitchenaid-hand-mixer/ | 2022-04-05 18:23:55+00:00 | Which KitchenAid hand mixer is best?
Mixing ingredients by hand not only takes a lot of time, but it can also be physically fatiguing. You may find that you quickly break a sweat trying to whip your egg whites to stiff peaks or get that perfect consistency on whipped cream. Powered hand mixers take all the hassle and effort out of those jobs, and KitchenAid makes some of the best.
KitchenAid mixers are available at various price points and in both cordless and corded models. They also come in a wide range of stylish colors, including red, tangerine, aqua cream and blue velvet.
One of the best things about hand mixers is how versatile they are, and that is where the KitchenAid Nine-Speed Digital Hand Mixer KHM926OB really shines. As the name says, it boasts nine speeds, and it comes with four types of attachments to handle all kinds of tasks.
WHAT TO KNOW BEFORE YOU BUY A KITCHENAID HAND MIXER
KitchenAid hand mixers vs. KitchenAid stand mixers
Stand mixers and hand mixers are commonly found in home and commercial kitchens. Both are very versatile tools, and there is a lot of overlap between the jobs they can perform. Some notable differences between the two may make one better suited for your personal needs than the other.
Perhaps the two most significant benefits of hand mixers are the lower cost and compact size. KitchenAid stand mixers can easily cost $400-$500, while hand mixers cost less than half of that. This makes them a better choice for those on a budget. Hand mixers are also notably smaller and easier to store, making them ideal for kitchens limited in space.
Stand mixers win in terms of convenience and versatility. In addition to things like mixing dough, beating eggs and blending ingredients, stand mixers can also be used for grinding meat, making ice cream and rolling out pasta, as long as you have the necessary attachments. Stand mixers can also perform many of their tasks autonomously without you having to stand there holding the machine the entire time.
Corded vs. cordless
KitchenAid hand mixers are available in corded and cordless models. Cordless models are easier to maneuver without having to worry about being tethered to a power outlet the entire time or a cord knocking something over on the counter.
The downside to cordless models is that you’ll have to remember to charge them regularly, and there is always a chance they could run out of juice in the middle of cooking. Thankfully, KitchenAid has mitigated this issue by making their cordless hand mixers capable of working while plugging them into charge.
WHAT TO LOOK FOR IN A QUALITY KITCHENAID HAND MIXER
Speeds
KitchenAid mixers have anywhere from three to nine speed settings depending on the model. The more speeds a hand mixer has, the more jobs you can use it for since some delicate tasks may require slower speeds while others are best performed at very fast speeds.
Soft start
Hand mixers with a soft start feature begin slowly and then work up to the set speed. This is very helpful for avoiding unwanted messes since you’ll have better control over the mixer and are less likely to send some of the ingredients flying out of the bowl.
Self-standing design
Though not vital to performance, a self-standing design is a nice-to-have feature. This allows you to set down the mixer to focus on another task without having to lay it on its side with the mixing attachments touching the counter.
Ejection button
Anything that adds convenience when in the kitchen helps to make your job easier, and ejection buttons do just that. They eliminate any potential hassle involved in trying to pull out the mixing attachments. Instead, you push a button, and they pop right off.
Attachments
The number of attachments a hand mixer has dictates its versatility in the kitchen. At the very least, every model will come with egg beaters. It is also common for them to include a whisk. Some less common attachments you may also get with some premium models are dough hooks and a blending rod.
HOW MUCH YOU CAN EXPECT TO SPEND ON A KITCHENAID HAND MIXER
KitchenAid hand mixers cost $50-$200.
KITCHENAID HAND MIXER FAQ
Do KitchenAid hand mixers come with a warranty?
A. KitchenAid hand mixers are backed by a limited one-year warranty covering replacement parts and labor for fixing manufacturer defects.
Are KitchenAid hand mixers difficult to clean?
A. KitchenAid hand mixers are designed to be easy to clean. They have minimal cracks and crevices for food to get stuck in, and the attachments are all dishwasher safe.
WHAT’S THE BEST KITCHENAID HAND MIXER TO BUY?
Top KitchenAid hand mixer
KitchenAid Nine-Speed Digital Hand Mixer KHM926OB
What you need to know: Boasting the most amount of speeds and attachments of any KitchenAid hand mixer, this model is a versatile workhorse suitable for any culinary setting.
What you’ll love: It comes with four attachment types and features a digital display that makes it easy to select your preferred speed setting quickly.
What you should consider: Its high price tag may not be worth the cost for those who don’t expect to use their mixer very often.
Where to buy: Sold by Amazon
Top KitchenAid hand mixer for the money
KitchenAid Five-Speed Ultra Power Hand Mixer KHM512ER
What you need to know: This budget-priced model is ideal for those who don’t cook often but want a convenient and reliable mixer when the time comes.
What you’ll love: The power cord can be locked in place to either side of the mixer, allowing both lefties and righties to work comfortably for whichever angle they choose.
What you should consider: It has just five speeds and only comes with a single attachment.
Where to buy: Sold by Amazon
Worth checking out
KitchenAid Cordless Hand Mixer KHMB732BM
What you need to know: This well-designed cordless mixer has seven speeds and a long-lasting battery to get you through all your food prep needs.
What you’ll love: It can be used while charging, so you never have to worry about the battery dying and leaving you unable to complete a task. It also has a slow start feature to reduce the chances of making a mess.
What you should consider: It is heavier than most of KitchenAid’s other hand mixers.
Where to buy: Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Brett Dvoretz writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. |
https://www.wistv.com/prnewswire/2022/04/06/alliancerx-walgreens-prime-become-alliancerx-walgreens-pharmacy/ | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:
SOURCE AllianceRx Walgreens Prime | 0 | 23,170 | 0 | https://www.wfmz.com/news/pr_newswire/pr_newswire_business/alliancerx-walgreens-prime-to-become-alliancerx-walgreens-pharmacy/article_6db9b9c7-84af-55a4-a999-e0192d7e34b1.html | 2022-04-06 12:31:21+00:00 | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-to-become-alliancerx-walgreens-pharmacy-301518224.html
SOURCE AllianceRx Walgreens Prime |
https://www.wistv.com/prnewswire/2022/04/06/alliancerx-walgreens-prime-become-alliancerx-walgreens-pharmacy/ | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:
SOURCE AllianceRx Walgreens Prime | 1 | 23,690 | 0 | https://www.wctv.tv/prnewswire/2022/04/06/alliancerx-walgreens-prime-become-alliancerx-walgreens-pharmacy/ | 2022-04-06 12:33:52+00:00 | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:
SOURCE AllianceRx Walgreens Prime |
https://www.wistv.com/prnewswire/2022/04/06/alliancerx-walgreens-prime-become-alliancerx-walgreens-pharmacy/ | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:
SOURCE AllianceRx Walgreens Prime | 2 | 27,368 | 0 | https://www.wjhg.com/prnewswire/2022/04/06/alliancerx-walgreens-prime-become-alliancerx-walgreens-pharmacy/ | 2022-04-06 12:48:33+00:00 | Tracey James, RPh, assumes chief operating officer position to support future company strategy.
ORLANDO, Fla., April 6, 2022 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand. Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
"While our name is changing, we will be the same specialty and home delivery pharmacy our patients trust and depend on for life-saving medications," says Joel Wright, RPh, chief executive officer. "We will continue putting patients first in everything we do to provide hope and care for better tomorrows."
Wright says additional company changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
"Our Specialty360 therapy teams were developed to enable us to improve patient outcomes, reduce cost of care, and enhance the patient and provider experience," Wright says. "As the pharmacy industry evolves, the complexity of our patients' needs led us to change our operating model to support them with therapy-specific teams."
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care. Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
"We're evolving the organization to support a more personalized pharmacy experience with specific clinical expertise for our patients, based on their diagnoses," James says. "This new structure will allow our team members to meet our patients where they need us most and position the company for future growth."
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Florida, and its pharmacies are accredited by several national pharmacy accreditation services.
Media Contact
Adrienne Foley, APR
External communications manager
adrienne.foley1@alliancerxwp.com
View original content to download multimedia:
SOURCE AllianceRx Walgreens Prime |
https://www.wistv.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute | 0 | 27,814 | 0 | https://www.wjhg.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | 2022-04-06 12:50:22+00:00 | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute |
https://www.wistv.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute | 1 | 27,867 | 0 | https://www.weau.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | 2022-04-06 12:50:37+00:00 | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute |
https://www.wistv.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute | 2 | 27,887 | 0 | https://www.wdtv.com/prnewswire/2022/04/06/cfa-institute-announces-agenda-flagship-alpha-summit-global/ | 2022-04-06 12:50:43+00:00 | Virtual conference for investment and wealth professionals set to welcome more than 3,000 delegates
NEW YORK, April 6, 2022 /PRNewswire/ -- CFA Institute, the global association of investment professionals, today announced the agenda for its flagship conference, Alpha Summit GLOBAL, set to take place between 17 and 19 May 2022. Registration is now open.
A fully virtual three-day event, Alpha Summit GLOBAL will address the industry's biggest challenges and trends. Calling on investment leaders and practitioners to "think beyond the horizon," Alpha Summit GLOBAL will deliver engagement with renowned industry leaders, investors, academics, entrepreneurs, and best-selling authors through five key themes:
- Opportunities and Responsibilities with Sustainable Investing: including ESG Standards and how finance can directly help society through investment. Sessions include:
- Excelling in a Post-Pandemic World: compelling the investment industry to build back better and smarter through beneficial systems and behaviors that can prepare the world for long-run risks. Sessions include:
- Harnessing the Benefits of Innovation and Technology: unlocking disruptive technologies to digitally transform internal processes, analytical skills, and customer experiences. Sessions include:
- The Future of Capital Markets Today: preparing investors to face the macro risks and uncertainties and continual market evolution and applying the skills required to help shape a better future for society through investment. Sessions include:
- Advancements for the Investment Management Professional: elevating and expanding knowledge and skills through organizational systems, technologies, and relationships to optimize the client experience. Sessions include:
Barbara Pettit, CFA, Managing Director, Professional Learning at CFA Institute, comments:
"Investment professionals are seeking high-quality continuous learning to ensure they remain ready to lead and support clients through the many acute and significant challenges facing investors. Our Alpha Summit will connect industry leaders, investors, analysts, advisors, and wealth managers with the content they need. I encourage all investment professionals to mark their calendars and register for this once-a-year global event."
Alpha Summit GLOBAL is sponsored by PGIM, the global asset management business of Prudential Financial Inc.
To register to attend Alpha Summit GLOBAL, or to view the full agenda, please visit here.
#AlphaSummit
For more information, contact PR@CFAInstitute.org
Alpha Summit is a three-part global and regional conference series for investment professionals hosted by CFA Institute. Alpha Summit GLOBAL is the third in the series, with delegate access available through Basic (free to register) and Premium package options. Early registration pricing is available for delegates enrolling before 19 April 2022. Delegates are eligible to earn up to 12 Professional Learning (PL) credits, including 2.25 Standards, Ethics, and Regulation credits. PL Credits for CFA Institute members and CFA charterholders registering through their online CFA Institute login will be automatically applied. APAC and EMEA Alpha Summit content, recorded in February 2022, is available on-demand here.
CFA Institute is the global association of investment professionals that sets the standard for professional excellence and credentials. The organization is a champion of ethical behavior in investment markets and a respected source of knowledge in the global financial community. Our aim is to create an environment where investors' interests come first, markets function at their best, and economies grow. There are more than 180,000 CFA® charterholders worldwide in more than 160 markets. CFA Institute has nine offices worldwide and there are 160 local societies. For more information, visit www.cfainstitute.org or follow us on LinkedIn and Twitter at @CFAInstitute.
View original content:
SOURCE CFA Institute |
https://www.wistv.com/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation | 0 | 19,650 | 0 | https://www.dakotanewsnow.com/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | 2022-04-06 12:15:25+00:00 | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation |
https://www.wistv.com/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation | 1 | 20,297 | 0 | https://www.nbc11news.com/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | 2022-04-06 12:18:24+00:00 | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation |
https://www.wistv.com/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation | 2 | 24,678 | 0 | https://www.wctv.tv/prnewswire/2022/04/06/fda-approves-novartis-vijoice-alpelisib-first-only-treatment-select-patients-with-pik3ca-related-overgrowth-spectrum-pros/ | 2022-04-06 12:37:33+00:00 | Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1
PROS is a spectrum of rare conditions and is characterized by atypical overgrowths and anomalies in blood vessels, the lymphatic system and other tissues2,3
Approval based on real-world data from EPIK-P1 study, which showed patients treated with Vijoice experienced reduction in the size of PROS lesions and improvement of PROS-related signs and symptoms
Novartis to offer robust patient support program that includes assistance to access medication, financial resources for eligible patients and continued education
EAST HANOVER, N.J., April 6, 2022 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.1 Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.2,3 In accordance with the Accelerated Approval Program, continued approval may be contingent upon verification and description of clinical benefit from confirmatory evidence.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9015251-fda-approves-novartis-vijoice-as-treatment-for-pros
"Today's approval of the first treatment for PROS offers hope for a better quality of life to patients and families affected by these rare conditions," said Kristen Davis, Executive Director of CLOVES Syndrome Community. "PROS conditions can be debilitating and disabling and can result in disruptions to everyday activities. Until today, often the only treatment options for patients were surgical or interventional radiology procedures."
PROS conditions can affect quality of life and pose a range of physical, emotional and social challenges for patients and their families, ranging from functional impacts and developmental delays to chronic pain, mobility issues, and feelings of isolation.3-6 PROS management can be challenging, requiring collaboration from a multidisciplinary team, and patients and physicians have only had access to interventions focused on symptom management.6,7
"I am proud of this outstanding achievement for the PROS community. The EPIK-P1 study results build on our earlier pre-clinical findings and demonstrate the efficacy of Vijoice for select PROS conditions, effectively reducing PROS growths," said Guillaume Canaud, MD, PhD, Necker-Enfants Malades Hospital – AP-HP, the Paris Descartes University, Inserm (INEM Institute Necker Enfants Malades – Centre for Molecular Medicine). "This is a significant advancement in therapy for PROS with the potential to positively change the treatment trajectory and outcomes for patients."
FDA approval was based on real-world evidence from EPIK-P1, a retrospective chart review study that showed patients treated with Vijoice experienced reduced target lesion volume and improvement in PROS-related symptoms and manifestations. The primary endpoint analysis conducted at week 24 showed 27% of patients (10/37) achieved a confirmed response to treatment, defined as 20% or greater reduction in the sum of PROS target lesion volume. Nearly three in four patients with imaging at baseline and week 24 (74%, 23/31) showed some reduction in target lesion volume, with a mean reduction of 13.7%, and no patients experienced disease progression at time of primary analysis. Additionally, at week 24, investigators observed patient improvements in pain (90%, 20/22), fatigue (76%, 32/42), vascular malformation (79%, 30/38), limb asymmetry (69%, 20/29), and disseminated intravascular coagulation (55%, 16/29). These improvements were observed in subsets of patients across the study population (n=57) who reported symptoms at baseline and at week 24.1,2
"The approval of Vijoice marks a turning point for patients who, until now, have not had an approved therapy to specifically address their disease," said Victor Bulto, President, Novartis Innovative Medicines US. "We are grateful to the physicians, patients and families who participated in the EPIK-P1 trial. We are continuing to invest in studies to advance the scientific understanding of PROS conditions and to understand the full potential of Vijoice."
In EPIK-P1, the most common adverse events (AEs) of any grade were diarrhea (16%), stomatitis (16%), and hyperglycemia (12%). The most common grade 3/4 AE was cellulitis (4%); one adult case was considered treatment-related.1
Novartis is committed to providing patients with access to medicines, as well as resources and support to address a range of needs. The Novartis Oncology Patient Support Program is available to help guide eligible patients through the various aspects of getting started on treatment, from providing educational information to helping them understand their insurance coverage and identify potential financial assistance options. Patients or providers can call 800-282-7630 or visit Patient.NovartisOncology.com or HCP.Novartis.com/Access to learn more about eligibility and to enroll.
About PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS classification was proposed by researchers and parent representatives of patient-family support and advocacy organizations at a National Institutes of Health workshop in 2013 to unite a group of rare overgrowth conditions caused by PIK3CA mutations.4,6 Specific conditions associated with PROS include KTS, CLOVES syndrome, ILM, MCAP/M–CM, HME, HHML, FIL, FAVA, macrodactyly, muscular HH, FAO, CLAPO syndrome and epidermal nevus, benign lichenoid keratosis, or seborrheic keratosis.4,6 The estimated prevalence of PROS conditions is approximately 14 people per million.3
About Vijoice
Vijoice® (alpelisib) is a kinase inhibitor that treats rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children with PIK3CA-Related Overgrowth Spectrum (PROS). Vijoice works by inhibiting the PI3K pathway, predominantly the PI3K-alpha isoform.1 Vijoice is the first FDA-approved treatment for PROS conditions. Vijoice is not approved for use outside the United States.
FDA approval of Vijoice is based primarily on real-world evidence from the EPIK-P1 study. To further understand the long-term efficacy and safety of alpelisib in PROS, Novartis is conducting additional clinical trials. EPIK-P2 is a prospective Phase II multi-center study with a randomized, double-blind, upfront 16-week placebo-controlled period, and extension period to evaluate the safety, the efficacy and pharmacokinetics of alpelisib to treat pediatrics and adults with PROS. EPIK-P3 is a Phase II study to assess long-term safety and efficacy of alpelisib in people with PROS who participated in EPIK-P1.
Important Safety Information
Indication
VIJOICE® (alpelisib) tablets is a prescription medicine used to treat adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy.
This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Important Safety Information
Patients should not take VIJOICE if they have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients in VIJOICE.
VIJOICE may cause serious side effects. VIJOICE can cause severe allergic reactions. Patients should tell their health care provider or get medical help right away if they have trouble breathing, flushing, rash, fever, or fast heart rate during treatment with VIJOICE. VIJOICE can cause severe skin reactions. Patients should tell their health care provider or get medical help right away if they get a severe rash or a rash that keeps getting worse; reddened skin; flu-like symptoms; blistering of the lips, eyes, or mouth; blisters on the skin or peeling skin, with or without a fever. VIJOICE can cause high blood sugar levels (hyperglycemia). Hyperglycemia is common with VIJOICE and can be severe. Health care providers will monitor blood sugar levels before patients start, and during treatment with, VIJOICE. Health care providers may monitor blood sugar levels more often if patients have a history of type 2 diabetes. Patients should tell their health care provider right away if they develop symptoms of hyperglycemia or its complications, including excessive thirst, dry mouth, urinating more often than usual or having a higher amount of urine than normal, increased appetite with weight loss, confusion, nausea, vomiting, fruity odor on breath, difficulty breathing, or dry or flushed skin. VIJOICE can cause lung problems (pneumonitis). Patients should tell their health care provider right away if they develop new or worsening symptoms of lung problems, including shortness of breath or trouble breathing, cough, or chest pain. Diarrhea is common with VIJOICE and can be severe. Severe diarrhea can lead to the loss of too much body water (dehydration) and kidney injury. Patients who develop diarrhea during treatment with VIJOICE should tell their health care provider right away.
Before taking VIJOICE, patients should tell their health care provider if they have a history of diabetes; skin rash; redness of skin; blistering of the lips, eyes, or mouth; peeling skin; are pregnant, or plan to become pregnant, because VIJOICE can harm their unborn baby. Females who can become pregnant should use effective birth control during treatment with VIJOICE and for 1 week after the last dose. Do not breastfeed during treatment with VIJOICE and for 1 week after the last dose. Males with female partners who can become pregnant should use condoms and effective birth control during treatment with VIJOICE and for 1 week after the last dose.
Patients should tell their health care provider about all the medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VIJOICE and other medicines may affect each other and cause side effects. Know the medicines you take. Keep a list of them to show your health care provider or pharmacist when you get a new medicine.
The most common side effects of VIJOICE are diarrhea, mouth sores (stomatitis), and hyperglycemia.
Please see full Prescribing Information for VIJOICE, available at VIJOICE.com.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "potential," "can," "will," "plan," "may," "could," "would," "expect," "anticipate," "look forward," "believe," "committed," "investigational," "pipeline," "launch," or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals Corporation – an affiliate of Novartis – is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis employs nearly 15,000 people in the United States. For more information, please visit https://www.novartis.us.
Novartis and Novartis US is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews and @NovartisUS at https://twitter.com/NovartisUS.
For Novartis multimedia content, please visit https://www.novartis.com/news/media-library.
For questions about the site or required registration, please contact media.relations@novartis.com.
References
- Vijoice: Prescribing Information. East Hanover, New Jersey, USA: Novartis Pharmaceuticals Corporation; April 2022.
- Canaud G, et al. EPIK-P1: Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib as Part of a Compassionate Use Programme. Presented at the 2021 ESMO Congress; September 17-21, 2021.
- Data on file. Novartis Pharmaceuticals Corp; 2020.
- Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713-1733.
- Parker VER, Keppler-Noreuil KM, Faivre L, et al. Genet Med. 2019;21(5):1189-1198.
- Mirzaa G, Conway R, Graham JM Jr, Dobyns WB. PIK3CA-related segmental overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2019.
- Hughes M, Hao M and Luu M. PIK3CA vascular overgrowth syndromes: an update. Current Opinion in Pediatrics. 2020;32(4):539-546.
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
E-mail: investor.relations@novartis.com
View original content:
SOURCE Novartis Pharmaceuticals Corporation |
https://www.justarsenal.com/two-arsenal-women-make-their-150th-appearance-in-5-0-thrashing-of-leicester/307260 | Beth Mead and Katie McCabe are two players that everybody knows and loves and when it comes to the team sheet they are both ever present no matter the manager. But they both reached an important milestone on the weekend and it deserves to be celebrated.
Although Arsenal ran out 5-0 winners over Leicester on the weekend, both of these ladies had double reason to smile at the end of the game as they both reached the 150-game milestone in their Arsenal careers so far.
Mead first donned an Arsenal shirt back in 2017 and within the space of five years has now taken to the pitch 150 times.
It didn’t take her long to get on the scoresheet in her 150th appearance either as two minutes into the game she got Arsenal’s first in a rout that would see them run out as 5-0 winners.
McCabe on the other hand although not on the scoresheet in the recent game, first joined Arsenal two years before Mead in 2015 and over the space of seven years has appeared 150 times.
Although when she first joined, 150 games might have seen a bit of a way off as after a lack of first team starts and injuries she saw herself be sent out on loan to Glasgow City in 2017 where she helped them to the Scottish title. She then returned to Arsenal from her loan spell in the same season and has since been an ever present in the side, putting behind her the struggles and injuries she first faced.
Another bit of good news is that Katie has also signed a new long-term contract not long ago at the club and will no doubt be aiming for 200 appearances, if not more.
For some players reaching the 50-game milestone is seen as an achievement, but 150 for both of these women is very impressive, and if they continue in the way they have been there will be many more appearances from both I am sure!
Shenel Osman
@sh3n3l_ | 0 | 12,543 | 0.862231 | https://www.fourfourtwo.com/news/arsenals-euro-stars-ready-to-prove-themselves-all-over-again-jonas-eidevall-1663232447000 | 2022-09-15 16:15:52+00:00 | Arsenal’s Euro stars ready to prove themselves all over again – Jonas Eidevall
Arsenal head coach Jonas Eidevall has no doubt England stars Leah Williamson and Beth Mead will return as hungry as ever to add to their medal collection when the new Barclays Women’s Super League campaign gets under way.
Following the postponement of all English football fixtures last weekend as a mark of respect after the Queen’s death, the new domestic season will begin when Arsenal host Brighton in Borehamwood on Friday night.
Meadow Park is a far cry from the bumper 87,192 Wembley crowd which roared the Lionesses on to victory over Germany in the Euro 2022 final earlier this summer.
Racing towards matchday like 💨 pic.twitter.com/dFSoJxyzwv— Arsenal Women (@ArsenalWFC) September 14, 2022
Nevertheless, Eidevall feels the likes of England captain Williamson and Euro 2022 Golden Boot winner Mead – along with defender Lotte Wubben-Moy, who was also part of Sarina Weigman’s successful squad – will be out to prove themselves all over again back in club colours.
“Part of the mental strength needed to be an excellent footballer is to concentrate on the pitch and to remember that, just because you have won something before – that’s great, it’s an achievement – but you are not entitled to anything for it on the pitch for future games,” the Swede said.
“You still have to do everything from the beginning every time you go on the pitch. Every day, you have to earn your right to play. You don’t get anything for free in football.
“That is the mindset you have to have, no matter how much you have won before or how many awards you have got – you have to start on the same page as everyone else.”
Eidevall added: “It’s important to emphasise that we have a lot of players that have been in finals, who have also won things before this summer. It is the shared pool of all those experiences that is really important.”
While the spotlight may firmly be on whether Mead can carry the momentum from the six goals she scored during the tournament into club football, Eidevall expects the 27-year-old to take it all in her stride.
“She brought the same intensity to the Euros as she had been doing with Arsenal, and she brings the same intensity back to Arsenal again now,” the Arsenal head coach said.
“You never know with people and the future, and that is why it is important that no matter how much you have won, it is about what are you moving forward and what you are doing in the present.
“That is where Beth needs to look forward, but every player in Arsenal needs to do that in order to achieve new things, because football is never standing still, so as a club, or a player, or a coach, we can’t stand still.”
Arsenal expect to have Australian pair Steph Catley and Caitlin Foord available after picking up minor knocks during the recent international break.
Eidevall has been impressed with the way Brighton are shaping up for the new WSL campaign.
“Some of the players they have got in over this window are of a really high quality, so we are expecting and preparing for a competitive game,” he said.
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1 |
https://www.justarsenal.com/two-arsenal-women-make-their-150th-appearance-in-5-0-thrashing-of-leicester/307260 | Beth Mead and Katie McCabe are two players that everybody knows and loves and when it comes to the team sheet they are both ever present no matter the manager. But they both reached an important milestone on the weekend and it deserves to be celebrated.
Although Arsenal ran out 5-0 winners over Leicester on the weekend, both of these ladies had double reason to smile at the end of the game as they both reached the 150-game milestone in their Arsenal careers so far.
Mead first donned an Arsenal shirt back in 2017 and within the space of five years has now taken to the pitch 150 times.
It didn’t take her long to get on the scoresheet in her 150th appearance either as two minutes into the game she got Arsenal’s first in a rout that would see them run out as 5-0 winners.
McCabe on the other hand although not on the scoresheet in the recent game, first joined Arsenal two years before Mead in 2015 and over the space of seven years has appeared 150 times.
Although when she first joined, 150 games might have seen a bit of a way off as after a lack of first team starts and injuries she saw herself be sent out on loan to Glasgow City in 2017 where she helped them to the Scottish title. She then returned to Arsenal from her loan spell in the same season and has since been an ever present in the side, putting behind her the struggles and injuries she first faced.
Another bit of good news is that Katie has also signed a new long-term contract not long ago at the club and will no doubt be aiming for 200 appearances, if not more.
For some players reaching the 50-game milestone is seen as an achievement, but 150 for both of these women is very impressive, and if they continue in the way they have been there will be many more appearances from both I am sure!
Shenel Osman
@sh3n3l_ | 1 | 68,703 | 0.869192 | https://sportstar.thehindu.com/football/beth-mead-double-helps-arsenal-to-4-0-wsl-win-over-brighton/article65901860.ece | 2022-09-18 04:38:57+00:00 | England international Beth Mead scored twice in a dominant 4-0 win for Arsenal over Brighton & Hove Albion as the Women’s Super League got underway on Friday at a sold-out Meadow Park.
With last week’s fixtures postponed due to the death of Queen Elizabeth, the season was only seven minutes old when Brighton lost Emma Kullberg to a straight red card after she brought down Swedish striker Stina Blackstenius.
That made the task all the tougher for the visitors and Kim Little gave the Gunners the lead in the 28th minute, with Blackstenius getting on the scoresheet five minutes after the break thanks to an assist from Mead.
Mead, who finished England’s victorious Euro 2022 campaign as the tournament’s top scorer, netted in the 63rd and 83rd minutes to round off the win for Arsenal, who finished second behind champions Chelsea last season. |
https://www.justarsenal.com/two-arsenal-women-make-their-150th-appearance-in-5-0-thrashing-of-leicester/307260 | Beth Mead and Katie McCabe are two players that everybody knows and loves and when it comes to the team sheet they are both ever present no matter the manager. But they both reached an important milestone on the weekend and it deserves to be celebrated.
Although Arsenal ran out 5-0 winners over Leicester on the weekend, both of these ladies had double reason to smile at the end of the game as they both reached the 150-game milestone in their Arsenal careers so far.
Mead first donned an Arsenal shirt back in 2017 and within the space of five years has now taken to the pitch 150 times.
It didn’t take her long to get on the scoresheet in her 150th appearance either as two minutes into the game she got Arsenal’s first in a rout that would see them run out as 5-0 winners.
McCabe on the other hand although not on the scoresheet in the recent game, first joined Arsenal two years before Mead in 2015 and over the space of seven years has appeared 150 times.
Although when she first joined, 150 games might have seen a bit of a way off as after a lack of first team starts and injuries she saw herself be sent out on loan to Glasgow City in 2017 where she helped them to the Scottish title. She then returned to Arsenal from her loan spell in the same season and has since been an ever present in the side, putting behind her the struggles and injuries she first faced.
Another bit of good news is that Katie has also signed a new long-term contract not long ago at the club and will no doubt be aiming for 200 appearances, if not more.
For some players reaching the 50-game milestone is seen as an achievement, but 150 for both of these women is very impressive, and if they continue in the way they have been there will be many more appearances from both I am sure!
Shenel Osman
@sh3n3l_ | 2 | 19,391 | 0.871907 | https://www.thecourier.co.uk/sport/3697327/arsenals-euro-stars-ready-to-prove-themselves-all-over-again-jonas-eidevall/ | 2022-09-17 20:36:07+00:00 | Arsenal head coach Jonas Eidevall has no doubt England stars Leah Williamson and Beth Mead will return as hungry as ever to add to their medal collection when the new Barclays Women’s Super League campaign gets under way.
Following the postponement of all English football fixtures last weekend as a mark of respect after the Queen’s death, the new domestic season will begin when Arsenal host Brighton in Borehamwood on Friday night.
Meadow Park is a far cry from the bumper 87,192 Wembley crowd which roared the Lionesses on to victory over Germany in the Euro 2022 final earlier this summer.
Nevertheless, Eidevall feels the likes of England captain Williamson and Euro 2022 Golden Boot winner Mead – along with defender Lotte Wubben-Moy, who was also part of Sarina Weigman’s successful squad – will be out to prove themselves all over again back in club colours.
“Part of the mental strength needed to be an excellent footballer is to concentrate on the pitch and to remember that, just because you have won something before – that’s great, it’s an achievement – but you are not entitled to anything for it on the pitch for future games,” the Swede said.
“You still have to do everything from the beginning every time you go on the pitch. Every day, you have to earn your right to play. You don’t get anything for free in football.
“That is the mindset you have to have, no matter how much you have won before or how many awards you have got – you have to start on the same page as everyone else.”
Eidevall added: “It’s important to emphasise that we have a lot of players that have been in finals, who have also won things before this summer. It is the shared pool of all those experiences that is really important.”
While the spotlight may firmly be on whether Mead can carry the momentum from the six goals she scored during the tournament into club football, Eidevall expects the 27-year-old to take it all in her stride.
“She brought the same intensity to the Euros as she had been doing with Arsenal, and she brings the same intensity back to Arsenal again now,” the Arsenal head coach said.
“You never know with people and the future, and that is why it is important that no matter how much you have won, it is about what are you moving forward and what you are doing in the present.
“That is where Beth needs to look forward, but every player in Arsenal needs to do that in order to achieve new things, because football is never standing still, so as a club, or a player, or a coach, we can’t stand still.”
Arsenal expect to have Australian pair Steph Catley and Caitlin Foord available after picking up minor knocks during the recent international break.
Eidevall has been impressed with the way Brighton are shaping up for the new WSL campaign.
“Some of the players they have got in over this window are of a really high quality, so we are expecting and preparing for a competitive game,” he said.
Brighton head coach Hope Powell is confident her squad will be ready to make the most of being centre stage on the opening night of the new campaign.
“I like Friday night games. It’s a sell-out match which is good for us and the game,” she told a press conference.
“The expectation is for Arsenal to win the game, but we won’t give it to them, we’ll make it difficult.”
“The squad is looking forward to it. For some, the league is new to them. The summer has been quite a long one so they’re ready to play now and are excited for it.” |
https://www.wistv.com/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed | 0 | 19,520 | 0 | https://www.wabi.tv/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | 2022-04-06 12:14:55+00:00 | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed |
https://www.wistv.com/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed | 1 | 20,694 | 0 | https://www.dakotanewsnow.com/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | 2022-04-06 12:20:32+00:00 | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed |
https://www.wistv.com/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed | 2 | 21,543 | 0 | https://www.nbc11news.com/prnewswire/2022/04/06/soc-telemed-completes-acquisition-by-patient-square-capital/ | 2022-04-06 12:24:02+00:00 | HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022.
Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warrants to purchase shares of Class A common stock have ceased trading and are no longer listed on Nasdaq.
With the closing of the transaction, SOC Telemed will now be a private company with the flexibility and resources to continue investing in its unique clinical capabilities, innovating its offering, and expanding its footprint.
SOC Telemed will continue to be led by Dr. Chris Gallagher, Chief Executive Officer, who assumed the role of CEO in September of 2021. Dr. Gallagher said, "We are excited about this next chapter in our company's journey. I am extremely grateful to our team members whose dedication and hard work have contributed to SOC Telemed's success and made this possible. We believe that with the support and expertise of Patient Square Capital, SOC Telemed will be well positioned to meet the growing needs of patients, physicians and our hospital partners."
Additional details can be found in a Current Report on Form 8-K filed by SOC Telemed this morning with the Securities and Exchange Commission (the "SEC").
About SOC Telemed
SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal-Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.
About Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. We utilize our deep industry expertise, our broad network of relationships and a true partnership approach to make investments in companies that will grow and thrive. We believe in the power these companies have to improve patient lives, strengthen communities and create a healthier world. Patient Square Capital is purpose built by a team of industry-leading executives, differentiated by the depth of our focus in health care, the breadth of our health care investing experience, and the network we can activate to drive differentiated outcomes. Most importantly, patients are squarely at the center of all that we do. For more information, visit www.patientsquarecapital.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on SOC Telemed's current expectations, estimates and projections about the potential benefits of the transaction, its business and industry, management's beliefs and certain assumptions made by SOC Telemed and Patient Square Capital, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements, including statements about the parties' ability to realize the anticipated benefits of the transaction are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the impact of the COVID-19 pandemic on SOC Telemed's business and general economic conditions; (ii) SOC Telemed's ability to implement its business strategy; (iii) significant transaction costs associated with the transaction; (iv) potential litigation relating to the transaction; (v) the risk that disruptions from the transaction will harm SOC Telemed's business, including current plans and operations; (vi) the ability of SOC Telemed to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the transaction; (viii) legislative, regulatory and economic developments affecting SOC Telemed's business; (ix) general economic and market developments and conditions; (x) the evolving legal, regulatory and tax regimes under which SOC Telemed operates; (xi) potential business uncertainty, including changes to existing business relationships, following the completion of the transaction that could affect SOC Telemed's financial performance; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities, or pandemics; (xiii) other factors as set forth from time to time in SOC Telemed's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2021, as may be updated or supplemented by any subsequent filings that SOC Telemed may file with the SEC, as well as SOC Telemed's response to any of the aforementioned factors. These risks, as well as other risks associated with the transaction, are more fully discussed in the Proxy Statement filed with the SEC in connection with the transaction. Investors are cautioned not to place undue reliance on such statements which speak only as of the date they are made. While the list of factors presented here is, and the list of factors presented in the Proxy Statement is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and other similar risks, any of which could have a material adverse effect on SOC Telemed's financial condition, results of operations, or liquidity. SOC Telemed does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media Contact
Doug Allen/Zach Kouwe
Dukas Linden Public Relations
646-722-6530
PatientSquare@DLPR.com
Investor Relations
Steve Rubis
Vice President, Investor Relations
SOC Telemed
(214) 681-7991
srubis@soctelemed.com
View original content:
SOURCE SOC Telemed |
https://www.wistv.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. | 0 | 1,172 | 0 | https://www.newschannel6now.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | 2022-04-04 22:21:17+00:00 | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. |
https://www.wistv.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. | 1 | 5,511 | 0 | https://www.wdam.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | 2022-04-04 22:38:52+00:00 | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. |
https://www.wistv.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. | 2 | 11,250 | 0 | https://www.kswo.com/2022/04/04/alaska-airlines-moves-gender-neutral-uniforms-allowing-tattoos-employees/ | 2022-04-04 23:07:22+00:00 | Alaska Airlines moves to gender-neutral uniforms, allowing tattoos for employees
(CNN) - Alaska Airlines is going gender-neutral with its uniform policy for employees.
In a statement this week, the airline said the updated guidelines will “provide more freedom and flexibility in individual and gender expression.”
The carrier will also collaborate with a designer to create gender-neutral uniform items for frontline workers, including flight attendants, customer service agents and lounge employees.
The change follows a 2021 employee allegation that Alaska Airlines’ uniform policy discriminated against workers whose gender expression did not fit male and female dress codes.
Previously, the airline required either “male” or “female” uniforms, along with regulations on other dress codes based on assumed gender. At the time, the carrier said flight attendants could order any “uniform kit of their choice, regardless of gender identity.”
The airline is also updating to allow more flexibility in personal expression, including with tattoos and hair style choices.
Copyright 2022 CNN Newsource. All rights reserved. |
https://www.dailyrecord.co.uk/in-your-area/lanarkshire/volunteers-new-lanarkshire-project-go-26646410 | An initiative aimed at tackling period poverty is being wheeled out in the Wishaw area.
Flo & Go, a joint project between Newmains Community Trust (NCT) and Cairney Cycles, will deliver eco-friendly sanitary products to women free-of-charge.
A team of volunteers are being recruited who will get on their bikes for the delivery programme.
The new scheme is in the final stages of planning, but it’s hoped it will go live next month.
Download the Lanarkshire Live app today
The Lanarkshire Live app is available to download now.
Get all the news from your area – as well as features, entertainment, sport and the latest on Lanarkshire’s recovery from the coronavirus pandemic – straight to your fingertips, 24/7.
The free download features the latest breaking news and exclusive stories, and allows you to customise your page to the sections that matter most to you.
Head to the App Store and never miss a beat in Lanarkshire - iOS - Android
Mary-Anne McCafferty is development manager at NCT - one of the places offering free sanitary products in the area.
She told Lanarkshire Live: "We work quite closely with the team from the council and we’d been discussing how we could increase the uptake of more of the reusable products and make things a bit more eco-friendly.
"During the discussions they said there was funding available to start up a delivery service, so that’s how it came about.”
The free products will also give those who use them the added bonus that they will be doing their bit for the environment.
“I think some people are afraid to try something different because they are so used to certain products,” Mary-Anne continued. “But if someone can deliver to you in the privacy of your own house, then why not give it a go?
"During lockdown we were giving out the products along with food parcels and stuff to make sure they weren’t going without.
“A lot of people feel guilty about waste and the amount of things that just go to landfill these days.”
Connor Mooney decided to set up Cairney Cycles during 2020 after struggling to have his own bike repaired promptly - he now also offers refurbished bikes for sale at affordable prices.
Amongst other things he will be responsible for training the volunteers on bike safety and maintenance.
He told us: “I’m going to help recruit volunteers and will volunteer myself too, if I can. Mary-Anne came to me with the idea for the project and was looking for help with the bike side of things and ordering.
"We put together some training for the volunteers. The sanitary products are eco-friendly and the bikes we’re using are refurbished.
“We’ve sourced a company that does kits and we’re converting two of the bikes to electric ones. They are really good and have around a 20 miles range, so they’re good for Newmains and the local area.
"Most of the electric kits can be fully charged in three or four hours. The motors on some of the bikes now are quite powerful.”
Mary-Anne and Connor had been talking just the day before her meeting with the council when the delivery option was first discussed.
“Connor had already linked up with us doing bicycle repairs and maintenance sessions in the centre," she added.
“He’s making cycling available and accessible to everybody and had suggested doing more work in the community.
“So I phoned him up and asked if he wanted to help me deliver period products and he said, ‘No bother!’.
“We’re really chuffed that Connor came along at the right time.
“He’s also been helping with sourcing all the bikes and equipment.
“At our side [NCT], we’ll support all the volunteers and take care of all the stock, stock management and getting it delivered out to people.
“Cycling may well become a more popular mode of transport now when you see the price of fuel, it might push some people to think they may not need to drive to work and that they could cycle six or seven miles.”
**Don't miss the latest headlines from around Lanarkshire. Sign up to our newsletters here.
And did you know Lanarkshire Live had its own app? Download yours for free here. | 0 | 12,453 | 0.682809 | https://www.dailyrecord.co.uk/in-your-area/lanarkshire/free-sanitary-products-delivered-south-26661049 | 2022-04-08 11:11:40+00:00 | South Lanarkshire residents can have free sanitary products delivered to their homes.
The service is available to everyone in the area who needs them regardless of income or personal circumstances. The council has teamed up with Hey Girls to offer products.
A range of different products are available to suit individual needs, to see what is on offer, visit here.
Download the Lanarkshire Live app today
The Lanarkshire Live app is available to download now.
Get all the news from your area – as well as features, entertainment, sport and the latest on Lanarkshire’s recovery from the coronavirus pandemic – straight to your fingertips, 24/7.
The free download features the latest breaking news and exclusive stories, and allows you to customise your page to the sections that matter most to you.
Head to the App Store and never miss a beat in Lanarkshire - iOS - Android
To order the free product, a form is available to complete, only one form is required for all the members of a household.
Funding for period products has been given by the Scottish Government to ensure those who need products are supplied.
Since 2019, the Community Planning Partnership in South Lanarkshire have provided sanitary products to all public buildings, leisure and culture facilities and to voluntary organisations across the area.
The council is working to add more locations and is asking organisations who want to distribute products to contact Period.Positive@southlanarkshire.gov.uk.
**Don't miss the latest headlines from around Lanarkshire. Sign up to our newsletters here.
And did yo u know Lanarkshire Live is on Facebook? Head over to our page to give us a like and share. |
https://www.dailyrecord.co.uk/in-your-area/lanarkshire/volunteers-new-lanarkshire-project-go-26646410 | An initiative aimed at tackling period poverty is being wheeled out in the Wishaw area.
Flo & Go, a joint project between Newmains Community Trust (NCT) and Cairney Cycles, will deliver eco-friendly sanitary products to women free-of-charge.
A team of volunteers are being recruited who will get on their bikes for the delivery programme.
The new scheme is in the final stages of planning, but it’s hoped it will go live next month.
Download the Lanarkshire Live app today
The Lanarkshire Live app is available to download now.
Get all the news from your area – as well as features, entertainment, sport and the latest on Lanarkshire’s recovery from the coronavirus pandemic – straight to your fingertips, 24/7.
The free download features the latest breaking news and exclusive stories, and allows you to customise your page to the sections that matter most to you.
Head to the App Store and never miss a beat in Lanarkshire - iOS - Android
Mary-Anne McCafferty is development manager at NCT - one of the places offering free sanitary products in the area.
She told Lanarkshire Live: "We work quite closely with the team from the council and we’d been discussing how we could increase the uptake of more of the reusable products and make things a bit more eco-friendly.
"During the discussions they said there was funding available to start up a delivery service, so that’s how it came about.”
The free products will also give those who use them the added bonus that they will be doing their bit for the environment.
“I think some people are afraid to try something different because they are so used to certain products,” Mary-Anne continued. “But if someone can deliver to you in the privacy of your own house, then why not give it a go?
"During lockdown we were giving out the products along with food parcels and stuff to make sure they weren’t going without.
“A lot of people feel guilty about waste and the amount of things that just go to landfill these days.”
Connor Mooney decided to set up Cairney Cycles during 2020 after struggling to have his own bike repaired promptly - he now also offers refurbished bikes for sale at affordable prices.
Amongst other things he will be responsible for training the volunteers on bike safety and maintenance.
He told us: “I’m going to help recruit volunteers and will volunteer myself too, if I can. Mary-Anne came to me with the idea for the project and was looking for help with the bike side of things and ordering.
"We put together some training for the volunteers. The sanitary products are eco-friendly and the bikes we’re using are refurbished.
“We’ve sourced a company that does kits and we’re converting two of the bikes to electric ones. They are really good and have around a 20 miles range, so they’re good for Newmains and the local area.
"Most of the electric kits can be fully charged in three or four hours. The motors on some of the bikes now are quite powerful.”
Mary-Anne and Connor had been talking just the day before her meeting with the council when the delivery option was first discussed.
“Connor had already linked up with us doing bicycle repairs and maintenance sessions in the centre," she added.
“He’s making cycling available and accessible to everybody and had suggested doing more work in the community.
“So I phoned him up and asked if he wanted to help me deliver period products and he said, ‘No bother!’.
“We’re really chuffed that Connor came along at the right time.
“He’s also been helping with sourcing all the bikes and equipment.
“At our side [NCT], we’ll support all the volunteers and take care of all the stock, stock management and getting it delivered out to people.
“Cycling may well become a more popular mode of transport now when you see the price of fuel, it might push some people to think they may not need to drive to work and that they could cycle six or seven miles.”
**Don't miss the latest headlines from around Lanarkshire. Sign up to our newsletters here.
And did you know Lanarkshire Live had its own app? Download yours for free here. | 1 | 64,828 | 0.71134 | https://www.northerndailyleader.com.au/story/7844423/period-poverty-plagues-cost-of-living-concerns-as-dignity-drive-launches/ | 2022-08-02 08:45:28+00:00 | A WORLD where women face period poverty is not a world Teagan Porter wants her daughters to grow up in.
The Share The Dignity volunteer is encouraging locals to donate sanitary products to help women around the region live worry free.
Advertisement
"Everybody should have the right to have access to period products," Ms Porter said.
"If you can't afford them you shouldn't have to choose between buying lunch for your kids or period products for yourself."
READ ALSO:
New and unopened packets of pads, tampons, period undies, menstrual cups and maternity pads can be dropped in the donation bins located at Woolworths Eastpoint, Woolworths Shoppingworld and Southgate Shopping Centre.
"It's something most of us can do when you're doing a shop. Just buy an extra packet and drop it in the box on your way out," Ms Porter said.
With the cost of living on the rise, for many women sanitary products have become a luxury rather than an essential.
"As women we tend to put our children first, where as we need to help each other and share the dignity with other women," Ms Porter said.
The dignity drive is set to run for the entire month of August with Woolworths also opting to donate five cents from each sanitary care product sold during the month to support local community initiatives.
Collected products will then be given to local charities for distribution in the community.
Our journalists work hard to provide local, up-to-date news to the community. This is how you can continue to access our trusted content:
- Bookmark northerndailyleader.com.au
- Make sure you are signed up for our breaking and regular headlines newsletters
- Follow us on Twitter
- Follow us on Instagram
- Follow us on Google News
Tess Kelly
Tess Kelly is a journalist at the Northern Daily Leader in Tamworth, reporting mostly on education, Gunnedah and the Liverpool Plains region. Story tips can be sent to tess.kelly@austcommunitymedia.com.au and you can keep up with what's happening around the region via @TessKelly_ on Twitter.
Tess Kelly is a journalist at the Northern Daily Leader in Tamworth, reporting mostly on education, Gunnedah and the Liverpool Plains region. Story tips can be sent to tess.kelly@austcommunitymedia.com.au and you can keep up with what's happening around the region via @TessKelly_ on Twitter. |
https://www.dailyrecord.co.uk/in-your-area/lanarkshire/volunteers-new-lanarkshire-project-go-26646410 | An initiative aimed at tackling period poverty is being wheeled out in the Wishaw area.
Flo & Go, a joint project between Newmains Community Trust (NCT) and Cairney Cycles, will deliver eco-friendly sanitary products to women free-of-charge.
A team of volunteers are being recruited who will get on their bikes for the delivery programme.
The new scheme is in the final stages of planning, but it’s hoped it will go live next month.
Download the Lanarkshire Live app today
The Lanarkshire Live app is available to download now.
Get all the news from your area – as well as features, entertainment, sport and the latest on Lanarkshire’s recovery from the coronavirus pandemic – straight to your fingertips, 24/7.
The free download features the latest breaking news and exclusive stories, and allows you to customise your page to the sections that matter most to you.
Head to the App Store and never miss a beat in Lanarkshire - iOS - Android
Mary-Anne McCafferty is development manager at NCT - one of the places offering free sanitary products in the area.
She told Lanarkshire Live: "We work quite closely with the team from the council and we’d been discussing how we could increase the uptake of more of the reusable products and make things a bit more eco-friendly.
"During the discussions they said there was funding available to start up a delivery service, so that’s how it came about.”
The free products will also give those who use them the added bonus that they will be doing their bit for the environment.
“I think some people are afraid to try something different because they are so used to certain products,” Mary-Anne continued. “But if someone can deliver to you in the privacy of your own house, then why not give it a go?
"During lockdown we were giving out the products along with food parcels and stuff to make sure they weren’t going without.
“A lot of people feel guilty about waste and the amount of things that just go to landfill these days.”
Connor Mooney decided to set up Cairney Cycles during 2020 after struggling to have his own bike repaired promptly - he now also offers refurbished bikes for sale at affordable prices.
Amongst other things he will be responsible for training the volunteers on bike safety and maintenance.
He told us: “I’m going to help recruit volunteers and will volunteer myself too, if I can. Mary-Anne came to me with the idea for the project and was looking for help with the bike side of things and ordering.
"We put together some training for the volunteers. The sanitary products are eco-friendly and the bikes we’re using are refurbished.
“We’ve sourced a company that does kits and we’re converting two of the bikes to electric ones. They are really good and have around a 20 miles range, so they’re good for Newmains and the local area.
"Most of the electric kits can be fully charged in three or four hours. The motors on some of the bikes now are quite powerful.”
Mary-Anne and Connor had been talking just the day before her meeting with the council when the delivery option was first discussed.
“Connor had already linked up with us doing bicycle repairs and maintenance sessions in the centre," she added.
“He’s making cycling available and accessible to everybody and had suggested doing more work in the community.
“So I phoned him up and asked if he wanted to help me deliver period products and he said, ‘No bother!’.
“We’re really chuffed that Connor came along at the right time.
“He’s also been helping with sourcing all the bikes and equipment.
“At our side [NCT], we’ll support all the volunteers and take care of all the stock, stock management and getting it delivered out to people.
“Cycling may well become a more popular mode of transport now when you see the price of fuel, it might push some people to think they may not need to drive to work and that they could cycle six or seven miles.”
**Don't miss the latest headlines from around Lanarkshire. Sign up to our newsletters here.
And did you know Lanarkshire Live had its own app? Download yours for free here. | 2 | 43,720 | 0.721635 | https://www.daventryexpress.co.uk/health/plea-for-daventry-businesses-to-help-support-girls-and-women-struggling-to-pay-for-period-products-3765570 | 2022-07-12 19:36:48+00:00 | Help is at hand for girls and women in Daventry struggling to pay for period products.
Supporters of ‘A Bag for Flo’ are appealing for businesses to support the project which is going to be discreet, free and anonymous.
Laura Cooper-Wortley, who is one of the organisers, said: “We are at the beginning stages of the product so are looking for companies and organisations to support us with providing products. They can contact me by using my email lauralcooper@icloud.com.”
‘Period poverty’ means being unable to access sanitary products and having a poor knowledge of menstruation often due to financial constraints. In the UK, 1 in 10 girls can’t afford to buy menstrual products, while 1 in 7 have struggled to afford them.
Laura added: “Once the scheme is ready those requiring products will be able go visit stores and other places around Daventry and ask for ‘A Bag for Flo’.” |
https://www.ourmidland.com/news/article/How-should-we-read-Dostoevsky-and-Tolstoy-during-17060861.php | (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ani Kokobobo, University of Kansas
(THE CONVERSATION) As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.”
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/how-should-we-read-dostoevsky-and-tolstoy-during-russias-war-against-ukraine-179932. | 0 | 33,617 | 0 | https://www.stamfordadvocate.com/news/article/How-should-we-read-Dostoevsky-and-Tolstoy-during-17060861.php | 2022-04-06 13:15:10+00:00 | (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ani Kokobobo, University of Kansas
(THE CONVERSATION) As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.”
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/how-should-we-read-dostoevsky-and-tolstoy-during-russias-war-against-ukraine-179932. |
https://www.ourmidland.com/news/article/How-should-we-read-Dostoevsky-and-Tolstoy-during-17060861.php | (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ani Kokobobo, University of Kansas
(THE CONVERSATION) As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.”
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/how-should-we-read-dostoevsky-and-tolstoy-during-russias-war-against-ukraine-179932. | 1 | 34,303 | 0 | https://www.michigansthumb.com/news/article/How-should-we-read-Dostoevsky-and-Tolstoy-during-17060861.php | 2022-04-06 13:18:44+00:00 | (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ani Kokobobo, University of Kansas
(THE CONVERSATION) As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.”
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/how-should-we-read-dostoevsky-and-tolstoy-during-russias-war-against-ukraine-179932. |
https://www.ourmidland.com/news/article/How-should-we-read-Dostoevsky-and-Tolstoy-during-17060861.php | (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ani Kokobobo, University of Kansas
(THE CONVERSATION) As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.”
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/how-should-we-read-dostoevsky-and-tolstoy-during-russias-war-against-ukraine-179932. | 2 | 5,886 | 0.190375 | https://theconversation.com/how-should-dostoevsky-and-tolstoy-be-read-during-russias-war-against-ukraine-179932 | 2022-04-07 10:40:20+00:00 | As someone who teaches Russian literature, I can’t help but process the world through the country’s novels, stories, poems and plays, even at a time when Russian cultural productions are being canceled around the world.
With the Russian army perpetrating devastating violence in Ukraine – which includes the slaughter of civilians in Bucha – the discussion of what to do with Russian literature has naturally arisen.
I’m not worried that truly valuable art can ever be canceled. Enduring works of literature are enduring, in part, because they are capacious enough to be read critically against the vicissitudes of the present.
You could make this argument about any great work of Russian literature, but as a scholar of Leo Tolstoy and Fyodor Dostoevsky, I will stick with Russia’s most famous literary exports.
After World War II, German critic Theodore Adorno described the Holocaust as a profound blow to Western culture and philosophy, even going so far as to question the very ability of human beings to “live after Auschwitz.”
This idea, born of the very specific context of the Holocaust, shouldn’t be haphazardly applied to the present moment. But following Adorno’s moral lead, I wonder whether – after the brutal shelling of the city of Mariupol, after the horrors on the streets of Bucha, along with atrocities committed in Kharkiv, Mykolaev, Kyiv and many more – the indiscriminate violence ought to change how readers approach Russia’s great authors.
Confronting suffering with clear eyes
Upon learning that Russian writer Ivan Turgenev had looked away at the last minute when witnessing the execution of a man, Dostoevsky made his own position clear: “[A] human being living on the surface of the earth has no right to turn away and ignore what is happening on earth, and there are higher moral imperatives for this.”
Seeing the rubble of a theater in Mariupol, hearing of Mariupol citizens starving because of Russian airstrikes, I wonder what Dostoevsky – who specifically focused his piercing moral eye on the question of the suffering of children in his 1880 novel “The Brothers Karamazov” – would say in response to the Russian army’s bombing a theater where children were sheltering. The word “children” was spelled out on the pavement outside the theater in large type so it could be seen from the sky. There was no misunderstanding of who was there.
Ivan Karamazov, the central protagonist in “The Brothers Karamazov,” is far more focused on questions of moral accountability than Christian acceptance or forgiveness and reconciliation. In conversation, Ivan routinely brings up examples of children’s being harmed, imploring the other characters to recognize the atrocities in their midst. He is determined to seek retribution.
Surely the intentional shelling of children in Mariupol is something Dostoevsky couldn’t possibly look away from either. Could he possibly defend a vision of Russian morality while seeing innocent civilians – men, women and children – lying on the streets of Bucha?
At the same time, nor should readers look away from the unseemliness of Dostoevsky and his sense of Russian exceptionalism. These dogmatic ideas about Russian greatness and Russia’s messianic mission are connected to the broader ideology that has fueled Russia’s past colonial mission, and current Russian foreign politics on violent display in Ukraine.
Yet Dostoevsky was also a great humanist thinker who tied this vision of Russian greatness to Russian suffering and faith. Seeing the spiritual value of human suffering was perhaps a natural outcome for a man sent to a labor camp in Siberia for five years for simply participating in a glorified socialist book club. Dostoevsky grew out of his suffering, but, arguably, not to a place where he could accept state-sponsored terror.
Would an author who, in his 1866 novel “Crime and Punishment,” explains in excruciating detail the toll of murder on the murderer – who explains that when someone takes a life, they kill part of themselves – possibly accept Putin’s vision of Russia? Warts and all, would Russia’s greatest metaphysical rebel have recoiled and rebelled against Russian violence in Ukraine?
I hope that he would, as many contemporary Russian writers have. But the dogmas of the Kremlin are pervasive, and many Russians accept them. Many Russians look away.
Tolstoy’s path to pacifism
No writer captures warfare in Russia more poignantly than Tolstoy, a former soldier turned Russia’s most famous pacifist. In his last work, “Hadji Murat,” which scrutinizes Russia’s colonial exploits in North Caucasus, Tolstoy showed how senseless Russian violence toward a Chechen village caused instant hatred of Russians.
Tolstoy’s greatest work about Russian warfare, “War and Peace,” is a novel that Russians have traditionally read during great wars, including World War II. In “War and Peace,” Tolstoy contends that the morale of the Russian military is the key to victory. The battles most likely to succeed are defensive ones, in which soldiers understand why they are fighting and what they are fighting to protect: their home.
Even then, he’s able to convey the harrowing experiences of young Russian soldiers coming into direct confrontation with the instruments of death and destruction on the battlefield. They disappear into the crowd of their battalion, but even a single loss is devastating for the families awaiting their safe return.
After publishing “War and Peace,” Tolstoy publicly denounced many Russian military campaigns. The last part of his 1878 novel “Anna Karenina” originally wasn’t published because it criticized Russia’s actions in the Russo-Turkish war. Tolstoy’s alter ego in that novel, Konstantin Levin, calls the Russian intervention in the war “murder” and thinks it is inappropriate that Russian people are dragged into it.
“The people sacrifice and are always prepared to sacrifice themselves for their soul, not for murder,” he says.
In 1904, Tolstoy penned a public letter denouncing the Russo-Japanese War, which has sometimes been compared with Russia’s war in Ukraine.
“Again war,” he wrote. “Again sufferings, necessary to nobody, utterly uncalled for; again fraud, again the universal stupefaction and brutalization of men.” One can almost hear him shouting “Bethink Yourselves,” the title of that essay, to his countrymen now.
In one of his most famous pacifist writings, 1900’s “Thou Shalt Not Kill,” Tolstoy presciently diagnosed the problem of today’s Russia.
“The misery of nations is caused not by particular persons, but by the particular order of Society under which the people are so bound up together that they find themselves all in the power of a few men, or more often in the power of one single man: a man so perverted by his unnatural position as arbiter of the fate and lives of millions, that he is always in an unhealthy state, and always suffers more or less from a mania of self-aggrandizement.”
The importance of action
If Dostoevsky would insist that one not look away, it is fair to say that Tolstoy would contend that people must act upon what they see.
During the Russian famine of 1891 to 1892, he started soup kitchens to help his countrymen who were starving and had been abandoned by the Russian government. He worked to help Russian soldiers evade the draft in the Russian empire, visiting and supporting jailed soldiers who did not wish to fight. In 1899 he sold his last novel, “Resurrection,” to help a Russian Christian sect, the Doukhobors, emigrate to Canada so they would not need to fight in the Russian army.
These writers have little to do with the current war. They cannot expunge or mitigate the actions of the Russian army in Ukraine. But they’re embedded on some level within the Russian cultural fabric, and how their books are still read matters. Not because Russian literature can explain any of what is happening, because it cannot. But because, as Ukrainian writer Serhiy Zhadan wrote in March 2022, Russia’s war in Ukraine marked a defeat for Russia’s great humanist tradition.
As this culture copes with a Russian army that has indiscriminately bombed and massacred Ukrainians, Russia’s great authors can and should be read critically, with one urgent question in mind: how to stop the violence. Russian opposition leader Alexey Navalny noted during his March 2022 trial that Tolstoy urged his countrymen to fight both despotism and war because one enables the other.
And Ukrainian artist Alevtina Kakhidze cited “War and Peace” in a February 2022 entry in her graphic diary.
“I’ve read your f—ing literature,” she wrote. “But looks like Putin did not, and you have forgotten.” |
https://www.dailymail.co.uk/news/article-10691195/How-UKs-Great-Lie-threatens-summer-chaos.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | As airports grind to a halt... how UK's 'Great Lie Down' threatens a summer of chaos: Hospitality, travel and farming STILL suffer staff shortages after 400,000 people left the work force during lockdowns (and it's all going to make inflation worse)
- MPs warn low employee numbers in the food and farming sector could see food prices continue to increase
- Economists say inability of UK businesses to fill job vacancies in coming months could push inflation higher
- The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force
- Employment is still down 450,000 on pre-pandemic levels and there are 1.83million active UK job adverts
The staff shortage chaos at Britain's airports could spread to other areas of the economy amid continuing chronic labour issues caused by hundreds of thousands of people leaving the UK workforce during lockdowns, recruitment experts warned today.
Vacancies are at all-time highs with hospitality, travel and farming all badly hit - and employers' attempts to attract workers with offers of higher wages threaten to push inflation up even further than its current level of 6.2 per cent.
The head of Manchester Airport quit after chaotic scenes over the past few months saw passengers queueing for up to four hours to make it through security - with unions claiming that this summer will be even worse.
John O'Neill, North West Regional Industrial Officer for the trade union Unite, warned: 'Summer is going to be far worse than this. It is the time to get everything in place otherwise summer is going to very difficult.'
Warning about the potential impact to the rest of the economy, Recruitment and Employment Confederation chief executive Neil Carberry told MailOnline today: 'Labour shortages are hitting sectors all over the British economy.
'Just this week we've had reports in industries varying from aviation to education to farming. These shortages have got worse over the course of the pandemic – we now have around 600,000 fewer people in the labour market than before Covid-19, and our own research shows the number of workers available to start new jobs is still falling month-on-month.'
And economists today claimed that it could take another two years for the recruitment crisis to ease and the country's labour force to return to its pre-pandemic size. The phenomenon dubbed 'The Great Lie-Down' has seen 400,000 workers permanently leave the workforce, according to the Office for Budget Responsibility (OBR).
Some 210,000 of those can be accounted for by a 'higher inactivity rate' among those of working age, which is 'largely the result of more early retirements and a greater prevalence of long-term sickness' after the pandemic.
And the other 190,000 of the figure is due to foreign-born workers leaving the UK during the Covid pandemic and Brexit making it harder for new European Union immigrant workers to enter the country, according to the OBR.
Meanwhile experts at research consultancy Capital Economics have also found that the rise in inactivity has been 'primarily concentrated among those over 50 years old, with the spread between men and women fairly even'.
Separately, the REC said vacancies have increased the most in North East England with job adverts in March up 81 per cent on January, while in London they rose 75 per cent.
Overall employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month - with particular high demand at the moment for hairdressers, security workers and bar staff.
But the REC warned that companies across Britain were 'having to work harder than ever to hire the staff they need' as they try to make adverts more attractive and offer more flexibility and benefits.
And an increase in wages could cause inflation to rise even faster - with the Consumer Prices Index already up by 6.2 per cent in the 12 months to February 2022, the latest figure which was a rise from 5.5 per cent in January.
Britons are already facing a cost of living crisis with National Insurance increasing by 1.25 percentage points, and the energy price cap up 54 per cent to an average of £1,971 a year from April 1 amid rising prices of various goods.
Regional data (eg for 'South East') shows how the number of active job postings in each region of the UK has changed, when the last week of March 2022 is compared with the first week of January 2022. Specific areas (eg for 'Westminster') shows the top ten county or unitary authorities for growth in job postings when March 21-27, 2022 is compared with March 14-20, 2022
Experts at Capital Economics said there had been a sharp rise in economic inactivity during the pandemic due to what people described as 'other' reasons, perhaps as they initially waited out lockdowns due to the huge uncertainty at the time
The rise in inactivity has been mostly concentrated among those aged over 50, with an even spread between men and women
Part of the reduction in the labour force has been due to workers leaving the UK in the past two years amid Brexit and Covid
And Sarah Coles, senior personal finance analyst at Hargreaves Lansdown, said: 'We've already seen specific instances of squeezed professions offering big pay rises to attract staff, with logistics being one of the most high profile examples.
'Overall pay figures show that wages have fallen behind inflation – and regular pay is down 1 per cent in real terms, but there are huge differences between sectors.
'The overall figure is dragged down by the public sector, where wages are up just 2.4 per cent in the year to January. Compare this to wholesaling, retailing, hotels and restaurants, up 5.9 per cent in the year to January. CPI at the time was 5.5 per cent.'
She added that 'retailers have been lining up to announce pay rises ahead of the minimum wage, to help them stand out and attract staff', and cited B&Q, Screwfix, John Lewis and Currys as examples.
Capital Economics economist Bethany Beckett has predicted that most of the drop in the size of the labour force since the pandemic begin will eventually reverse, but she 'wouldn't be surprised if this took another two years or so amid slow recoveries in both the domestic labour supply and in inward flows of migration'.
The OBR, which is the Government's budget watchdog, forecasts that inflation will peak at a 40-year high of 8.7 per cent towards the end of this year, due to surging energy costs and broader price rises.
MPs warned today that low employee numbers in the food and farming sector could see food prices continue to rise, while economists say the inability of UK businesses to fill job vacancies could push inflation even higher.
Capital Economics said there were three main reasons for the increase in inactivity - one that workers were waiting out lockdowns due to uncertainty; the second being a rise in those calling themselves students and not looking for work; and the third being a rise in retirements and those unable to work due to ill health.
It comes as flights continued to be cancelled in the UK today with huge queues again forming at Birmingham, Manchester and Stansted airports. The bedlam is being blamed mostly on 'staffing shortages and recruitment challenges', and a sudden surge in passenger numbers - caused both by Covid and curbs being eased.
The REC said there were 172,000 new job postings in the final week of March - but this was lower than the week before and the lowest since mid-January, with the labour market therefore showing signs of stabilising.
The REC reported a significant increase in job adverts for hairdressers and barbers (up 9.4 per cent), security workers (up 9 per cent), and bar staff (up 8.4 per cent) in March 21 to 27, compared to March 14 to 20.
Other hospitality, leisure and service sector roles such as waiters and waitresses (up 6.6 per cent) also saw big rises, as well as specialist skilled occupations such as vets (up 8.3 per cent) and photographers (up 7.2 per cent).
The devolved nations are also desperate to fill jobs, with five of the top ten hiring hotspots in Scotland and three in Northern Ireland, according to the REC. But the area with the highest weekly rise in job adverts was in fact Westminster (up 18 per cent), then West Dunbartonshire (up 13 per cent) and Highland (up 11 per cent).
This graphic from the Recruitment and Employment Confederation shows growth in job adverts in key occupations in the UK
Employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month
London and the North East regions have seen the highest increase in active job postings for March 2022 to January 2022
The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force. This graph shows it expects unemployment to trough in the first quarter of 2022 at 3.9 per cent, which is 1.1 percentage points lower than it had forecasted in October 2021. The OBR added that a combination of record-high vacancies, lower participation and low redundancies indicates a tighter labour market than had been expected in October 2021, meaning unemployment rises only slightly. It expects it to settle at 4.1 per cent in the medium term, 0.1 percentage points lower than assumed in October 2021
Inflation is already running rampant, with the Consumer Prices Index rising by 6.2 per cent in the 12 months to February 2022
Mr Carberry said: 'Businesses are having to work harder than ever to hire the staff they need, but it is possible to hire if you get your offer right. Consulting with recruitment experts about your approach, including broadening your search, making job ads more attractive and offering enhanced flexibility and benefits can all help, without breaking the bank.'
He also told MailOnline that there were 'many reasons' for low labour supply - including 'workers retiring or stopping work to care for someone, some staying in college and some EU workers leaving the UK'.
But he continued: 'These are long-term trends that existed long before the pandemic, and they will need long-term solutions. Collaboration between recruiters and government will be essential to make sure Job Centres can support people into work with the right training, links and advice.'
He said that the jobs market had been 'super-heated' in the first few months of the year, but the 'first signs' of stabilisation may now be emerging. Mr Carberry added: 'Over the next few weeks, we will see whether this is the cooling we expected, or a slower market developing as employers factor rising inflation into their plans.'
Capital Economics expert Ms Beckett said economists fear that a small portion of the rise in economic inactivity 'may prove permanent', adding: 'Most of the rise has been concentrated among the population aged over 50 years old, with around half of the newly inactive population saying they cannot work because they are long-term sick.'
She told MailOnline: 'These groups may be unwilling to return to work or may face greater obstacles to do so.
'That suggests to us that the labour market will be tighter for longer than expected by most other analysts, including the Bank of England, and explains our view that faster wage growth will exert growing upward pressure on inflation in the coming months.
'As it stands, we have pencilled in nominal wage growth of over 5 per cent in 2022, though we suspect the risks to this forecast are skewed to the upside. Nonetheless, with inflation set to average over 7 per cent in 2022 as a whole, that still won't be enough to avert a protracted period of negative real wage growth.'
Ms Beckett also pointed to 'tentative evidence' that sectors facing the greatest shortages of workers such as hospitality are now experiencing the fastest wage growth.
There are also problems with filling jobs in the travel industry, with the World Travel and Tourism Council estimating at the end of 2021 that there would be an average shortfall of 15,000 workers in the industry this year with the labour market 'expected to remain tight'.
And tourism body VisitEngland said it had finished its English Tourism Week campaign just last month during which it had been 'shining the spotlight' on the 'huge range and variety of jobs across the industry' to encourage more people to consider a career in tourism.
VisitEngland director Andrew Stokes added: 'From tour operating, destination marketing, hospitality and hotel management to business events, visitor attractions and policy development, our people-focused sector has a huge amount to offer employees.'
Crowds are seen at Heathrow Airport's Terminal 2 in London this morning as families try and get away for the Easter holidays
British Airways axed at least 78 flights scheduled to and from Heathrow for today. Pictured: Heathrow Terminal 2 this morning
Huge queues started forming at airports including Manchester Airport (pictured today) from early this morning
Meanwhile Ms Coles from Hargreaves Lansdown said: 'Higher wages will come as a huge relief to people in the short term. They're facing horrifying price rises on all sides, and a pay rise offers the hope of making ends meet.
'The problem comes over the long term if rises are high enough to feed into an inflationary spiral. Clearly this is a risk, but right now it could go either way. Employers are also under enormous price pressures, and will be keen to keep a lid on pay where they can.'
The latest official Government data from the Office for National Statistics released on March 15 reported a quarterly increase in the employment rate and a drop in the unemployment rate - but also found that economic inactivity had increased slightly on the quarter.
Statisticians reported that that the UK employment rate increased by 0.1 percentage points on the quarter to 75.6 per cent, which was driven by full-time employees.
The ONS added that while the number of part-time employees decreased greatly during the pandemic, it has been rising since April to June 2021. However, it said that the number of self-employed workers remains low.
It also reported that the unemployment rate decreased by 0.2 percentage points on the quarter to 3.9 per cent, while the economic inactivity rate increased by 0.1 percentage points to 21.3 per cent.
Increases in economic inactivity compared with the previous three-month period were largely driven by those aged 16 to 24 years old, the statisticians reported.
However, they said the number of economically inactive people aged 16 to 24 has been decreasing since early 2021, with those aged 50 to 64 years driving the recent increases in economic inactivity.
The ONS said professional occupations saw the largest difference for those aged 50 to 70 years, with 30,000 more people moving to 'economic inactivity' between the second and third quarters of in 2021 than in 2019.
The sectors of caring, leisure and other service occupations saw the largest proportional difference of 2.9 percentage points to 6 per cent moving to inactivity in the same period.
Meanwhile growth in average total pay - including bonuses - was 4.8 per cent and growth in regular pay - excluding bonuses - was 3.8 per cent among employees in November 2021 to January 2022.
However, in real terms - adjusted for inflation - growth in total pay was 0.1 per cent and regular pay fell on the year at -1 per cent.
James Reed, chairman of the Reed employment group, told The Mail On Sunday last month that the impact of the pandemic on workforce size has been felt in many other economies and that the phrase 'The Great Lie-Down' had been used in China to describe the phenomenon.
He added: 'During the pandemic, a lot of people decided they just wanted to change their lifestyle. A lot of those were over 50. That might have been a combination of health concerns or reprioritising lifestyle choices, such as family over work.' | 0 | 42,358 | 0.658006 | https://www.dailymail.co.uk/news/article-10870877/What-causing-chaos-airports-Shocking-scenes-blamed-recruitment.html | 2022-05-31 12:17:32+00:00 | What is causing the chaos at airports? Shocking scenes are blamed on airlines and airports not recruiting staff quickly enough to cope with spike in demand after mass layoffs during Covid
- Airlines let many workers go during the pandemic while flights were grounded
- Now, with flights and demand back up, they have struggled to rehire old staff
- They are also struggling to hire new staff amid delays on background checks
Brits are facing a summer of airport chaos amid chronic staffing shortages and IT glitches.
Shocking scenes from around the country in recent weeks have shown holidaymakers stuck in huge queues with some forced to sleep on the floor of airports amid long delays.
Industry chiefs have pointed the finger at mass layoffs during the pandemic which saw staff let go because of the collapse in demand for travel during the various lockdowns.
Airlines are now struggling to rehire workers previously let go, leading to a shortage of security staff, ground handlers and check-in staff.
Industry sources say staffing levels are around 80 to 90 per cent of where they need to be for the peak summer season at larger airports and about 70 per cent at smaller ones.
Some workers have also decided to quit the industry and not return following the pandemic, it has been suggested.
Another issue has been the vetting of new staff, with background checks taking several weeks.
Unions and aviation chiefs say the security check backlog could be approaching 20,000 applications.
Meanwhile, the UK is facing a labour shortage, with more vacancies than workers available to fill them. This has led to suggestions that potential airport staff recruits are unwilling to accept lower wages and more demanding roles.
A busy terminal 2 heathrow airport as passengers continue to face lengthy delays during the half term period
Passengers at Stansted Airport sleeping at the airport overnight due to flight cancelations and excessive delays during the half term weekend
Meanwhile, Julian Knight, chairman of the Commons Digital, Culture, Media and Sport committee, called for an investigation into claims airlines are selling more tickets than they can service.
Rory Boland, the travel editor of consumer group Which? said that the government must intervene to make sure airlines stop selling flights 'they can't actually provide'.
He told The Times: 'We're already seeing very long queues, widespread chaos at airports, huge stress for people planning to get away, and we haven't hit the peak yet.
'Airports and airlines have known this recovery was coming for a period of time now. We're continuing to see things get worse, not better.'
But airport bosses says queues have been exacerbated by passengers turning up earlier than normal from the early hours.
Paul Charles, of travel consultancy The PC Agency, previously said that Covid travel restrictions led to a 'destruction of talent through job losses'.
Kully Sandhu, managing director of Aviation Recruitment Network, said: 'In my opinion, it could be up to 12 months before we see staffing at airports back to pre-pandemic levels. Recruitment for people at airports takes longer than roles elsewhere because of necessary, additional security and background checks.
'Routine recruitment campaigns ground to halt during the pandemic and have been slow to start again as international travel has had a number of restrictions on it until recently. That means the recruitment pipeline was cut off and needs to be re-established.
'Aviation has lost its appeal, not only for returners but also for people who have never worked in an airport environment before.'
Airlines are now asking travellers to arrive earlier for their flights - contributing to the long queues seen at airports.
Meanwhile, some experts have discussed the long delays in vetting new recruits, adding to the chaos.
The Unite union said there are 'chronic staff shortages across the board', and that 'current pay and conditions in the industry are so poor that workers are voting with their feet', adding: 'It can only be resolved by offering higher wages and better working conditions for staff.'
Union officials added that many airport staff are being asked to work extra hours, and 'relying on staff overtime to run the business can't be a long-term solution'.
Experts said that airlines 'are simply unable to cope with that demand due to a lack of resources' and warned that the 'nightmare' disruption could last all year.
BA has axed hundreds of flights up on some routes to the US and the Far East until September, affecting thousands of travellers after it had already cancelled more than 1,000 flights in little more than three weeks.
Gatwick: Tired travellers lay on the carousel at the West Sussex airport as they wait for their bags to arrive in chaotic scenes
Manchester: Row after row of uncollected luggage at the north-west airport that has suffered problems for weeks
Bristol: Passengers have been queuing through the night as they try to get through airports that are lacking staff to cope
Bristol: There were lines snaking around the terminal at 3.30am today
Industry experts have also pointed the finger at security checks for issues with staff numbers, with vetting for new staff taking up to twice as long as the 14 weeks it is supposed to. They also believe that loss of thousands of experienced staff who were laid off during the pandemic has had an impact, with many not returning after finding jobs elsewhere.
'Covid travel restrictions have brought about a destruction of talent through job losses,' Mr Charles said.
He also told the Telegraph: 'In the short-term you have got Covid [absence] which is becoming less of an issue, but in the longer term, there are still complications over recruiting enough staff.
'BA is only recruiting staff who already have security passes. The airline's planners obviously believe there is a maximum number of people they feel they will recruit, therefore it has to cut back on frequency now based on its expected level of recruitment.
'It is readjusting in order to give as much notice as it can before it's inevitable that they have to cancel those flights anyway. It is responding to concerns expressed by their customers and Government ministers about the lack of notice given to consumers.'
George Morgan-Grenville, chief executive of Red Savannah Luxury Travel, added: 'It is an unfortunate perfect storm and airlines and airports are trying to ramp up again after the pandemic.
'The travel industry is not an industry that can be turned on and then off again and it was inevitable it was going to take time. My own feeling is I don't think we are going to see a problem-free summer by any stretch of the imagination. If it is as bad as it has been purported to be, I think you will get a lot of very upset people.' |
https://www.dailymail.co.uk/news/article-10691195/How-UKs-Great-Lie-threatens-summer-chaos.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | As airports grind to a halt... how UK's 'Great Lie Down' threatens a summer of chaos: Hospitality, travel and farming STILL suffer staff shortages after 400,000 people left the work force during lockdowns (and it's all going to make inflation worse)
- MPs warn low employee numbers in the food and farming sector could see food prices continue to increase
- Economists say inability of UK businesses to fill job vacancies in coming months could push inflation higher
- The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force
- Employment is still down 450,000 on pre-pandemic levels and there are 1.83million active UK job adverts
The staff shortage chaos at Britain's airports could spread to other areas of the economy amid continuing chronic labour issues caused by hundreds of thousands of people leaving the UK workforce during lockdowns, recruitment experts warned today.
Vacancies are at all-time highs with hospitality, travel and farming all badly hit - and employers' attempts to attract workers with offers of higher wages threaten to push inflation up even further than its current level of 6.2 per cent.
The head of Manchester Airport quit after chaotic scenes over the past few months saw passengers queueing for up to four hours to make it through security - with unions claiming that this summer will be even worse.
John O'Neill, North West Regional Industrial Officer for the trade union Unite, warned: 'Summer is going to be far worse than this. It is the time to get everything in place otherwise summer is going to very difficult.'
Warning about the potential impact to the rest of the economy, Recruitment and Employment Confederation chief executive Neil Carberry told MailOnline today: 'Labour shortages are hitting sectors all over the British economy.
'Just this week we've had reports in industries varying from aviation to education to farming. These shortages have got worse over the course of the pandemic – we now have around 600,000 fewer people in the labour market than before Covid-19, and our own research shows the number of workers available to start new jobs is still falling month-on-month.'
And economists today claimed that it could take another two years for the recruitment crisis to ease and the country's labour force to return to its pre-pandemic size. The phenomenon dubbed 'The Great Lie-Down' has seen 400,000 workers permanently leave the workforce, according to the Office for Budget Responsibility (OBR).
Some 210,000 of those can be accounted for by a 'higher inactivity rate' among those of working age, which is 'largely the result of more early retirements and a greater prevalence of long-term sickness' after the pandemic.
And the other 190,000 of the figure is due to foreign-born workers leaving the UK during the Covid pandemic and Brexit making it harder for new European Union immigrant workers to enter the country, according to the OBR.
Meanwhile experts at research consultancy Capital Economics have also found that the rise in inactivity has been 'primarily concentrated among those over 50 years old, with the spread between men and women fairly even'.
Separately, the REC said vacancies have increased the most in North East England with job adverts in March up 81 per cent on January, while in London they rose 75 per cent.
Overall employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month - with particular high demand at the moment for hairdressers, security workers and bar staff.
But the REC warned that companies across Britain were 'having to work harder than ever to hire the staff they need' as they try to make adverts more attractive and offer more flexibility and benefits.
And an increase in wages could cause inflation to rise even faster - with the Consumer Prices Index already up by 6.2 per cent in the 12 months to February 2022, the latest figure which was a rise from 5.5 per cent in January.
Britons are already facing a cost of living crisis with National Insurance increasing by 1.25 percentage points, and the energy price cap up 54 per cent to an average of £1,971 a year from April 1 amid rising prices of various goods.
Regional data (eg for 'South East') shows how the number of active job postings in each region of the UK has changed, when the last week of March 2022 is compared with the first week of January 2022. Specific areas (eg for 'Westminster') shows the top ten county or unitary authorities for growth in job postings when March 21-27, 2022 is compared with March 14-20, 2022
Experts at Capital Economics said there had been a sharp rise in economic inactivity during the pandemic due to what people described as 'other' reasons, perhaps as they initially waited out lockdowns due to the huge uncertainty at the time
The rise in inactivity has been mostly concentrated among those aged over 50, with an even spread between men and women
Part of the reduction in the labour force has been due to workers leaving the UK in the past two years amid Brexit and Covid
And Sarah Coles, senior personal finance analyst at Hargreaves Lansdown, said: 'We've already seen specific instances of squeezed professions offering big pay rises to attract staff, with logistics being one of the most high profile examples.
'Overall pay figures show that wages have fallen behind inflation – and regular pay is down 1 per cent in real terms, but there are huge differences between sectors.
'The overall figure is dragged down by the public sector, where wages are up just 2.4 per cent in the year to January. Compare this to wholesaling, retailing, hotels and restaurants, up 5.9 per cent in the year to January. CPI at the time was 5.5 per cent.'
She added that 'retailers have been lining up to announce pay rises ahead of the minimum wage, to help them stand out and attract staff', and cited B&Q, Screwfix, John Lewis and Currys as examples.
Capital Economics economist Bethany Beckett has predicted that most of the drop in the size of the labour force since the pandemic begin will eventually reverse, but she 'wouldn't be surprised if this took another two years or so amid slow recoveries in both the domestic labour supply and in inward flows of migration'.
The OBR, which is the Government's budget watchdog, forecasts that inflation will peak at a 40-year high of 8.7 per cent towards the end of this year, due to surging energy costs and broader price rises.
MPs warned today that low employee numbers in the food and farming sector could see food prices continue to rise, while economists say the inability of UK businesses to fill job vacancies could push inflation even higher.
Capital Economics said there were three main reasons for the increase in inactivity - one that workers were waiting out lockdowns due to uncertainty; the second being a rise in those calling themselves students and not looking for work; and the third being a rise in retirements and those unable to work due to ill health.
It comes as flights continued to be cancelled in the UK today with huge queues again forming at Birmingham, Manchester and Stansted airports. The bedlam is being blamed mostly on 'staffing shortages and recruitment challenges', and a sudden surge in passenger numbers - caused both by Covid and curbs being eased.
The REC said there were 172,000 new job postings in the final week of March - but this was lower than the week before and the lowest since mid-January, with the labour market therefore showing signs of stabilising.
The REC reported a significant increase in job adverts for hairdressers and barbers (up 9.4 per cent), security workers (up 9 per cent), and bar staff (up 8.4 per cent) in March 21 to 27, compared to March 14 to 20.
Other hospitality, leisure and service sector roles such as waiters and waitresses (up 6.6 per cent) also saw big rises, as well as specialist skilled occupations such as vets (up 8.3 per cent) and photographers (up 7.2 per cent).
The devolved nations are also desperate to fill jobs, with five of the top ten hiring hotspots in Scotland and three in Northern Ireland, according to the REC. But the area with the highest weekly rise in job adverts was in fact Westminster (up 18 per cent), then West Dunbartonshire (up 13 per cent) and Highland (up 11 per cent).
This graphic from the Recruitment and Employment Confederation shows growth in job adverts in key occupations in the UK
Employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month
London and the North East regions have seen the highest increase in active job postings for March 2022 to January 2022
The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force. This graph shows it expects unemployment to trough in the first quarter of 2022 at 3.9 per cent, which is 1.1 percentage points lower than it had forecasted in October 2021. The OBR added that a combination of record-high vacancies, lower participation and low redundancies indicates a tighter labour market than had been expected in October 2021, meaning unemployment rises only slightly. It expects it to settle at 4.1 per cent in the medium term, 0.1 percentage points lower than assumed in October 2021
Inflation is already running rampant, with the Consumer Prices Index rising by 6.2 per cent in the 12 months to February 2022
Mr Carberry said: 'Businesses are having to work harder than ever to hire the staff they need, but it is possible to hire if you get your offer right. Consulting with recruitment experts about your approach, including broadening your search, making job ads more attractive and offering enhanced flexibility and benefits can all help, without breaking the bank.'
He also told MailOnline that there were 'many reasons' for low labour supply - including 'workers retiring or stopping work to care for someone, some staying in college and some EU workers leaving the UK'.
But he continued: 'These are long-term trends that existed long before the pandemic, and they will need long-term solutions. Collaboration between recruiters and government will be essential to make sure Job Centres can support people into work with the right training, links and advice.'
He said that the jobs market had been 'super-heated' in the first few months of the year, but the 'first signs' of stabilisation may now be emerging. Mr Carberry added: 'Over the next few weeks, we will see whether this is the cooling we expected, or a slower market developing as employers factor rising inflation into their plans.'
Capital Economics expert Ms Beckett said economists fear that a small portion of the rise in economic inactivity 'may prove permanent', adding: 'Most of the rise has been concentrated among the population aged over 50 years old, with around half of the newly inactive population saying they cannot work because they are long-term sick.'
She told MailOnline: 'These groups may be unwilling to return to work or may face greater obstacles to do so.
'That suggests to us that the labour market will be tighter for longer than expected by most other analysts, including the Bank of England, and explains our view that faster wage growth will exert growing upward pressure on inflation in the coming months.
'As it stands, we have pencilled in nominal wage growth of over 5 per cent in 2022, though we suspect the risks to this forecast are skewed to the upside. Nonetheless, with inflation set to average over 7 per cent in 2022 as a whole, that still won't be enough to avert a protracted period of negative real wage growth.'
Ms Beckett also pointed to 'tentative evidence' that sectors facing the greatest shortages of workers such as hospitality are now experiencing the fastest wage growth.
There are also problems with filling jobs in the travel industry, with the World Travel and Tourism Council estimating at the end of 2021 that there would be an average shortfall of 15,000 workers in the industry this year with the labour market 'expected to remain tight'.
And tourism body VisitEngland said it had finished its English Tourism Week campaign just last month during which it had been 'shining the spotlight' on the 'huge range and variety of jobs across the industry' to encourage more people to consider a career in tourism.
VisitEngland director Andrew Stokes added: 'From tour operating, destination marketing, hospitality and hotel management to business events, visitor attractions and policy development, our people-focused sector has a huge amount to offer employees.'
Crowds are seen at Heathrow Airport's Terminal 2 in London this morning as families try and get away for the Easter holidays
British Airways axed at least 78 flights scheduled to and from Heathrow for today. Pictured: Heathrow Terminal 2 this morning
Huge queues started forming at airports including Manchester Airport (pictured today) from early this morning
Meanwhile Ms Coles from Hargreaves Lansdown said: 'Higher wages will come as a huge relief to people in the short term. They're facing horrifying price rises on all sides, and a pay rise offers the hope of making ends meet.
'The problem comes over the long term if rises are high enough to feed into an inflationary spiral. Clearly this is a risk, but right now it could go either way. Employers are also under enormous price pressures, and will be keen to keep a lid on pay where they can.'
The latest official Government data from the Office for National Statistics released on March 15 reported a quarterly increase in the employment rate and a drop in the unemployment rate - but also found that economic inactivity had increased slightly on the quarter.
Statisticians reported that that the UK employment rate increased by 0.1 percentage points on the quarter to 75.6 per cent, which was driven by full-time employees.
The ONS added that while the number of part-time employees decreased greatly during the pandemic, it has been rising since April to June 2021. However, it said that the number of self-employed workers remains low.
It also reported that the unemployment rate decreased by 0.2 percentage points on the quarter to 3.9 per cent, while the economic inactivity rate increased by 0.1 percentage points to 21.3 per cent.
Increases in economic inactivity compared with the previous three-month period were largely driven by those aged 16 to 24 years old, the statisticians reported.
However, they said the number of economically inactive people aged 16 to 24 has been decreasing since early 2021, with those aged 50 to 64 years driving the recent increases in economic inactivity.
The ONS said professional occupations saw the largest difference for those aged 50 to 70 years, with 30,000 more people moving to 'economic inactivity' between the second and third quarters of in 2021 than in 2019.
The sectors of caring, leisure and other service occupations saw the largest proportional difference of 2.9 percentage points to 6 per cent moving to inactivity in the same period.
Meanwhile growth in average total pay - including bonuses - was 4.8 per cent and growth in regular pay - excluding bonuses - was 3.8 per cent among employees in November 2021 to January 2022.
However, in real terms - adjusted for inflation - growth in total pay was 0.1 per cent and regular pay fell on the year at -1 per cent.
James Reed, chairman of the Reed employment group, told The Mail On Sunday last month that the impact of the pandemic on workforce size has been felt in many other economies and that the phrase 'The Great Lie-Down' had been used in China to describe the phenomenon.
He added: 'During the pandemic, a lot of people decided they just wanted to change their lifestyle. A lot of those were over 50. That might have been a combination of health concerns or reprioritising lifestyle choices, such as family over work.' | 1 | 98,686 | 0.659525 | https://www.walesonline.co.uk/whats-on/travel/reasons-airlines-like-easyjet-ba-24154912 | 2022-06-06 12:34:13+00:00 | Summer holidaymakers are facing further potential flight misery as staffing issues continue to wreak havoc on the travel industry. Airport chaos over the half-term holiday saw passengers stuck in horrendous queues at Manchester, Gatwick, Bristol and Birmingham.
And as reported by the Mirror, hundreds of flights have been cancelled or delayed, with many people left stuck abroad and unable to return to work and school on time. BA, TUI and easyJet passengers were among those affected and the problems look set to continue over the summer.
Low levels of staffing are being blamed as airports struggle to fill low-paid positions such as baggage handler roles. One anonymous baggage handler told the BBC: "The problem is that during furlough some were asked to take on paid leave, maybe be laid off temporarily.
"'Yeah we're going to put you on hold, when everything comes back to normal you'll be the first person to be employed'. That went on.
"And people have financial commitments, so they moved on. I know one (baggage handler) who has ended up being a fireman.
"Another colleague, he is running his own restaurant. Some decided to go back to their country, some are working as plumbers and electricians. I can tell you, about three days ago one of those people was travelling through the airport and he was saying it's the best decision of his life."
For security reasons, the recruitment process means positions are hard to fill quickly. References need to be gathered from previous employers which can be time-consuming for people who have worked several jobs during the pandemic.
Airlines for Europe, Europe’s largest airline association, expects the problems impacting airports and airlines in the UK and Europe to persist “for a good chunk of the summer season” the Financial Times reports. The group, whose members include EasyJet, British Airways owner IAG and Ryanair, blamed a series of factors for the chaos.
These include staff shortages, long waits for new staff to pass background checks and also higher than normal sickness rates. While pandemic social distancing restrictions have been lifted in the UK, coronavirus is still infecting people and forcing them to isolate, meaning whittled down workforces are further impacted.
Another factor is Brexit, which has meant many Europeans who may have come to the UK looking for work are now no longer allowed to do so. Over the weekend Labour Mayor of London Sadiq Khan urged the Government to relax visa rules to deal with the staff shortages at airports.
“The government should recognise that there are shortages in this occupation, of those who work in aviation,” the mayor told BBC1’s Sunday Morning. What you can do very easily is to make sure those who were in those jobs before, who’ve gone back to their country of origin in the EU, are encouraged to come back."
Transport Secretary Grant Shapps denied that the issues were Brexit related, even though problems at the UK's airports are more severe and wide ranging than those in any EU country. He told interviewer Sophie Raworth: “The answer can’t always be to reach for the lever marked ‘More immigration’.”
“We are seeing the same problems across Europe. If it were only to do with Brexit, then there wouldn’t be a problem at Schiphol (airport in Amsterdam) or elsewhere. So that clearly can’t be true."
In a proactive move to deal with the issues, British Airways recently decided to cut 8,000 roundtrips from its March to October timetable. EasyJet made a similar move as it cancelled several hundred flights in April and grounded dozens in May, as well as a cancelling a further 80 on Sunday.
Meanwhile, TUI announced that it was cancelling a number of flights from Manchester until the end of June. BA points out that the challenges facing the aviation industry since the coronavirus pandemic broke out are enormous in their scale.
Globally the industry lost more than £145bn and an estimated four million jobs since the start of the pandemic, with the knock on impact on staffing levels still being felt to this day. EasyJet alone cut 1,400 jobs at the beginning of 2021, while BA axed 10,000 during the pandemic, eventually rehiring about 4,000 as of last summer.
A BA spokesperson said that ramping up capacity from 30 to 80 per cent in a short space of time was "always going to be challenging, but this is being faced by the industry and not just us".
They added: "The past few weeks have been challenging for the entire industry and at British Airways we're completely focused on three priorities: our customers, supporting the biggest recruitment drive in our history and increasing our operational resilience.
"We've taken action to reduce our schedule to help provide certainty for our customers and are giving them maximum flexibility to either rebook with us or another airline as close to their original departure time as possible, or to receive a full refund."
An easyJet spokesperson said: "easyJet is operating around 1,650 daily flights across the network, carrying around a quarter of a million people each day." |
https://www.dailymail.co.uk/news/article-10691195/How-UKs-Great-Lie-threatens-summer-chaos.html?ns_mchannel=rss&ito=1490&ns_campaign=1490 | As airports grind to a halt... how UK's 'Great Lie Down' threatens a summer of chaos: Hospitality, travel and farming STILL suffer staff shortages after 400,000 people left the work force during lockdowns (and it's all going to make inflation worse)
- MPs warn low employee numbers in the food and farming sector could see food prices continue to increase
- Economists say inability of UK businesses to fill job vacancies in coming months could push inflation higher
- The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force
- Employment is still down 450,000 on pre-pandemic levels and there are 1.83million active UK job adverts
The staff shortage chaos at Britain's airports could spread to other areas of the economy amid continuing chronic labour issues caused by hundreds of thousands of people leaving the UK workforce during lockdowns, recruitment experts warned today.
Vacancies are at all-time highs with hospitality, travel and farming all badly hit - and employers' attempts to attract workers with offers of higher wages threaten to push inflation up even further than its current level of 6.2 per cent.
The head of Manchester Airport quit after chaotic scenes over the past few months saw passengers queueing for up to four hours to make it through security - with unions claiming that this summer will be even worse.
John O'Neill, North West Regional Industrial Officer for the trade union Unite, warned: 'Summer is going to be far worse than this. It is the time to get everything in place otherwise summer is going to very difficult.'
Warning about the potential impact to the rest of the economy, Recruitment and Employment Confederation chief executive Neil Carberry told MailOnline today: 'Labour shortages are hitting sectors all over the British economy.
'Just this week we've had reports in industries varying from aviation to education to farming. These shortages have got worse over the course of the pandemic – we now have around 600,000 fewer people in the labour market than before Covid-19, and our own research shows the number of workers available to start new jobs is still falling month-on-month.'
And economists today claimed that it could take another two years for the recruitment crisis to ease and the country's labour force to return to its pre-pandemic size. The phenomenon dubbed 'The Great Lie-Down' has seen 400,000 workers permanently leave the workforce, according to the Office for Budget Responsibility (OBR).
Some 210,000 of those can be accounted for by a 'higher inactivity rate' among those of working age, which is 'largely the result of more early retirements and a greater prevalence of long-term sickness' after the pandemic.
And the other 190,000 of the figure is due to foreign-born workers leaving the UK during the Covid pandemic and Brexit making it harder for new European Union immigrant workers to enter the country, according to the OBR.
Meanwhile experts at research consultancy Capital Economics have also found that the rise in inactivity has been 'primarily concentrated among those over 50 years old, with the spread between men and women fairly even'.
Separately, the REC said vacancies have increased the most in North East England with job adverts in March up 81 per cent on January, while in London they rose 75 per cent.
Overall employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month - with particular high demand at the moment for hairdressers, security workers and bar staff.
But the REC warned that companies across Britain were 'having to work harder than ever to hire the staff they need' as they try to make adverts more attractive and offer more flexibility and benefits.
And an increase in wages could cause inflation to rise even faster - with the Consumer Prices Index already up by 6.2 per cent in the 12 months to February 2022, the latest figure which was a rise from 5.5 per cent in January.
Britons are already facing a cost of living crisis with National Insurance increasing by 1.25 percentage points, and the energy price cap up 54 per cent to an average of £1,971 a year from April 1 amid rising prices of various goods.
Regional data (eg for 'South East') shows how the number of active job postings in each region of the UK has changed, when the last week of March 2022 is compared with the first week of January 2022. Specific areas (eg for 'Westminster') shows the top ten county or unitary authorities for growth in job postings when March 21-27, 2022 is compared with March 14-20, 2022
Experts at Capital Economics said there had been a sharp rise in economic inactivity during the pandemic due to what people described as 'other' reasons, perhaps as they initially waited out lockdowns due to the huge uncertainty at the time
The rise in inactivity has been mostly concentrated among those aged over 50, with an even spread between men and women
Part of the reduction in the labour force has been due to workers leaving the UK in the past two years amid Brexit and Covid
And Sarah Coles, senior personal finance analyst at Hargreaves Lansdown, said: 'We've already seen specific instances of squeezed professions offering big pay rises to attract staff, with logistics being one of the most high profile examples.
'Overall pay figures show that wages have fallen behind inflation – and regular pay is down 1 per cent in real terms, but there are huge differences between sectors.
'The overall figure is dragged down by the public sector, where wages are up just 2.4 per cent in the year to January. Compare this to wholesaling, retailing, hotels and restaurants, up 5.9 per cent in the year to January. CPI at the time was 5.5 per cent.'
She added that 'retailers have been lining up to announce pay rises ahead of the minimum wage, to help them stand out and attract staff', and cited B&Q, Screwfix, John Lewis and Currys as examples.
Capital Economics economist Bethany Beckett has predicted that most of the drop in the size of the labour force since the pandemic begin will eventually reverse, but she 'wouldn't be surprised if this took another two years or so amid slow recoveries in both the domestic labour supply and in inward flows of migration'.
The OBR, which is the Government's budget watchdog, forecasts that inflation will peak at a 40-year high of 8.7 per cent towards the end of this year, due to surging energy costs and broader price rises.
MPs warned today that low employee numbers in the food and farming sector could see food prices continue to rise, while economists say the inability of UK businesses to fill job vacancies could push inflation even higher.
Capital Economics said there were three main reasons for the increase in inactivity - one that workers were waiting out lockdowns due to uncertainty; the second being a rise in those calling themselves students and not looking for work; and the third being a rise in retirements and those unable to work due to ill health.
It comes as flights continued to be cancelled in the UK today with huge queues again forming at Birmingham, Manchester and Stansted airports. The bedlam is being blamed mostly on 'staffing shortages and recruitment challenges', and a sudden surge in passenger numbers - caused both by Covid and curbs being eased.
The REC said there were 172,000 new job postings in the final week of March - but this was lower than the week before and the lowest since mid-January, with the labour market therefore showing signs of stabilising.
The REC reported a significant increase in job adverts for hairdressers and barbers (up 9.4 per cent), security workers (up 9 per cent), and bar staff (up 8.4 per cent) in March 21 to 27, compared to March 14 to 20.
Other hospitality, leisure and service sector roles such as waiters and waitresses (up 6.6 per cent) also saw big rises, as well as specialist skilled occupations such as vets (up 8.3 per cent) and photographers (up 7.2 per cent).
The devolved nations are also desperate to fill jobs, with five of the top ten hiring hotspots in Scotland and three in Northern Ireland, according to the REC. But the area with the highest weekly rise in job adverts was in fact Westminster (up 18 per cent), then West Dunbartonshire (up 13 per cent) and Highland (up 11 per cent).
This graphic from the Recruitment and Employment Confederation shows growth in job adverts in key occupations in the UK
Employment is still down 450,000 on pre-pandemic levels and there were 1.83million active UK job adverts last month
London and the North East regions have seen the highest increase in active job postings for March 2022 to January 2022
The Office for Budget Responsibility expects there will be 400,000 fewer people in the UK's labour force. This graph shows it expects unemployment to trough in the first quarter of 2022 at 3.9 per cent, which is 1.1 percentage points lower than it had forecasted in October 2021. The OBR added that a combination of record-high vacancies, lower participation and low redundancies indicates a tighter labour market than had been expected in October 2021, meaning unemployment rises only slightly. It expects it to settle at 4.1 per cent in the medium term, 0.1 percentage points lower than assumed in October 2021
Inflation is already running rampant, with the Consumer Prices Index rising by 6.2 per cent in the 12 months to February 2022
Mr Carberry said: 'Businesses are having to work harder than ever to hire the staff they need, but it is possible to hire if you get your offer right. Consulting with recruitment experts about your approach, including broadening your search, making job ads more attractive and offering enhanced flexibility and benefits can all help, without breaking the bank.'
He also told MailOnline that there were 'many reasons' for low labour supply - including 'workers retiring or stopping work to care for someone, some staying in college and some EU workers leaving the UK'.
But he continued: 'These are long-term trends that existed long before the pandemic, and they will need long-term solutions. Collaboration between recruiters and government will be essential to make sure Job Centres can support people into work with the right training, links and advice.'
He said that the jobs market had been 'super-heated' in the first few months of the year, but the 'first signs' of stabilisation may now be emerging. Mr Carberry added: 'Over the next few weeks, we will see whether this is the cooling we expected, or a slower market developing as employers factor rising inflation into their plans.'
Capital Economics expert Ms Beckett said economists fear that a small portion of the rise in economic inactivity 'may prove permanent', adding: 'Most of the rise has been concentrated among the population aged over 50 years old, with around half of the newly inactive population saying they cannot work because they are long-term sick.'
She told MailOnline: 'These groups may be unwilling to return to work or may face greater obstacles to do so.
'That suggests to us that the labour market will be tighter for longer than expected by most other analysts, including the Bank of England, and explains our view that faster wage growth will exert growing upward pressure on inflation in the coming months.
'As it stands, we have pencilled in nominal wage growth of over 5 per cent in 2022, though we suspect the risks to this forecast are skewed to the upside. Nonetheless, with inflation set to average over 7 per cent in 2022 as a whole, that still won't be enough to avert a protracted period of negative real wage growth.'
Ms Beckett also pointed to 'tentative evidence' that sectors facing the greatest shortages of workers such as hospitality are now experiencing the fastest wage growth.
There are also problems with filling jobs in the travel industry, with the World Travel and Tourism Council estimating at the end of 2021 that there would be an average shortfall of 15,000 workers in the industry this year with the labour market 'expected to remain tight'.
And tourism body VisitEngland said it had finished its English Tourism Week campaign just last month during which it had been 'shining the spotlight' on the 'huge range and variety of jobs across the industry' to encourage more people to consider a career in tourism.
VisitEngland director Andrew Stokes added: 'From tour operating, destination marketing, hospitality and hotel management to business events, visitor attractions and policy development, our people-focused sector has a huge amount to offer employees.'
Crowds are seen at Heathrow Airport's Terminal 2 in London this morning as families try and get away for the Easter holidays
British Airways axed at least 78 flights scheduled to and from Heathrow for today. Pictured: Heathrow Terminal 2 this morning
Huge queues started forming at airports including Manchester Airport (pictured today) from early this morning
Meanwhile Ms Coles from Hargreaves Lansdown said: 'Higher wages will come as a huge relief to people in the short term. They're facing horrifying price rises on all sides, and a pay rise offers the hope of making ends meet.
'The problem comes over the long term if rises are high enough to feed into an inflationary spiral. Clearly this is a risk, but right now it could go either way. Employers are also under enormous price pressures, and will be keen to keep a lid on pay where they can.'
The latest official Government data from the Office for National Statistics released on March 15 reported a quarterly increase in the employment rate and a drop in the unemployment rate - but also found that economic inactivity had increased slightly on the quarter.
Statisticians reported that that the UK employment rate increased by 0.1 percentage points on the quarter to 75.6 per cent, which was driven by full-time employees.
The ONS added that while the number of part-time employees decreased greatly during the pandemic, it has been rising since April to June 2021. However, it said that the number of self-employed workers remains low.
It also reported that the unemployment rate decreased by 0.2 percentage points on the quarter to 3.9 per cent, while the economic inactivity rate increased by 0.1 percentage points to 21.3 per cent.
Increases in economic inactivity compared with the previous three-month period were largely driven by those aged 16 to 24 years old, the statisticians reported.
However, they said the number of economically inactive people aged 16 to 24 has been decreasing since early 2021, with those aged 50 to 64 years driving the recent increases in economic inactivity.
The ONS said professional occupations saw the largest difference for those aged 50 to 70 years, with 30,000 more people moving to 'economic inactivity' between the second and third quarters of in 2021 than in 2019.
The sectors of caring, leisure and other service occupations saw the largest proportional difference of 2.9 percentage points to 6 per cent moving to inactivity in the same period.
Meanwhile growth in average total pay - including bonuses - was 4.8 per cent and growth in regular pay - excluding bonuses - was 3.8 per cent among employees in November 2021 to January 2022.
However, in real terms - adjusted for inflation - growth in total pay was 0.1 per cent and regular pay fell on the year at -1 per cent.
James Reed, chairman of the Reed employment group, told The Mail On Sunday last month that the impact of the pandemic on workforce size has been felt in many other economies and that the phrase 'The Great Lie-Down' had been used in China to describe the phenomenon.
He added: 'During the pandemic, a lot of people decided they just wanted to change their lifestyle. A lot of those were over 50. That might have been a combination of health concerns or reprioritising lifestyle choices, such as family over work.' | 2 | 109,132 | 0.664465 | https://www.hulldailymail.co.uk/whats-on/whats-on-news/reasons-airlines-like-easyjet-ba-7170585 | 2022-06-06 13:18:07+00:00 | Holidaymakers are facing further potential flight misery as staffing issues continue to wreak havoc on the travel industry. Airport chaos over the half-term holiday saw passengers stuck in horrendous queues at Manchester, Gatwick and Birmingham.
Hundreds of flights were cancelled or delayed, with many people left stuck abroad and unable to return to work and school on time. BA, TUI and easyJet passengers were among those affected and the problems look set to continue over the summer.
As reported by the Mirror, low levels of staffing are being blamed as airports struggle to fill low-paid positions such as baggage handler roles. One anonymous baggage handler told the BBC: "The problem is that during furlough some were asked to take on paid leave, maybe be laid off temporarily.
"'Yeah we're going to put you on hold, when everything comes back to normal you'll be the first person to be employed'. That went on.
"And people have financial commitments, so they moved on. I know one (baggage handler) who has ended up being a fireman.
"Another colleague, he is running his own restaurant. Some decided to go back to their country, some are working as plumbers and electricians. I can tell you, about three days ago one of those people was travelling through the airport and he was saying it's the best decision of his life."
For security reasons, the recruitment process means positions are hard to fill quickly. References need to be gathered from previous employers which can be time-consuming for people who have worked several jobs during the pandemic.
Airlines for Europe, Europe’s largest airline association, expects the problems impacting airports and airlines in the UK and Europe to persist “for a good chunk of the summer season” the Financial Times reports. The group, whose members include EasyJet, British Airways owner IAG and Ryanair, blamed a series of factors for the chaos.
These include staff shortages, long waits for new staff to pass background checks and also higher than normal sickness rates. While pandemic social distancing restrictions have been lifted in the UK, coronavirus is still infecting people and forcing them to isolate, meaning whittled down workforces are further impacted.
Another factor is Brexit, which has meant many Europeans who may have come to the UK looking for work are now no longer allowed to do so. Over the weekend Labour Mayor of London Sadiq Khan urged the Government to relax visa rules to deal with the staff shortages at airports.
“The government should recognise that there are shortages in this occupation, of those who work in aviation,” the mayor told BBC1’s Sunday Morning. What you can do very easily is to make sure those who were in those jobs before, who’ve gone back to their country of origin in the EU, are encouraged to come back."
Transport Secretary Grant Shapps denied that the issues were Brexit related, even though problems at the UK's airports are more severe and wide ranging than those in any EU country. He told interviewer Sophie Raworth: “The answer can’t always be to reach for the lever marked ‘More immigration’.”
“We are seeing the same problems across Europe. If it were only to do with Brexit, then there wouldn’t be a problem at Schiphol (airport in Amsterdam) or elsewhere. So that clearly can’t be true."
In a proactive move to deal with the issues, British Airways recently decided to cut 8,000 roundtrips from its March to October timetable. EasyJet made a similar move as it cancelled several hundred flights in April and grounded dozens in May, as well as a cancelling a further 80 on Sunday.
Meanwhile, TUI announced that it was cancelling a number of flights from Manchester until the end of June. BA points out that the challenges facing the aviation industry since the coronavirus pandemic broke out are enormous in their scale.
Globally the industry lost more than £145bn and an estimated four million jobs since the start of the pandemic, with the knock on impact on staffing levels still being felt to this day. EasyJet alone cut 1,400 jobs at the beginning of 2021, while BA axed 10,000 during the pandemic, eventually rehiring about 4,000 as of last summer.
A BA spokesperson said that ramping up capacity from 30 to 80 per cent in a short space of time was "always going to be challenging, but this is being faced by the industry and not just us".
They added: "The past few weeks have been challenging for the entire industry and at British Airways we're completely focused on three priorities: our customers, supporting the biggest recruitment drive in our history and increasing our operational resilience.
"We've taken action to reduce our schedule to help provide certainty for our customers and are giving them maximum flexibility to either rebook with us or another airline as close to their original departure time as possible, or to receive a full refund."
An easyJet spokesperson said: "easyJet is operating around 1,650 daily flights across the network, carrying around a quarter of a million people each day." |
https://www.thecourier.co.uk/business-environment/business/3170324/accidental-damage-claims-involving-children-cost-500-typically-says-admiral/ | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.” | 0 | 22,303 | 0 | https://www.pressandjournal.co.uk/business/uk-and-abroad/4134125/accidental-damage-claims-involving-children-cost-500-typically-says-admiral/ | 2022-04-05 23:16:52+00:00 | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.” |
https://www.thecourier.co.uk/business-environment/business/3170324/accidental-damage-claims-involving-children-cost-500-typically-says-admiral/ | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.” | 1 | 12,863 | 0.060564 | https://www.independent.ie/world-news/accidental-damage-claims-involving-children-cost-500-typically-says-admiral-41522148.html | 2022-04-05 12:28:11+00:00 | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with moreNoel Summerfield, Admiral
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.” |
https://www.thecourier.co.uk/business-environment/business/3170324/accidental-damage-claims-involving-children-cost-500-typically-says-admiral/ | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.” | 2 | 132,862 | 0.068964 | https://neptunepine.com/accidental-damage-claims-involving-children-cost-500-typically-says-admiral/ | 2022-04-05 21:13:55+00:00 | Accidental damage claims involving children cost around £500 typically, according to analysis by an insurer.
Just over four-fifths of such incidents involve damage to technology, Admiral found.
Items being dropped and accidents involving toys were among the main reasons for claims, with many cases relating to damage to televisions.
In one case dealt with by Admiral, a TV was damaged when a child’s karate classes moved online during lockdown. In another case, a TV screen was used as a drawing board.
Pasta sauce on a laptop and nappy cream smeared on sofas are also among cases the insurer has dealt with involving children.
Noel Summerfield, head of household at Admiral, said: “Many parents will be expecting the house to get a little messy over the Easter holidays, but some will be faced with more.
“We’ve looked at 1,500 home insurance claims caused by children over the last year and found the average cost was £531.
“No doubt some parents will turn to tech at some point during the holidays to help keep the kids busy.
“This could explain why so many claims where kids were involved feature mobile phones, TVs, laptops, tablets and even VR headsets.
“When we analysed the data, we found that 81% of the claims involving kids mentioned damage to tech devices.”
Source Link Accidental damage claims involving children cost £500 typically, says Admiral |
https://www.wflx.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. | 0 | 31,583 | 0 | https://www.wbrc.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | 2022-04-06 13:05:42+00:00 | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. |
https://www.wflx.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. | 1 | 32,096 | 0 | https://www.waff.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | 2022-04-06 13:07:57+00:00 | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. |
https://www.wflx.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. | 2 | 32,258 | 0 | https://www.wvva.com/2022/04/06/jury-deliberations-enter-3rd-day-gov-whitmer-kidnap-plot/ | 2022-04-06 13:08:42+00:00 | Jury deliberations enter 3rd day in Gov. Whitmer kidnap plot
GRAND RAPIDS, Mich. (AP) — Jurors entered a third day of deliberations Wednesday in a trial that centers on a plot to kidnap Michigan Gov. Gretchen Whitmer.
U.S. District Judge Robert Jonker disclosed that the jury had asked for sticky notes. He also told lawyers that two jurors saw him outside the courthouse. Their reaction: “Wow, you look so different without your robe,” the judge said.
Adam Fox, Barry Croft Jr., Daniel Harris and Brandon Caserta are charged with a kidnapping conspiracy. Three of them also face additional charges, including conspiracy to use a weapon of mass destruction, namely an explosive.
The trial has covered 18 days since March 8, including 13 days of testimony.
Prosecutors said the conspiracy against Whitmer was fueled by anti-government extremism and anger over her COVID-19 restrictions. The men trained with a crudely built “shoot house” to replicate her vacation home in September 2020, according to testimony.
Fox and Croft, traveled to Elk Rapids, Michigan, that same weekend to see the location of the governor’s lakeside property and a nearby bridge, evidence showed. Harris and Caserta have been described as “soldiers” in the scheme.
Another man, Ty Garbin, who pleaded guilty, said the goal was to get Whitmer before the fall election and create enough chaos to create a civil war and stop Joe Biden from winning the presidency.
Defense lawyers attacked the government’s investigation and the use of a crucial informant, Dan Chappel. They claimed Chappel was the real leader, taking direction from the FBI and keeping the group on edge while recording them for months.
Croft is from Bear, Delaware, while the others are from Michigan.
Whitmer, a Democrat, rarely talks publicly about the plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
Copyright 2022 The Associated Press. All rights reserved. |
https://www.thecourier.co.uk/fp/sport/football/dundee-united/3170237/kevin-mcdonald-dundee-derby-united/ | For Kevin McDonald, it all started at Dens Park — a fresh-faced, bleach blonde midfielder making a name for himself in the old First Division.
Seventeen years after his Dee debut, the Dark Blues afforded McDonald the platform to train and rebuild his fitness as he recuperated from a life-threatening kidney transplant.
The allegiances of McDonald’s friends and family are liberally split across both sides of Tannadice Street.
As such, United star McDonald will never have a negative word to say about Dundee.
He will, of course, relish every moment of an intense, inimitable occasion — but acrimony can be cast aside.
“I’m 33 years of age and, after everything I’ve been through, I’d never say a bad word about Dundee, even as a United player,” said McDonald, who made 106 appearances for the Dee.
“That is where my journey started and I’ll always be grateful. I’ve played in plenty of derbies but this one is different, given the circumstances.
“Dundee were the first club I trained with after my [kidney] operation, as I considered what was next.
“James McPake was the manager at the time and he was brilliant with me; all the boys were great. I owe them a massive thanks.
“The same goes for St Johnstone, who allowed me to train and build my fitness, getting to a point where I could say, ‘right, let’s see where we are’.”
Friendships on hold
Indeed, the former Fulham and Scotland midfielder, who hails from Carnoustie, will achieve a lifelong goal on Saturday if he lines up against Dundee at Tannadice.
“I’ve never played in a competitive Dundee derby so that will be special,” he continued.
“All of my friends are either Dundee United or Dundee fans so there’s always that extra banter and extra rivalry in the build-up. It will be a great atmosphere through the whole city and I hope it’s a cracking spectacle.
“I’ve got a huge respect for everyone at Dundee but those friendships are irrelevant for 90 minutes.
“We’ve got to put emotion to one side and understand that three very important points are at stake.”
The race for Europe
Even a solitary point would see Dundee United secure top-six qualification for Tam Courts’ men.
That would represent a solid achievement for the Tangerines in their second season back in the Premiership.
Yet, a slight tinge of exasperation persists for McDonald.
“Honestly, it’s frustrating that we even need to get something from the derby to finish in the top-six,” McDonald told Courier Sport.
“It’s been there for us for weeks and we’ve not taken three points often enough. Too many draws. If we had turned just one of those draws into wins, we’d already be in there.”
Should United get the job done — and it would take a remarkable sequence of results for them to slip out of the top half of the table on Saturday — then attention will turn to a mouth-watering race for Europe.
Tannadice has not hosted continental competition since 2012 and, with consistency in short supply among those fighting for fourth spot, there is a golden opportunity to grasp that place.
“Although there is that frustration about some dropped points, we have ultimately put ourselves in a good position,” added McDonald. “With Europe on offer, we are playing for fourth place — albeit plenty of teams will be saying the same.”
Dundee United analysis: Has Mathew Cudjoe played his way into Tannadice derby picture? | 0 | 89,784 | 0.726785 | https://www.thecourier.co.uk/fp/sport/football/dundee-fc/3247319/dundee-star-niall-mcginn-makes-aberdeen-vow-as-ex-reds-hero-prepares-for-high-stakes-pittodrie-return/ | 2022-04-30 07:45:47+00:00 | Niall McGinn made over 350 appearances for Aberdeen and occupies a special place in the hearts of the club’s fans.
However, the 34-year-old, who still owns a house in the Granite City, will be doing everything in his power to sicken those supporters at Pittodrie this afternoon.
The Northern Irish international joined Dundee in January and will travel north to his old stomping ground as part of a Dark Blues squad staring relegation firmly in the face, sitting rock bottom of the Premiership, five points adrift of St Johnstone.
Aberdeen are also under pressure in ninth just five points ahead of Saints but McGinn insists there will be no room for sentiment from him as Dundee attempt to pull off a remarkable great escape.
McGinn said: “I had great times up there and the fans were always good to me.
“Even when I left and since leaving the messages have been unbelievable.
“I still spend a lot of time in Aberdeen and I have my house up there. I am looking forward to the game.
“I am here now and a Dundee player. I will be doing all I can to contribute and win a game of football.”
McGinn added: “I was there for a long time. Fans, rightly so, can get a wee bit anxious and frustrated if they are not doing well, creating chances or scoring goals.
“I take that as a positive because the fans come and want to see attacking football, good players getting on the ball, creating and scoring goals.
“Us being the away team and me knowing the environment and the players it is about us going there, defending right, creating and hopefully taking chances.”
The odds are firmly stacked against Dundee avoiding automatic relegation but McGinn refuses to hoist the white flag of surrender.
He added: “I definitely believe. Being a professional you are in to win games and to do well for the club.
“Looking round the changing-room there is a good squad of players who have under-achieved for most of the season. The table doesn’t lie.
‘Time is running out’
“We have struggled because we haven’t kept many clean sheets. Hopefully that can change.
“Time is running out because there are only four games left in the season.
“It is about getting as many wins as possible. We are not looking beyond going up to Aberdeen and trying to win the game.
“I am looking forward to it. I am disappointed I didn’t play earlier in the 2-2 game.
“Hopefully, I get the opportunity on Saturday. I am looking forward to seeing a few old faces and the fans again.”
PODCAST: Twa Teams, One Street – United’s Euro crunch and Dee heading doon |
https://www.thecourier.co.uk/fp/sport/football/dundee-united/3170237/kevin-mcdonald-dundee-derby-united/ | For Kevin McDonald, it all started at Dens Park — a fresh-faced, bleach blonde midfielder making a name for himself in the old First Division.
Seventeen years after his Dee debut, the Dark Blues afforded McDonald the platform to train and rebuild his fitness as he recuperated from a life-threatening kidney transplant.
The allegiances of McDonald’s friends and family are liberally split across both sides of Tannadice Street.
As such, United star McDonald will never have a negative word to say about Dundee.
He will, of course, relish every moment of an intense, inimitable occasion — but acrimony can be cast aside.
“I’m 33 years of age and, after everything I’ve been through, I’d never say a bad word about Dundee, even as a United player,” said McDonald, who made 106 appearances for the Dee.
“That is where my journey started and I’ll always be grateful. I’ve played in plenty of derbies but this one is different, given the circumstances.
“Dundee were the first club I trained with after my [kidney] operation, as I considered what was next.
“James McPake was the manager at the time and he was brilliant with me; all the boys were great. I owe them a massive thanks.
“The same goes for St Johnstone, who allowed me to train and build my fitness, getting to a point where I could say, ‘right, let’s see where we are’.”
Friendships on hold
Indeed, the former Fulham and Scotland midfielder, who hails from Carnoustie, will achieve a lifelong goal on Saturday if he lines up against Dundee at Tannadice.
“I’ve never played in a competitive Dundee derby so that will be special,” he continued.
“All of my friends are either Dundee United or Dundee fans so there’s always that extra banter and extra rivalry in the build-up. It will be a great atmosphere through the whole city and I hope it’s a cracking spectacle.
“I’ve got a huge respect for everyone at Dundee but those friendships are irrelevant for 90 minutes.
“We’ve got to put emotion to one side and understand that three very important points are at stake.”
The race for Europe
Even a solitary point would see Dundee United secure top-six qualification for Tam Courts’ men.
That would represent a solid achievement for the Tangerines in their second season back in the Premiership.
Yet, a slight tinge of exasperation persists for McDonald.
“Honestly, it’s frustrating that we even need to get something from the derby to finish in the top-six,” McDonald told Courier Sport.
“It’s been there for us for weeks and we’ve not taken three points often enough. Too many draws. If we had turned just one of those draws into wins, we’d already be in there.”
Should United get the job done — and it would take a remarkable sequence of results for them to slip out of the top half of the table on Saturday — then attention will turn to a mouth-watering race for Europe.
Tannadice has not hosted continental competition since 2012 and, with consistency in short supply among those fighting for fourth spot, there is a golden opportunity to grasp that place.
“Although there is that frustration about some dropped points, we have ultimately put ourselves in a good position,” added McDonald. “With Europe on offer, we are playing for fourth place — albeit plenty of teams will be saying the same.”
Dundee United analysis: Has Mathew Cudjoe played his way into Tannadice derby picture? | 1 | 115,539 | 0.757679 | https://www.thecourier.co.uk/fp/sport/football/dundee-fc/3178355/craziness-derby-day-upset-form-dundee-victory-mark-mcghee/ | 2022-04-09 10:27:23+00:00 | Manager Mark McGhee has urged his Dundee players to embrace the “craziness” of derby day.
The Dark Blues head to Tannadice in dire need of victory to ignite their survival bid.
McGhee’s side make the short trip across the road as the Premiership’s bottom side and will be underdogs against the country’s fourth-placed team.
But the manager of over 30 years insists the form table means nothing in a local derby.
As a player, McGhee played in Old Firm matches for Celtic and the Tyne-Wear derby for Newcastle.
He has also been an opposing player at Tannadice in the glory days of the New Firm rivalry between Aberdeen and Dundee United.
‘Craziness’
And he has charged his Dundee players with using the chaotic nature of a derby match to their advantage this weekend.
“Derbies are better games when it isn’t quite as critical,” McGhee admitted.
“But I love the Rangers-Celtic games, I love the Newcastle-Sunderland games, I’ve been involved in local derbies all through my career.
“With Aberdeen, Dundee United were probably the local derby. During our successful time, Dundee United would have been the team that beat us more than anybody.
“Local derbies for me are fantastic.
“There is a craziness about local derbies. Regardless of where you are in the league, it doesn’t always go to standard – things go right, things go wrong and it can be contrary to form.
“We hope we can use that to our advantage.”
‘They have done what we are trying to’
United can secure their place in the top six by avoiding defeat against their oldest rivals while victory would put them one step closer to fourth place and European football.
McGhee admits he’s been impressed by the approach by the Tangerines this season with a focus on strong defence keeping them high in the table.
That’s something he’d like to emulate across the road.
McGhee said: “They are organised, they are physical and athletic.
“They aren’t free-scoring but they get the job done and are sitting high in the league.
“They have done what we are trying to do in making themselves hard to beat.
“United have had a few 1-0s over the season so that shows resilience and they are prepared to grind games out.
“I’ve been impressed by them.”
Dundee derby: The Opta stats tell us how United or Dee can win crunch Tannadice clash |
https://www.thecourier.co.uk/fp/sport/football/dundee-united/3170237/kevin-mcdonald-dundee-derby-united/ | For Kevin McDonald, it all started at Dens Park — a fresh-faced, bleach blonde midfielder making a name for himself in the old First Division.
Seventeen years after his Dee debut, the Dark Blues afforded McDonald the platform to train and rebuild his fitness as he recuperated from a life-threatening kidney transplant.
The allegiances of McDonald’s friends and family are liberally split across both sides of Tannadice Street.
As such, United star McDonald will never have a negative word to say about Dundee.
He will, of course, relish every moment of an intense, inimitable occasion — but acrimony can be cast aside.
“I’m 33 years of age and, after everything I’ve been through, I’d never say a bad word about Dundee, even as a United player,” said McDonald, who made 106 appearances for the Dee.
“That is where my journey started and I’ll always be grateful. I’ve played in plenty of derbies but this one is different, given the circumstances.
“Dundee were the first club I trained with after my [kidney] operation, as I considered what was next.
“James McPake was the manager at the time and he was brilliant with me; all the boys were great. I owe them a massive thanks.
“The same goes for St Johnstone, who allowed me to train and build my fitness, getting to a point where I could say, ‘right, let’s see where we are’.”
Friendships on hold
Indeed, the former Fulham and Scotland midfielder, who hails from Carnoustie, will achieve a lifelong goal on Saturday if he lines up against Dundee at Tannadice.
“I’ve never played in a competitive Dundee derby so that will be special,” he continued.
“All of my friends are either Dundee United or Dundee fans so there’s always that extra banter and extra rivalry in the build-up. It will be a great atmosphere through the whole city and I hope it’s a cracking spectacle.
“I’ve got a huge respect for everyone at Dundee but those friendships are irrelevant for 90 minutes.
“We’ve got to put emotion to one side and understand that three very important points are at stake.”
The race for Europe
Even a solitary point would see Dundee United secure top-six qualification for Tam Courts’ men.
That would represent a solid achievement for the Tangerines in their second season back in the Premiership.
Yet, a slight tinge of exasperation persists for McDonald.
“Honestly, it’s frustrating that we even need to get something from the derby to finish in the top-six,” McDonald told Courier Sport.
“It’s been there for us for weeks and we’ve not taken three points often enough. Too many draws. If we had turned just one of those draws into wins, we’d already be in there.”
Should United get the job done — and it would take a remarkable sequence of results for them to slip out of the top half of the table on Saturday — then attention will turn to a mouth-watering race for Europe.
Tannadice has not hosted continental competition since 2012 and, with consistency in short supply among those fighting for fourth spot, there is a golden opportunity to grasp that place.
“Although there is that frustration about some dropped points, we have ultimately put ourselves in a good position,” added McDonald. “With Europe on offer, we are playing for fourth place — albeit plenty of teams will be saying the same.”
Dundee United analysis: Has Mathew Cudjoe played his way into Tannadice derby picture? | 2 | 120,538 | 0.773384 | https://www.thecourier.co.uk/fp/sport/football/dundee-fc/3183521/dundee-star-cammy-kerr-ready-for-derby-day-pelters-from-dundee-united-supporting-best-pal/ | 2022-04-10 06:02:30+00:00 | Cammy Kerr knows there will be one Dundee United fan in particular giving him pelters at Tannadice today – his best pal Jack.
Friendship will be forgotten for 90 minutes, with the defender determined to help the Dark Blues pick up a vital victory in their bid to beat the drop while his mate in tangerine will be trying to roar his favourites into the top six.
United fans are also looking to gain a measure of revenge for the “Doon Derby” at Dens in 2016 that saw the Tangerines relegated.
However, once the dust has settled this afternoon, Kerr will meet up with Jack to go for something to eat and chew over the game – no matter who has bragging rights.
Kerr, who is in his testimonial year with Dundee, said: “My best pal Jack Inglis is a big United fan and he will be abusing me for 90 minutes.
“He will be giving me it stinking, I know where he sits at Tannadice – he’s already told me where to look in the Eddie Thompson stand.
“But I’ll be avoiding looking up because I know what I’ll be getting off him.
“Do they want revenge for 2016? I won’t go too much into that. It was a good night for Dundee and we don’t want a repeat of that for our sake.
“I have so many United-supporting friends so the banter between everyone is incredible, but that’s what it’s all about.
“I’ve spotted a few of them at other derbies, giving me everything under the sun.
“But I do enjoy it, I tell them they get 90 minutes then it’s forgotten about.
“I will see Jack after the game and we’ll go for food. Whether he’s a United fan or not, we grew up together and he’s always been there for me.
“I can’t just unfriend him because he’s a United fan!”
That friendly rivalry is not unique to Kerr and his pals with similar stories all over the City of Discovery.
‘Friendly rivalry’
And the full-back admitted that is just one more reason to ensure rock bottom Dundee remain in the Premiership so there will be more derbies next season.
Kerr added: “There will be so many people in Dundee in the same boat this weekend.
“They’ll meet up on Saturday morning, go to the pub, put a bet on and the loser will come back after the game to pay up.
“That’s what it’s all about. As much as for 90 minutes Dundee hate United and United hate Dundee, it’s a friendly rivalry and that’s important.
“On Saturday night everyone will be mixing together and there will be loads of banter – just the way it should be.
“Hopefully we can make sure the derbies are still around in the league next season.”
Kerr is fully aware that if it is to happen, Dundee simply have to start winning games.
He added: “There’s no beating around the bush, it’s crunch time for everyone.
“We are under no illusions about how big a game this is – we have to get a result.
“The longer you go without winning there becomes less of a margin for error, so we know that and we have to deal with that.
“You can put all the pressure in the world on yourself but we have to just focus on the game of football.”
Dundee United v Dundee: Key battles in Saturday’s crunch derby clash |
https://www.thecourier.co.uk/lifestyle/3172391/former-rugby-league-player-rob-burrow-absolutely-honoured-to-receive-mbe/ | Former rugby league player Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.”
After the ceremony his wife Lindsey, who was joined by her husband’s parents Geoff and Irene Burrow, said: “It’s just a really proud honourable moment, just to be here with Rob, in recognition of all that he’s done – just incredibly proud.
“Rob would say himself he accepts this award on behalf of the MND community, all the work that’s been going on in Rob’s name to help the families – that’s why we’re doing this. It’s lovely to get these awards but it’s about the other people who are suffering with this disease.”
Burrow’s former teammate Kevin Sinfield has raised millions in support of MND with a series of gruelling challenges and was recently made an OBE for his work.
Chris James, from the MND Association, joined the former player and his family at Windsor Castle and said Rob’s efforts had encouraged others to fundraise for the charity.
He said: “I think what Rob has managed to do is incredibly brave, to live his journey with MND in the public eye as he had done. He’s done a huge amount to raise awareness of MND which is a disease that doesn’t get as much attention as other diseases.
“We know that directly as a result of Rob’s awareness raising that the MND Association has raised over £4 million pounds as a result of this.”
Burrow speaks using an electronic system where his eye movements over letters creates words and he recorded a message that was played to Anne when he received his MBE.
His wife said: “I didn’t actually go with Rob when he got his award, but he did write a little message to Her Royal Highness.
“It just said he was honoured to be here and he loved Windsor Castle and it was lovely because she’s a patron of the MND (Association) so that’s really nice.” | 0 | 26,025 | 0 | https://www.pressandjournal.co.uk/news/uk/4137125/former-rugby-league-player-rob-burrow-absolutely-honoured-to-receive-mbe/ | 2022-04-05 23:33:37+00:00 | Former rugby league player Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.”
After the ceremony his wife Lindsey, who was joined by her husband’s parents Geoff and Irene Burrow, said: “It’s just a really proud honourable moment, just to be here with Rob, in recognition of all that he’s done – just incredibly proud.
“Rob would say himself he accepts this award on behalf of the MND community, all the work that’s been going on in Rob’s name to help the families – that’s why we’re doing this. It’s lovely to get these awards but it’s about the other people who are suffering with this disease.”
Burrow’s former teammate Kevin Sinfield has raised millions in support of MND with a series of gruelling challenges and was recently made an OBE for his work.
Chris James, from the MND Association, joined the former player and his family at Windsor Castle and said Rob’s efforts had encouraged others to fundraise for the charity.
He said: “I think what Rob has managed to do is incredibly brave, to live his journey with MND in the public eye as he had done. He’s done a huge amount to raise awareness of MND which is a disease that doesn’t get as much attention as other diseases.
“We know that directly as a result of Rob’s awareness raising that the MND Association has raised over £4 million pounds as a result of this.”
Burrow speaks using an electronic system where his eye movements over letters creates words and he recorded a message that was played to Anne when he received his MBE.
His wife said: “I didn’t actually go with Rob when he got his award, but he did write a little message to Her Royal Highness.
“It just said he was honoured to be here and he loved Windsor Castle and it was lovely because she’s a patron of the MND (Association) so that’s really nice.” |
https://www.thecourier.co.uk/lifestyle/3172391/former-rugby-league-player-rob-burrow-absolutely-honoured-to-receive-mbe/ | Former rugby league player Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.”
After the ceremony his wife Lindsey, who was joined by her husband’s parents Geoff and Irene Burrow, said: “It’s just a really proud honourable moment, just to be here with Rob, in recognition of all that he’s done – just incredibly proud.
“Rob would say himself he accepts this award on behalf of the MND community, all the work that’s been going on in Rob’s name to help the families – that’s why we’re doing this. It’s lovely to get these awards but it’s about the other people who are suffering with this disease.”
Burrow’s former teammate Kevin Sinfield has raised millions in support of MND with a series of gruelling challenges and was recently made an OBE for his work.
Chris James, from the MND Association, joined the former player and his family at Windsor Castle and said Rob’s efforts had encouraged others to fundraise for the charity.
He said: “I think what Rob has managed to do is incredibly brave, to live his journey with MND in the public eye as he had done. He’s done a huge amount to raise awareness of MND which is a disease that doesn’t get as much attention as other diseases.
“We know that directly as a result of Rob’s awareness raising that the MND Association has raised over £4 million pounds as a result of this.”
Burrow speaks using an electronic system where his eye movements over letters creates words and he recorded a message that was played to Anne when he received his MBE.
His wife said: “I didn’t actually go with Rob when he got his award, but he did write a little message to Her Royal Highness.
“It just said he was honoured to be here and he loved Windsor Castle and it was lovely because she’s a patron of the MND (Association) so that’s really nice.” | 1 | 84,338 | 0.145912 | https://www.dailymail.co.uk/wires/pa/article-10688805/Former-rugby-league-player-Rob-Burrow-absolutely-honoured-receive-MBE.html?ns_mchannel=rss&ns_campaign=1490&ito=1490 | 2022-04-05 17:49:28+00:00 | Former rugby league player Rob Burrow `absolutely honoured´ to receive MBE
Former Rugby League legend Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.”
After the ceremony his wife Lindsey, who was joined by her husband’s parents Geoff and Irene Burrow, said: “It’s just a really proud honourable moment, just to be here with Rob, in recognition of all that he’s done – just incredibly proud.
“Rob would say himself he accepts this award on behalf of the MND community, all the work that’s been going on in Rob’s name to help the families – that’s why we’re doing this. It’s lovely to get these awards but it’s about the other people who are suffering with this disease.”
Burrow’s former teammate Kevin Sinfield has raised millions in support of MND with a series of gruelling challenges and was recently made an OBE for his work.
Chris James, from the MND Association, joined the former player and his family at Windsor Castle and said Rob’s efforts had encouraged others to fundraise for the charity.
He said: “I think what Rob has managed to do is incredibly brave, to live his journey with MND in the public eye as he had done. He’s done a huge amount to raise awareness of MND which is a disease that doesn’t get as much attention as other diseases.
“We know that directly as a result of Rob’s awareness raising that the MND Association has raised over £4 million pounds as a result of this.”
Burrow speaks using an electronic system where his eye movements over letters creates words and he recorded a message that was played to Anne when he received his MBE.
His wife said: “I didn’t actually go with Rob when he got his award, but he did write a little message to Her Royal Highness.
“It just said he was honoured to be here and he loved Windsor Castle and it was lovely because she’s a patron of the MND (Association) so that’s really nice.” |
https://www.thecourier.co.uk/lifestyle/3172391/former-rugby-league-player-rob-burrow-absolutely-honoured-to-receive-mbe/ | Former rugby league player Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.”
After the ceremony his wife Lindsey, who was joined by her husband’s parents Geoff and Irene Burrow, said: “It’s just a really proud honourable moment, just to be here with Rob, in recognition of all that he’s done – just incredibly proud.
“Rob would say himself he accepts this award on behalf of the MND community, all the work that’s been going on in Rob’s name to help the families – that’s why we’re doing this. It’s lovely to get these awards but it’s about the other people who are suffering with this disease.”
Burrow’s former teammate Kevin Sinfield has raised millions in support of MND with a series of gruelling challenges and was recently made an OBE for his work.
Chris James, from the MND Association, joined the former player and his family at Windsor Castle and said Rob’s efforts had encouraged others to fundraise for the charity.
He said: “I think what Rob has managed to do is incredibly brave, to live his journey with MND in the public eye as he had done. He’s done a huge amount to raise awareness of MND which is a disease that doesn’t get as much attention as other diseases.
“We know that directly as a result of Rob’s awareness raising that the MND Association has raised over £4 million pounds as a result of this.”
Burrow speaks using an electronic system where his eye movements over letters creates words and he recorded a message that was played to Anne when he received his MBE.
His wife said: “I didn’t actually go with Rob when he got his award, but he did write a little message to Her Royal Highness.
“It just said he was honoured to be here and he loved Windsor Castle and it was lovely because she’s a patron of the MND (Association) so that’s really nice.” | 2 | 67,032 | 0.153557 | https://www.shropshirestar.com/news/uk-news/2022/04/05/former-rugby-league-player-rob-burrow-absolutely-honoured-to-receive-mbe/ | 2022-04-05 16:40:04+00:00 | Former Rugby League legend Rob Burrow has described his shock at being made an MBE by the Princess Royal saying he was “absolutely honoured”.
Burrow, 39, had an illustrious playing career with Leeds Rhinos but his battles off the pitch, after being diagnosed with Motor Neurone Disease (MND) in 2019, has endeared him to sports fans and the general public alike.
He won eight Grand Finals and 20 international caps during his playing days and his efforts raising awareness about MND and his sporting achievements have been recognised with the MBE.
Burrow also paid tribute to his wife Lindsey, saying the day had given his partner the chance to “get dressed up” and indulge in some “escapism” away from her normal role looking after her husband.
The former sportsman, who now uses a wheelchair and speaks with the aid of a special machine, said: “I’m shocked to be accepting the MBE award, it’s not something that was on the list of things that I wanted to achieve but I am absolutely honoured to receive this award.
“Any excuse to see my wife get dressed up in the dresses she deserves to be, I hope she enjoys the occasion like me.
“I’ve always got a kick out of giving close ones that experience like no other. It gives my Lindsey escapism from a normal day-to-day management of looking after me.
“I’m so proud to receive this because of my rugby and the awareness for MND, this most importantly means that MND continues to be talked about and keeping it in the public (eye).
“I’m blown away by the response to me getting the disease and I hope they know – it’s all for you.” |
https://www.legacy.com/us/obituaries/cumberlink/name/romaine-sunday-obituary?id=11036020 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
Funeral services provided by:
Parthemore Funeral Home & Cremation Services Inc
MAKE A DONATION
MEMORIES & CONDOLENCES
Sponsored by Parthemore Funeral Home & Cremation Services Inc.
1 Entry
So sorry to hear of your passing Aunt Romaine. I was hoping for a few more visits before these times come. You were such a great person to know and talk to. I will for sure miss all the conversations about your brothers, my dad included. rest in peace, Aunt Romaine. | 0 | 18,279 | 0.591481 | https://www.legacy.com/us/obituaries/beatricedailysun/name/carolyn-eltiste-obituary?id=7753957 | 2022-04-09 15:47:55+00:00 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
Funeral services provided by:
Wherry Mortuary - TECUMSEH
MAKE A DONATION
MEMORIES & CONDOLENCES
Sponsored by Wherry Mortuary - TECUMSEH.
2 Entries
I am so sorry you have lost such a special person. Such shock for those of us in the Auburn area. She will be missed by so many.
Pat Lunzmann
March 18, 2021
To my beautiful and dear sister, I simply cannot grasp that you´re no longer here. I know you are with our Lord Jesus Christ but my pain-like that of the hundreds of people whose lives you touched-runs very deep. I miss you terribly. Much love. |
https://www.legacy.com/us/obituaries/cumberlink/name/romaine-sunday-obituary?id=11036020 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
Funeral services provided by:
Parthemore Funeral Home & Cremation Services Inc
MAKE A DONATION
MEMORIES & CONDOLENCES
Sponsored by Parthemore Funeral Home & Cremation Services Inc.
1 Entry
So sorry to hear of your passing Aunt Romaine. I was hoping for a few more visits before these times come. You were such a great person to know and talk to. I will for sure miss all the conversations about your brothers, my dad included. rest in peace, Aunt Romaine. | 1 | 74,087 | 0.594687 | https://www.legacy.com/us/obituaries/wacotrib/name/helen-wooten-obituary?pid=200285336 | 2022-04-16 06:11:59+00:00 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
MAKE A DONATION
MEMORIES & CONDOLENCES
2 Entries
Craig and Val, I am so sorry for your loss. I will forever remember your mom's sweet smile. You are very fortunate to have had her for so long. She was am awesome lady. My thoughts and prayers are with you and your family. I love you guys.
Pete Rowe
Friend
October 4, 2021
May God rest her soul. What a beautiful Lady she was. |
https://www.legacy.com/us/obituaries/cumberlink/name/romaine-sunday-obituary?id=11036020 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
Funeral services provided by:
Parthemore Funeral Home & Cremation Services Inc
MAKE A DONATION
MEMORIES & CONDOLENCES
Sponsored by Parthemore Funeral Home & Cremation Services Inc.
1 Entry
So sorry to hear of your passing Aunt Romaine. I was hoping for a few more visits before these times come. You were such a great person to know and talk to. I will for sure miss all the conversations about your brothers, my dad included. rest in peace, Aunt Romaine. | 2 | 142,869 | 0.633756 | https://www.legacy.com/us/obituaries/omaha/name/lori-naill-obituary?id=5844428 | 2022-04-12 08:11:17+00:00 | To plant trees in memory, please visit the Sympathy Store.
MEMORIAL EVENTS
To offer your sympathy during this difficult time, you can now have memorial trees planted in a National Forest in memory of your loved one.
Funeral services provided by:
Heafey Hoffmann Dworak Cutler Mortuaries
MAKE A DONATION
MEMORIES & CONDOLENCES
Sponsored by Heafey Hoffmann Dworak Cutler Mortuaries.
2 Entries
Lori It has been 9 months, since you went to heaven. I miss you everyday. See you when I see you.
Vic Valenzuela
March 8, 2022
God Rest Your Soul , Lori , you always said I was like a sister , go with God , no more struggling with your health , no more pain , until we meet again beyond Heavens Doors . |
https://www.thestar.co.uk/news/people/kate-josephs-secrecy-surrounds-fines-over-her-leaving-party-which-breached-covid-19-rules-she-helped-create-3642420 | Kate Josephs: Secrecy surrounds fines over her leaving party which breached Covid-19 rules she helped create
Attendees of a leaving party for Kate Joseph’s before she took up her new role at the helm of Sheffield City Council have been handed Covid-19 fines for breaching restrictions, it is reported.
Ms Josephs, who at the time was leaving her role as director-general of the Covid-19 taskforce, is currently suspended as Chief Executive of Sheffield City Council, which pays £190,000 a year.
It means she would have played a key role in writing the lockdown rules that were enforced across the country when her leaving party took place.
Fixed penalty notices have been issued against attendees, according to media reports.
However, it is not known if Ms Josephs herself has been fined, with the Met, which has investigated alleged breaches at Government gatherings, having not named anybody involved.
Sheffield Council has also refused to reveal any information.
Now, readers of The Star have had their say on the scandal, which has seen officials call for Ms Josephs’ resignation.
“Before people comment as to why she should still be in a job its simple,” reader Malcolm Wood said. “She was not convicted of anything. (If) she has received a Fixed Penalty Notice, many people on here have had them for driving offences. It’s not right or just but it is the law. Also the offences took place under her previous job so she cannot be dismissed for misconduct of another job.”
In response, another reader, Steve Platts, wrote: “If (for example) a police officer had broken the law, I wouldn’t expect them to get away with nothing more than a fine and some weak apology, I’d expect them to be sacked. This is the same for Kate Josephs, she’s not some ‘lackey’ with little to no responsibility, she the head of the Covid taskforce and someone who should’ve being leading by example.
“Why should anybody at all have been expected to follow the rules, when the very people issuing them, didn’t follow them?”
Both Ms Josephs and the city council have been criticised for “secrecy” over the scandal.
Before the leaving do was revealed by the press almost a year after it happened, Ms Josephs posted a statement on social media saying she gathered with colleagues for drinks in the Cabinet Office, and apologised.
She has not responded to media inquiries about the fine.
Meanwhile, the council brought in an external investigator, who has not been named, to report back to a cross party committee with findings to inform their decision on what should be done.
Who the investigator is and what their remit is has been kept secret by the local authority.
The committee met in private last week to discuss the investigation but the council said it will not share any information.
“What a farce,” commented Star reader Matthew Eyre.
“Is this the standard we should expect from those in public office?” said reader Richard Perry.
A Freedom of Information request confirmed Sheffield Council does hold correspondence with the Cabinet Office about the event but it is withholding it, arguing that keeping it secret is in the public interest.
The committee comprises of councillors Penny Baker, Douglas Johnson, Shaffaq Mohammed and Sioned-Mair Richards and it is chaired by Councillor Julie Grocutt. | 0 | 137,981 | 0.493684 | https://www.thestar.co.uk/news/politics/kate-josephs-covid-19-partygate-fines-issued-for-sheffield-council-boss-leaving-do-3640953 | 2022-04-05 21:33:48+00:00 | Kate Josephs: Covid-19 partygate fines issued for Sheffield Council boss’ leaving do
The Metropolitan Police has dealt Covid-19 fines to people involved in Kate Josephs’ Cabinet Office leaving party, according to reports.
The Telegraph reported that fixed penalty notices were issued to attendees of Ms Josephs’ farewell party when she left the Cabinet Office in December 2020 before taking up her current role as chief executive of Sheffield Council.
Dozens of officials were said to have attended and it is not yet clear whether Ms Josephs, who was head of the Covid Taskforce and responsible for writing the lockdown rules at the time, received a fine.
Just before the leaving do was exposed in the press, Ms Josephs posted a statement on social media saying she gathered with colleagues for drinks in the Cabinet Office and apologised.
At the time of the event, people in London were banned from socialising indoors away from their household or support bubble.
The chief executive is currently on paid leave from her £190,000 a year council role while Eugene Walker, a senior council officer who is normally paid around £150,000 a year, is covering for her on extra pay – the amount of which has not yet been confirmed.
Secrecy around Kate Josephs’ party
Ms Josephs has not responded to media inquiries about the fine. Those who do receive one are not obliged to inform their employer and their names will not be made public by police.
The Met Police and Sheffield Council have also refused to reveal any information.
The council brought in an external investigator, who has not been named, to report back to a cross party committee with findings to inform their decision on what should be done.
Who the investigator is, what their remit and other information is has been kept secret by the local authority.
The committee met in private last week to discuss the investigation but the council said it will not share any information.
The committee comprises councillors: Penny Baker, Douglas Johnson, Shaffaq Mohammed and Sioned-Mair Richards and it is chaired by Coun Julie Grocutt.
A Freedom of Information request confirmed Sheffield Council does hold correspondence with the Cabinet Office about the event but it is withholding it, arguing that keeping it secret is in the public interest. |
https://www.thestar.co.uk/news/people/kate-josephs-secrecy-surrounds-fines-over-her-leaving-party-which-breached-covid-19-rules-she-helped-create-3642420 | Kate Josephs: Secrecy surrounds fines over her leaving party which breached Covid-19 rules she helped create
Attendees of a leaving party for Kate Joseph’s before she took up her new role at the helm of Sheffield City Council have been handed Covid-19 fines for breaching restrictions, it is reported.
Ms Josephs, who at the time was leaving her role as director-general of the Covid-19 taskforce, is currently suspended as Chief Executive of Sheffield City Council, which pays £190,000 a year.
It means she would have played a key role in writing the lockdown rules that were enforced across the country when her leaving party took place.
Fixed penalty notices have been issued against attendees, according to media reports.
However, it is not known if Ms Josephs herself has been fined, with the Met, which has investigated alleged breaches at Government gatherings, having not named anybody involved.
Sheffield Council has also refused to reveal any information.
Now, readers of The Star have had their say on the scandal, which has seen officials call for Ms Josephs’ resignation.
“Before people comment as to why she should still be in a job its simple,” reader Malcolm Wood said. “She was not convicted of anything. (If) she has received a Fixed Penalty Notice, many people on here have had them for driving offences. It’s not right or just but it is the law. Also the offences took place under her previous job so she cannot be dismissed for misconduct of another job.”
In response, another reader, Steve Platts, wrote: “If (for example) a police officer had broken the law, I wouldn’t expect them to get away with nothing more than a fine and some weak apology, I’d expect them to be sacked. This is the same for Kate Josephs, she’s not some ‘lackey’ with little to no responsibility, she the head of the Covid taskforce and someone who should’ve being leading by example.
“Why should anybody at all have been expected to follow the rules, when the very people issuing them, didn’t follow them?”
Both Ms Josephs and the city council have been criticised for “secrecy” over the scandal.
Before the leaving do was revealed by the press almost a year after it happened, Ms Josephs posted a statement on social media saying she gathered with colleagues for drinks in the Cabinet Office, and apologised.
She has not responded to media inquiries about the fine.
Meanwhile, the council brought in an external investigator, who has not been named, to report back to a cross party committee with findings to inform their decision on what should be done.
Who the investigator is and what their remit is has been kept secret by the local authority.
The committee met in private last week to discuss the investigation but the council said it will not share any information.
“What a farce,” commented Star reader Matthew Eyre.
“Is this the standard we should expect from those in public office?” said reader Richard Perry.
A Freedom of Information request confirmed Sheffield Council does hold correspondence with the Cabinet Office about the event but it is withholding it, arguing that keeping it secret is in the public interest.
The committee comprises of councillors Penny Baker, Douglas Johnson, Shaffaq Mohammed and Sioned-Mair Richards and it is chaired by Councillor Julie Grocutt. | 1 | 15,572 | 0.499769 | https://www.thestar.co.uk/news/crime/kate-josephs-sheffield-council-boss-who-wrote-nations-covid-19-restrictions-fined-over-leaving-do-3653893 | 2022-04-13 19:11:48+00:00 | Kate Josephs: Sheffield Council boss who wrote nation's Covid-19 restrictions fined over leaving do
Kate Josephs, chief executive of Sheffield Council, has been fined over her leaving do when she left her role as director-general of Whitehall’s Covid-19 taskforce.
Ms Josephs was in charge of writing lockdown laws before she took up her new role at the helm of the city council for £190,000.
However, as The Star revealed in January this year, the ex-director-general attended a ‘boozy’ leaving do with “dozens of officials” as she left her post on December 17, 2020.
Now, The Telegraph reports the ex-director-general was fined £50 by the Met Police in the first wave of penalties at the end of March over the ‘Partygate’ investigation.
Both Ms Josephs and the city council have been criticised for “secrecy” over the scandal.
Before the leaving do was revealed by the press almost a year after it happened, Ms Josephs posted a statement on social media saying she gathered with colleagues for drinks in the Cabinet Office.
Ms Josephs issued a public apology for her part in the event, saying she was "truly sorry" about her participation.
She has been on paid leave from her £190,000-a-year job since then.
In her job, she would have played a key role in writing the lockdown rules that were enforced across the country when her leaving party took place.
It was also revealed last week the official was under “no obligation” to inform the council if she was fined. She also declined to comment to any media enquiries.
The Telegraph reports she was issued an FPN on April 1, which has been paid, according to “sources close to the investigation”.
Meanwhile, the council brought in an external investigator, who was not named, to report back to a cross party committee with findings to inform their decision on what should be done.
Who the investigator is and what their remit was has been kept secret by the local authority.
The committee met in private in late March to discuss the investigation but the council said it will not share any information.
The committee is chaired by councillor Julie Grocutt, with councillors Penny Baker, Douglas Johnson, Shaffaq Mohammed and Sioned-Mair Richards.
Senior director Eugene Walker has been given a salary top-up to cover the CEO role in her absence. |
https://www.thestar.co.uk/news/people/kate-josephs-secrecy-surrounds-fines-over-her-leaving-party-which-breached-covid-19-rules-she-helped-create-3642420 | Kate Josephs: Secrecy surrounds fines over her leaving party which breached Covid-19 rules she helped create
Attendees of a leaving party for Kate Joseph’s before she took up her new role at the helm of Sheffield City Council have been handed Covid-19 fines for breaching restrictions, it is reported.
Ms Josephs, who at the time was leaving her role as director-general of the Covid-19 taskforce, is currently suspended as Chief Executive of Sheffield City Council, which pays £190,000 a year.
It means she would have played a key role in writing the lockdown rules that were enforced across the country when her leaving party took place.
Fixed penalty notices have been issued against attendees, according to media reports.
However, it is not known if Ms Josephs herself has been fined, with the Met, which has investigated alleged breaches at Government gatherings, having not named anybody involved.
Sheffield Council has also refused to reveal any information.
Now, readers of The Star have had their say on the scandal, which has seen officials call for Ms Josephs’ resignation.
“Before people comment as to why she should still be in a job its simple,” reader Malcolm Wood said. “She was not convicted of anything. (If) she has received a Fixed Penalty Notice, many people on here have had them for driving offences. It’s not right or just but it is the law. Also the offences took place under her previous job so she cannot be dismissed for misconduct of another job.”
In response, another reader, Steve Platts, wrote: “If (for example) a police officer had broken the law, I wouldn’t expect them to get away with nothing more than a fine and some weak apology, I’d expect them to be sacked. This is the same for Kate Josephs, she’s not some ‘lackey’ with little to no responsibility, she the head of the Covid taskforce and someone who should’ve being leading by example.
“Why should anybody at all have been expected to follow the rules, when the very people issuing them, didn’t follow them?”
Both Ms Josephs and the city council have been criticised for “secrecy” over the scandal.
Before the leaving do was revealed by the press almost a year after it happened, Ms Josephs posted a statement on social media saying she gathered with colleagues for drinks in the Cabinet Office, and apologised.
She has not responded to media inquiries about the fine.
Meanwhile, the council brought in an external investigator, who has not been named, to report back to a cross party committee with findings to inform their decision on what should be done.
Who the investigator is and what their remit is has been kept secret by the local authority.
The committee met in private last week to discuss the investigation but the council said it will not share any information.
“What a farce,” commented Star reader Matthew Eyre.
“Is this the standard we should expect from those in public office?” said reader Richard Perry.
A Freedom of Information request confirmed Sheffield Council does hold correspondence with the Cabinet Office about the event but it is withholding it, arguing that keeping it secret is in the public interest.
The committee comprises of councillors Penny Baker, Douglas Johnson, Shaffaq Mohammed and Sioned-Mair Richards and it is chaired by Councillor Julie Grocutt. | 2 | 27,226 | 0.548504 | https://www.examinerlive.co.uk/news/local-news/council-boss-who-drafted-covid-23689930 | 2022-04-14 11:04:51+00:00 | Sheffield's council boss who helped craft laws banning people from mixing indoors has been fined for breaking the same rules she drafted.
Kate Josephs, who now works as chief executive of Sheffield Council was the director general of the Cabinet Office Covid19 task force until December 2020.
She has been at the centre of a controversy since it emerged she threw a leaving party at the end of her time in Whitehall, before joining Sheffield City Council, while London was still under strick lockdown rules. Now the Telegraph has reported that Ms Josephs has been fined by the Met police, and was among the first tranche of fines issued late last month.
Earlier this year, Ms Josephs issued a public apology after details of her boozy leaving party were published in the media. In a statement released on January 14, this year, Ms Josephs expressed regret, writing: "On the evening of Dec 17, I gathered with colleagues that were at work that day, with drinks, in our office in the Cabinet Office to mark my leaving the Civil Service.
""I am truly sorry that I did this and for the anger that people will feel as a result."
What do you think about this story? Tell us in the comments below.
She has been on paid leave from her £190,000-a-year job at the helm of Sheffield council since then, and the council roped in an external but unnamed investigator to report back to a cross party committee with findings which can inform council on what decision it should make.
And, now, the Telegraph reports that Ms Josephs was issued a fine for the party. According to the report, Ms Josephs received a fixed penalty notice on April 1. Sources close to the investigation say the fine has already been paid.
Ms Josephs, who was a Companion of the Order of the Bath in the Queen's Birthday honours last year did not respond when the Telegraph reached out to her for comment. |
https://wcfcourier.com/news/national/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall/article_be309875-0431-5a20-8e8e-55c15bf74cab.html | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia's invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel's “The Fight of Our Lives.” Mendel served as Zelenskyy's press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy's meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal's announcement reads in part.
People are also reading…
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.”
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. | 0 | 41,645 | 0 | https://siouxcityjournal.com/news/national/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall/article_e75bb886-978b-55a5-b092-7f14773c640f.html | 2022-04-06 13:53:23+00:00 | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia's invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel's “The Fight of Our Lives.” Mendel served as Zelenskyy's press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy's meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal's announcement reads in part.
People are also reading…
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.”
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. |
https://wcfcourier.com/news/national/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall/article_be309875-0431-5a20-8e8e-55c15bf74cab.html | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia's invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel's “The Fight of Our Lives.” Mendel served as Zelenskyy's press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy's meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal's announcement reads in part.
People are also reading…
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.”
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. | 1 | 90,449 | 0.043358 | https://wtmj.com/entertainment/2022/04/06/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall-2/ | 2022-04-06 17:09:25+00:00 | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia’s invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel’s “The Fight of Our Lives.” Mendel served as Zelenskyy’s press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy’s meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal’s announcement reads in part.
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.”
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. |
https://wcfcourier.com/news/national/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall/article_be309875-0431-5a20-8e8e-55c15bf74cab.html | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia's invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel's “The Fight of Our Lives.” Mendel served as Zelenskyy's press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy's meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal's announcement reads in part.
People are also reading…
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.”
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. | 2 | 961 | 0.059803 | https://www.siouxlandproud.com/entertainment-news/former-zelenskyy-aide-iuliia-mendel-has-book-out-this-fall/ | 2022-04-07 10:13:18+00:00 | NEW YORK (AP) — A journalist and former aide to Ukrainian President Volodymyr Zelenskyy has a book coming out this fall, one of the first announced releases about Zelenskyy and Russia’s invasion of Ukraine.
One Signal Publishers announced Wednesday that it had acquired Iuliia Mendel’s “The Fight of Our Lives.” Mendel served as Zelenskyy’s press secretary and spokesperson from 2019-2021 and has been sending dispatches about the war to the Washington Post. According to One Signal, a Simon & Schuster imprint, Mendel will write about everything from Zelenskyy’s meetings with Soviet leader Vladimir Putin to the phone calls with then-President Donald Trump that led to his impeachment for trying to pressure Zelenskyy into investigating Joe Biden.
Mendel also will write on the “massive economic problems facing Ukraine, entrenched corrupt oligarchs in league with Russia, and — in shades of the United States’ recent federal election — the Kremlin’s repeated attacks to discredit Zelenskyy through disinformation and an army of bots and trolls,” One Signal’s announcement reads in part.
Mendel, 35, has written for the Post and The New York Times among others.
“I’ve dreamed all my life of telling the story of Ukraine. It’s a triumphant one.” Mendel said in a statement. “A story not of victims, but of heroes in defense of freedom. Now, as Ukraine, the largest of the post-Soviet republics, stands up for democracy against the Russian army for all to see, I can finally share that story with the world.” |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.